ML20138F850
| ML20138F850 | |
| Person / Time | |
|---|---|
| Site: | Hope Creek  |
| Issue date: | 11/30/1985 |
| From: | SOURCE TECHNOLOGIES, INC. |
| To: | |
| Shared Package | |
| ML20138F843 | List: |
| References | |
| PROC-851130, NUDOCS 8512160183 | |
| Download: ML20138F850 (117) | |
Text
-_
O OFFSITE DOSE CALCULATION MANUAL FOR PUBLIC SERVICE ELECTRIC AND GAS COMPANY HOPE CREEK GENERATING STATION b
O Revision 1 NOVEMBER, 1985 Prepared by SOURCE TECHNOLOGIES, INC.
Quantum Technology Division 830 Franklin Court C. Marietta, Georgia 30067
, 5 k2 DO A
)
p-..
TABLE OF CONTENTS Page List of Tables iii List of Figures iv References v
1.0 INTRODUCTION
1.0-1 2.0 LIQUID EFFLUENTS ,
2.0-1 2.1 Liquid Effluent Moniter Setpoint Calculations 2.0-1 2.1.1. Liquid Radwaste Discharge Line Monitor 2.0 2.1.1.1 Releases of Single Liquid Radwaste Streams 2.0-3 2.1.1.2 Simultaneous Releases of Liquid Radwaste Streams 2.0-11.
2.1.2 Cooling Tower Blowdown Line Effluent Monitor 2.0-12
, (^N, q,j 2.2 Liquid Effluent Dose Calculations 2.0-15 2.3 Definitions of Liquid Effluent Terms 2.0-24 3.0 GASEOUS EFFLUENTS 3.0-1 3.1 Gaseous Effluent Monitor Setpoint
' Calculations 3.0-1 3.1.1 Normal Setpoint Method 3.0-2 3.1.2 Startup Setpoint Method 3.0-5 3.2 Gaseous Effluent Dose Calculations 3.0-8 3.2.1 Site Boundary Dose 3.0-8 3.2.2 Air Dose 3.0-10 3.2.3 Dose to a Member of the Public 3.0-11 3.3 Meteorological Model 3.0-48 3.4 Definitions of Gaseous Effluents Terms 3.0-53 Quantum:HCGS ODCM i -
Rev. 1, 11/85
[
?
V
. TABLE OF CONTENTS (continued)
Page 4.0. SPECIAL DOSE CALCULATIONS 4.0-1 I
4.1 Necessity of Operating Effluent Treatment Systems 4.0-1 4.1.1 Liquid Radwaste Treatment System 4.0-1 4.1.2 Ventilation Exhaust Treatment System 4.0-3 4.1.3 Gaseous Radwaste Treatment System 4.0-4 4.2 Total Fuel Cycle Dose 4.0-8 s4.3-Initial Evaluation of Unplanned Gaseous Releases 4.0-9 4.4 Dose to a Member of-the Public Due to Activities Inside the Site Boundary 4.0-17 O
s l 5.0 .1ADIOLOGICAL ENVIRONMENTAL MONITORING-PROGRAM 5.0-1 -
5.1 Sampling Program 5.0-1 5.2.Interlaboratory Comparison Program 5.0-13 l
l O
Quantum:HCGS ODCM ii Rev. 1, 11/85 1
l I
t
(/o)
LIST OF TABLES Number Title Page 2.1-1 Maximum Permissible Concentration of Dissolved or Entrained Noble Gases Released from the Site to Unrestricted Areas in Liquid Waste 2.0-13 2.1-2 Maximum Discharge Capacity of Liquid Radwaste Streams for the. Hope Creek Generating Station 2.0-14
.2.2-1 Site Related Ingestion Dose Commitment Factor, A 2.0-19 it 2.2-2 Bioaccumulation Factors 2.0-21 2.2-3 Adult Ingestion Dose Factors 2.0-22 3.1-1 Dose Factors for Exposure to a Semi-Infinite
,r 's Cloud of Noble Gases 3.0-7
_('
3.2-1 Pathway-Dose-Factors for Section 3.2.1.b (Pio) 3.0-14 3.2 Pathway Dose Factors for-Section 3.2.3 (R ijo) 3.0-22 3.2-3 Parameters Used in Dose Factor Calculations. 3.0-44 4.3-1 Infant Pathway Dose Factors for Section 4.3 (R ij) 4.0-10 4.3-2 Child Pathway Dose Factors for Section 4.3 (R ij) 4.0-13 5.0-1 Radiological Environmental Monitoring Program 5.0-2 A
U
-Quantum:HCGS ODCM iii Rev. 1, 11/85
. = . . - . . .- -. . . _
i P >
LIST OF FIGURES Number Title Page
- 4.1-1 Liquid.Radwaste Treatment System 4.0-5
' 4.1-2 Ventilation Exhaust Treatment System 4.0-6 4.1 Gaseous Radwaste Treatment System 4.0-7 5.1- 1 Onsite Sampling Locations, Artificial Island 5.0-11 5 .~ 1 - 2 ' offsite Sampling Locations, Artificial Island 5.0-12 r
p-V f
f -e O
j- Quantum:HCGS ODCM iv Rev. 1, 11/85
- - . . - - . - - - . . . - . . . _ - , . . - , , . . - . - . . _ . _ . . - . - . = - - - - .
REFERENCES 1
The following documents are referred to by number in the text of this Manual.
l
- 1. 'Ra'diological Effluent Technical Specifications, Hope Creek '
Generating Station, Draft, March 1985. !
- 2. Final Safety Analysis Report, Hope Creek Generating Station, updated through Amendment 9.
3.- Applicant's Environmental' Report - Operating License Stage, Hope Creek Generating Station, updated through Amendment 4.
~
r
- 4. U. S. Nuclear Regulatory Commission, " Calculation of Annual i Doses to Man from Routine Releases of Reactor Effluents for.the Purpose of Evaluating Compliance with 10 CFR Part 50,. Appendix I," Regulatory Guide 1.109, Revision 1, 1977.
- 5. .U. S. Nuclear Regulatory Commission, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents sj in Routine Releases from Light-Water-Cooled Reactors,"
Regulatory Guide--l.111, Revision.1, 1977. -
l 4
- 6. U. S.. Nuclear' Regulatory Commission, " Preparation of Radio- I logical-Effluent Technical Specifications for Nuclear Power- i
' Plants," USNRC Rept. NUREG-0133, 1978.
4 7. " Artificial Island Radiological Environmental Monitoring Program - 1983 Radiological Report," Public Service Electric and Gas Company, March 1984.. l l
- 8. U._S. Nuclear. Regulatory Commission, " Final Environmental Statement Related to the Operation of the Hope Creek Generating Station," USNRC Rept. NUREG-1974, 1984.
l
- 9. Lawrence Radiation Laboratory, " Concentration Factors of I Chemical Elements in Edible Aquatic Organisms," USAEC
. Rept. UCRL-50564, Rev. 1, 1972.
O G
Quantum: HCGS ODCM V Rev. 1, 11/85
- s. -r - -
y s 1 ,
, ._, N.
e *q _
p ; _; , - s.
Section 1.0 .
INTRODUCTION s
1 4
h The OFFSITE DOSE CALCULATION MANUAL is a supporting document of the RADIOLOGICAL EFFDUIENT TECHNIC AL ' SPECIFICATION 3.' A h, such < t
- the-ODCM-describes the methodology and parameters to be used in the calculation.of offsite doses due to radioactiVO. liquid s
s and gaseous effluent's, and in.the calculation of liquiC and .
y gaseous effluent monitoring instrumentation ala'rm/ trip setpoints.
The ODCM'contains a list and graphlqal description of the specific sample locations for the radiological environmental monitoring -
i program. Schematic configurations of Mquid a w and .qaseous radwaste
. < 34, .
- effluent systems are also incl'uded.
5 , .<.
' ' 4 e ,a N og o l'w 1 The ODCM will be maintained.at the plant for use as a reference- '-
, Q ,/ %: . .
guide and - training document of accepted methodologies' and calcu- :(
lations. Changes in.the calculational methods '3or parameters will be incorporated into the ODCM in ordttr'to, assure that the ODCM represents the present methodology in all applipable areas.
Computer software to perform the' described calcuIations will be. maintained current with the.ODCM.; -
4
\
4
. k y .e
- ,a**
s
\ k g
's. ,, % i x s _, t Quantum: HCGS ODCM 1.0-1[~ R e v . 'i'; 11/85 4
---,v- - - , , , , y g 9 , , . - ,_-----.4 k, - - , _ - - -- ,- -
m yk :
s Section 2.0 LIQUID EFFLUENTS
[ -
The Hope Creek Generating Station is located on the Delaware River which supplies service make-up water to the Cooling Tower Basin andtreceives. water.from.the Cooling Tower Blowdown Line.
All releases from the liquid waste management system are made toithe Liquid Radwaste Discharge Line which releases into the
~ Cooling Tower Blowdown Line for dilution prior to. discharge to the Delaware. River.
-2.1 LIQUID EFFLUENT MONITOR SETPOINT CALCULATIONS Technical Specification 3.3.7.10 states, in part:
The radioactive liquid effluent monitoring instrumentation channels shown.in Table 3.3.7.10-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of. Specification 3.11.1.1 are not. exceeded.
The limits for radioactive liquid effluents presented below are'as stated in. Specification 3.11.1.1:
The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10CFR20,-Appendix B, Table II, Column 2 for radionuclides other than' dissolved or entrained noble' gases. For' dissolved or entrained noble gases, the concentration shall be limited as shown in Table 3.l'l-1 (of RETS). [RETS Table 3.11-1 is included as Table 2.1-1 of the ODCM.]
~ The - two liquid ef fluent monitors listed in Technical Specifi-cation Table 3.3.7.10-1 are the following:
RE4861 - Liquid Radwaste Discharge Line Monitor RE8817 - Cooling Tower Blowdown Ef fluent Line Monitor O !
-Quantum: HCGS ODCM 2.0-1 Rev. 1, 11/85 4
- - -, - , ,,-,.-,.,,.,.c.--..-..,--- , - , . , . , , - - .-,,n. - _ . _ _ . , , - , , . _ , , . , - . - . . , . . , ,e-.
i The-methodology of this section applies to setpoints for these two montiors. The setpoints calculated according to this section are regarded as upper bounds for the actual _>
monitor setpoints. That is, setpoint adjustments.are'not:
required to be performed if the existing setpoint?levd1 \
corresponds to a lower count rate than the calculated value. 1 The actual monitor setpoint, which corresponds to the calculated concentration plus background for the specific monitore, 1
is determined from calibration data or from operational data associated with. liquid sample analysis.' data.
For the purpose of satisfying Technical Specification 3.3.7.10, ,
the setpoints of,each of the two station liquid effluent line monitors shall be , established according to the methodology ,
presented for each monitor below.
2.1.1 Liquid Radwaste Discharge Line Monitor - RE4861 i \
U The liquid radwaste dis'harge c line monitor _provides alarm and automatic termination of release functions prior to exceeding the concentration limits specified in 10CFR20, Appendix B, Table II, Column 2 at the release point to the unrestricted area. 'To meet this specification, the alarm / trip setpoints for the liquid radwaste discharge monitor and flow measurement devices are set to assure that the following equation is satisfied:
.i ,
cf < C (2-1) .
MPC F+f where:
CMPC = the effluent concentration limit (Specification 3.11.1.1) implementing 10CFR20 for the site, ,
corresponding to the specific mix of radio' l 1
nuclides in the ef fluent stream being considered l
j
(,,) for discharge [uci/ml].
Quantum:HCGS ODCM 2.0-2 Rev. 1, 11/85
/
c j
\s >
c = the setpoint [uci/ml] of the radioactivity monitor. measuring the radioactivity concen-tration in the effluent line prior to dilution and subsequent release; the setpoint represents a value which, if exceeded, would result y ?.f ' .in concentrations exceeding the limits of i y 10CFR20 in the unrestricted area.
s Si a S f = the flow setpoint as determined at the radiation l'.
(* 7 monitor. location, in volume per. unit time,
'; but in the same units as F, below.
1 F = the dilution water flow setpoint as determined prior to'the release point, in volume per
-I'y ,
unit time.
- (v
,_ , 2.1.1.1 Releases of Single Liquid Radwaste Streams At the Hope Creek Generating Station, the r' Liquid Waste Sample Tanks, the Floor Drain Sample Tanks, the Detergent Drain Tanks,
- y .' and the Condensate Storage Tanks all discharge
, ,I
,'t to the Liquid Radwaste Discharge Line.
A,-
, The effluent in the Liquid Radwaste Discharge
- ' 3 'Line is monitored prior to discharge into
!, '/ -
i- the Cooling Tower Blowdown Line to the Delaware j )
River. The Cooling Tower Blowdown Line furnishes the dilution flow (F). The waste effluent flow (f) and the monitor setpoint (c) for the Liquid Radwaste Discharge Line Monitor are determined and set to meet the O conditions of equation (2-1) for a given
\- effluent concentration, C. The method by
,fQuantum: HCGS ODCM 2.0-3 Rev. 1, 11/85
(*
0 ~ _ _ _ .
(9
/
_,/ which this is accomplished is as follows:
Step 1) The potential l'iquid radwaste streams at the Hope Creek Generating Station are the following:
a) Waste Sample Tanks b) Floor Drain Sample Tanks c) Detergent Drain Tanks d) Condensate Storage Tank A sample is obtained from the tank (s). planned for discharge into the Liquid Radwaste Discharge Line.
' Step 2) The radionuclide concentration for'a liquid waste tank to be released is obtained from p)
( the sum of measured concentrations as determined by the analyses required in RETS Table 4.11-1:
C 1= C g
+ (C, + C, + Cf+Ct}
i - g -
where:
Cg = the concentration of each measured gamma emitter observed by gamma-ray
-spectroscopy of each waste sample
[uci/ml].
Ca = the concentration of alpha emitters in liquid waste as measured in the most recent QUARTERLY composite sanple for the tank under consideration
[uci/ml]. (NOTE: Sample is analyzed
. for gross alpha.)
r Quantum: HCGS ODCM ~2.0-4 Rev. 1, 11/85
}
'Q) l C3 = the' measured concentrations of Sr-89 and Sr-90 in liquid waste as observed in the most recent QUARTERLY composite sample for the tank under consideration
[uci/ml].
Cg = the measured concentration of Fe-55 in liquid waste as observed in the most recent QUARTERLY composite sanple for the tank under consideration
[uci/ml].
Ct = the measured concentration of H-3 in liquid waste as determined from analysis of the most recent
.( gj' QUARTERLY composite sample for
.ws the tank under consideration [uci/ml].
A new Cg term will be included in the analysis-of each batch. Results from the most current QUARTERLY composite will comprise values used in the terms for alpha, strontiums, iron, and tritium.
Step 3) The measured radionuclide concentrations
- are used to calculate a Dilution Factor, DF, which is the ratio of total dilution
- flow rate to tank flow rate required to assu're that the limiting concentrations of 10CFR20, Appendix B, Table II, Column 2 are_ met at the point of diseb3rge.to the Delaware River.
,~p '
Quantum: HCGS ODCM 2.0-5 Rev. 1, 11/85 l-
C f.
DF = p SF i ~
C Ca Cs Cg Ct
= .
g +
+ + + : SF MPC MPC a MPC 3 MPCg MPC t g
9 where:
Ci = the measured concentration of Cg,Cae C Cg and Ct.as defined in Step 2.
3, MPC= MP C MPC a ,- MPCs, MPCg, and MPCt are g,
limiting concentrations.of the appropriate radionuclides from 10CFR20, Appendix
+
B, Table II, Column 2. For dissolved or entrained noble gases,-the concentra-ti.on shall be limited to the specific k, MPC values presented in Table 2.1-1.
SF = the safety factor; a conservative factor
- used to compensate for statistical fluctuations and errors of measurements.
The actual value to be used for the safety factor will be determined in implementing procedures.(For examp'le, SP-= 0.5 corresponds to a 100 percent 4 variation.)
Step 4) -The dilution flow rate setpoint for minimum dilution flow rate, Fd, is established at
~
-ninety-percent of the expected dilution flow rate:
, , F d'=(0.9) X.(Expected Cooling Tower. Blowdown Line Flow Rate)
Quantum:HCGS ODCM 2.0-6 Rev. 1, 11/85
1
)
i
/
j NOTE: If radioactivity from plant operations I accumulates in the Cooling Tower Blowdown Basin such that measurable quantities of radionuclides are detected in the Cooling Tower Blowdown Basin, calculations of Fd must include a term to account for radioactivity present in the dilution stream prior to the introduction of the liquid waste tank effluent:
F d' =(Fd) X (1 - MPC fraction of the Cooling Tower Blowdown).
Step 5) For the case DP<l, the liquid waste tank'
~
effluent concentration meets the limits of 10CFR20 without dilution, and effluent
. 'Q) discharge flow rate may be assigned any desired value. For DF>l, the setpoint for the maximum permissible effluent discharge flow' rate, fe, must be calculated:
=F + f "
1 i
i where:
fe = maximum permissible ef fluent discharge flow rate (i .e. , for effluent discharging through the Liquid Radwaste Discharge Line into the Cooling Tower Blowdown
'Line).
Quantum: HCGS ODCM 2.0-7 Rev. 1, 11/85
l l
l l
[v)- '
Fd = the dilution flow rate setpoint from Step 4.
f t
= the expected flow rate-of liquid waste tank discharge. (This value will have an up'per limit of the maximum discharge capacity of the particular liquid waste tank pump (s).) The maximum discharge capacities for the liquid waste tanks at HCGS are presented in Table 2.1-2.
DF = Dilution Factor from Step 3.
Step 6) The liquid radwaste effluent radiation monitor a setpoint may now be determined based on k.s) the values o f' C i, f e and Fd which were -
specified to provide compliance with the limits of 10 CFR20, Appendix B, Table II, Column 2. The monitor response is primairly to gamma radiation; therefore, the actual.
setpoint is based on C The monitor g.
setpoint which corresponds to the particular setpoint concentration, c, is determined based on monitor calibration data or on operational data which correlates monitor response to sample analyses associated with actual effluent releases.
.The setpoint concentration, c [uci/ml], is determined as follows:
.p c=A C g [uCi/ml]
. g Quantum:HCGS ODCM 2.0-8 Rev. 1, 11/85
T'N t <
A./
where:
bCg = the sum of the concentrations of all measured 9 gamma emitters as determined in Step 2.
A = Adjustment factor which will allow the setpoint to be established in a practical manner for conve-nience and to prevent spurious alarms. So as to alarm should an inadvertent release occur, A is not.to exceed 20.
f A = e (See Note 2 below.)
f t
where:
10 f
.g e = maximum permissible ef fluent discharge flow rate determined according to Step 5~above.
f t
= the expected flow rate of liquid waste tank discharge from Step 5 above.
'I f A > 1, Calculate c and determine the maximum value for the actual monitor setpoint.
If A < 1, Release may not _ be made as planned. Re-evaluate Steps 3,4, and 5.
NOTE 1: The calculated setpoint concentration, c, establishes the base value for the monitor setpoint. However, in establishing the actual monitor setpoint for a particular monitor, background radiation levels must be con'aidered. Normally, Quantum:HCGS ODCM 2.0-9 Rev. 1, 11/85
t%.
() the actual monitor setpoint includes the calculated setpoint value plus background. Background levels must be controlled such that radioactivity levels in the effluent stream being monitored can be accurately assessed at or ~below the calculated setpoint value.
NOTE 2: If DP<l, then A = (1/DF),.not to' exceed A = 20.
If calculated setpoint values are near actual concen-trations planned for release, it may be impractical to set the m'onitor alarm based on this value. In this case a new setpoint may be calculated by decreasing the effluent flow, increasing the dilution flow, or by decreasin9 Ci by further processing of the liquid p radwaste planned for rblease, and by following'the (l methodology presented in Steps 3, 4, and 5.
If no discharge is planned.for this pathway, the monitor setpoint should be established as close to background as practical to prevent spurious alarms and yet alarm should an inadvertent release' occur.
4 O
Quantum:HCGS ODCM 2.0-10 Rev. 1, 11/85
l l
1 l
l l
- A
-A v) 2.1.1.2 Simultaneous Releases of Liquid Radwaste Streams I f- two or more liquid waste tanks (or liquid waste streams) are to be released simultaneously, then the Liquid Radwaste Discharge Line Radiation Monitor setpoint is determined as follows:
Step-A)' Perform Step 3 from Section 2.1.1.1 separately for each liquid waste tank, solving the equation for DF using the values in the concentration term from the sample analyses of each liquid waste stream to be discharged simultaneously. (DF 1) = DF for Tank 1, (DF2) = DF for Tank 2, ...
Step'B) . Determine DF', which-is the greatest value N _ for DF selected .from DFy , DF2 , DF3 ... determined in Step A'above. Use DF' in the determination Of f e in Step E below.
Step C) Determine f 3, which is the sum of the expected flow rates for all waste tanks releasing simultaneously. Use f 3 in the determination Of fe in Step E below.
f =
s 'ft1 + ft2 + ft3 Step D) Perform Step 4 of Section 2.1.1.1.
Step E) Perform Step 5 of Section 2.1.1.1, where f t = fs as determined in Step C above; DF = DF' as determined in Step B above; p and where all other terms in Step 5 are as previously defined.
Quantum: HCGS ODCM 2.0-11 Rev. 1, 11/85
e
.\j NOTE: If'f, < f 3, Simultaneous releases may not be made-as planned; Re-evaluate Steps As B, C and D.
If f e > f 3, Then individual tanks may be released at expected flow rates; proceed to Step F to determine the actual monitor-setpoint.
Step F) Perform Step 6 of Section 2.1.1.1 to determine the monitor setpoint, where ft
- fs as determined in. Step C above; and where the value for g Cg is_the highest value for any of the tanks releasing simultaneously.
2.1.2 Coolino Tower Blowdown Line Effluent Monitor (RE8817)
LIO L/
The. Cooling Tower Blowdown Line-is the blowdown line to the Delaware River, and it provides dilution for the liquid radwaste discharges. The radiation monitor has no control function, but serves as support (backup) for the Liquid Radwaste Discharge Line Monitor. The Cooling Tower Blowdown Line Effluent Monitor setpoint is established as follows:
c =
([ Cg) DF [uci/ml]
9 where bg Cg and DP have values as determined in Section 2.1.1 Step 2 and Step 3 respectively for the. liquid radwaste sample tank (s) planned for release.
(For practicality, for this monitor only, if DF,is determined to be < 1, DF may be set equal to 1 for
( the purpose of. calculating the monitor setpoint.)
Quantum:HCGS ODCM 2.0-12 Rev. 1, 11/85
- k/ ' Table 2.1-1 MAXIMUM PERMISSIBLE CONCENTRATION OF DISSOLVED OR ENTRAINED NOBLE GASES RELEASED FROM THE SITE TO UNRESTRICTED AREAS IN LIQUID. WASTE
- NUCLIDE MPC (uCi/ml)
Kr 85m 2E-4 Kr 85 SE-4 Kr 87 4E-5 Kr 88 9E-5 Ar-41 7E-5 Xe 133m SE-4 Xe 133 6E-4 Xe 135m ,
- -- From Table 3.11-1 of Reference 1.
O l
Quantum:HCGS ODCM 2.0-13 Rev. 1, 11/85 i l
)
Table'2.1-2 MAXIMUM DISCHARGE CAPACITY OF LIQUID RADWASTE STREAMS FOR THE HOPE CREEK GENERATING STATION Maximum Discharge Capacity Liquid Radwaste Stream Flow Rate (GPM)
- 1. Waste Sample Tanks 176
- 2. Floor Drain Sample Tanks. 176 *
- 3. Detergent Drain Tanks 25
- i 4. Condensate Storage Tanks 1300 +
i
~
- -- Section 11.2.3, Ref. 2.
+ -- Chapter 9, Ref. 2.
Quantum: HCGS ODCM 2.0-14 Rev. 1, 11/85
F L
) ;
'2. 2 LIQUID EFFLUENT DOSE CALCULATIONS Technical Specification 3.11.1.2 states, in part:
The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials-in liquid effluents released, from
- ' each reactor unit,.to UNRESTRICTED ARFAS shall be limited
4
- a. During any calendar quarter to less than or equal
_to 1.5 mrems to the total body and to less than or equal to 5 mrems to any organ,-and 1 b. During any calendar year to less than or equal to 3 mrems ,to the total body and to less than or equal to 10 mreas to any organ.
There is no potable ' water pathway for liquids from HCGS.. Thus, t
.for liquid dose calculations, only the fish and invertebrate l consumption pathways are applicable (Ref.,2, Section 11.2.4) .
The methodology by which dose computations shall be performed for ~ the purpose of demonstrating compliance with this Technical Specification is presented below.
The. dose contribution to an exposed individual by way of fish and invertebrate consumption from all radionuclides identified in liquid effluents released to un' restricted areas is calculated using the following expression:
m l D t
" A it bO 1 il Fy]
i 1=1 where:
t
~
Dt = the cumulative dose commitment to'the total body or any organ t, due to radioactivity j in liquid effluents for the total time period m
{ At1, [ mrem] (Ref. 6, Section 4.3).
l=1 i
Quantum:HCGS ODCM 2.0-15 Rev. 1, 11/85
~
i:
. _ .-- ..___...,..-__,_.,__.,......._.-_.,___-.,,_m..._, .
l
( l k/ At1= the length of the lth time period over which C il and F 1 are averaged for all liquid releases, [ hours].
Cil = the average concentration of radionuclide i, in undiluted liquid ef fluent during time period Atl from any liquid release [uci/ml].
F1 = the near field average dilution factor for Cil during any liquid effluent release [ unit-less]. Defined as the ratio of the undiluted liquid. waste flow durin'g release to the product of the average flow from the discharge structure to unrestricted receiving water times Z.
q Fy .- (average undiluted liquid waste flow)
(average flow.from.the discharge-structure during periods of radioactive materials release) * (Z)
NOTE: The denominator is limited to 1000 cfs (448,000 gpm) or less. (Ref. 6, Section 4.3)
NOTE: If radioactivity in the Cooling Tower Blowdown Line becomes > LLD, prior to the junction with the Liquid Radwaste Effluent Line, that concentration must be included in the dose determination. For this part of the dose calculation, F 1 = 1/Z and '
Ati = the entire time period for which the dose is being calculated.
Z = 10, which is the applicable dilution factor for
% the receiving water body at the Hope Creek Generating (V Station, (Ref. 2, Chapter 11).
Quantum:HCGS ODCM 2.0-16 Rev. 1, 11/85
+
Ait= the site related fish and invertebrate consumption dose commitment factor to the total body or any organ.t.for each identified principal gamma and beta emitter listed in Table 2.2-1 [ mrem /hr per uCi/ml].
Ait = Ko (Up
- BFi) +(UI
- BI i)
DFi where .
Ko = Units conversion factor, 1.14 E+5
= 1 E+6 pCi * - 1 E+3 ml + 8760 hr
' uCi 1 yr UF = Adult fish consumption (21 kg/yr).
b)
-i
+
BFi= Bioaccumulation factor for radionuclide'i, in fish, [pci/kg per pCi/l], fro.m Table 2.2-2. The more conservative of salt and fresh water values for radionuclide i is incorporated into Table 2.2-2 for use in the liquid dose calculations (Ref. 4, Table A-1). -
UI = Adult invertebrate consumption (5 kg/yr).
BI i= Bioaccumulation factor for radionuclide i, in invertebrates [pci/kg per pCi/l],
from Table 2.2-2. The more conservative of salt and fresh water values for radionuclide i is incorporated into Table 2.2-2 for use in the liquid dose calculations (Ref. 4, Table A-1).
Quantum: HCGS ODCM 2.0-17 Rev. 1, 11/85
t DFi= Dose conversion factor for radionuclide'i,
.for~ adults in preselected ~ organ t [ mrem /pci] l from Table 2.2-3 (Ref. 4, Table E-ll).' ,
i 7
i
- l i
h ..
I 4-i l
4 t
' Quantum: HCGS'ODCM 2.0-18 Rev. 1, 11/85
Table 2.2-1 D- SITE RELATED INGESTION DOSE COMMITMENT FACTOR, A.
(FISH AND INVERTEBRATE CONSUMPTION)
(mrem /hr per uCi/ml)
Page 1 of 2 HUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUHG GI-LLI H-3 0.00E+00 2.82E-01 2.82E-01 2.82E-01 2.82E-01 2.82E-01 2.82E-01 C-14 4.60E+04 9.20E+03 9.20E+03 9.20E+03 9.20E+03 9.20E+03 9.20E+03 Ha-24 6.01E+02 6.01E+02 6.01E+02 6.01E+02 6.01E+02 6.01E+02 6.01E+02 P-32 4.95E+07 3.08E+06 1.91E+06 0.00E+00 0.00E+00 0.00E+00 5.57E+06 Cr-51 0.00E+00 0.00E+00 5.58E+00 3.34E+00 1.23E+00 7.40E+00 1.40E+03 Mn-54 0.00E+00 2.40E+05 4.59E+04 0.00E+00 7.16E+04 0.00E+00 7.17E+0*
Mr.'C2 C.0LL+so 6.00E+03 l' . 0 7 E,03 0.00E+00 7.o8E+03 0.00E+00 1.93E+05 Fe-55 5.11E+04 3.53E+04 8.23E+03 0.00E+00 0.00E+00 1.97E+04 2.03E+04
- Fs-59 S.06E+04 1,90E+05 7.77F+04 0 "AE*00 0 007400 5.70E404 d.5;E+u3
-Co-58 0.00E+00 6.03E+02 1.35E+03 0.00E+00 0.00E+00 0.00E+00 1.22E+04 Co-60 0.00E+00 1.73E+03 3.82E+03 0.00E+00 0.00E+00 0.00E+00 3.25E+04 Hi-63 4.96E+04 3.44E+03 1.67E+03 0.00E+00 0.00E+00 0.00E+00 7.18E+02 Hi-65 2.02E+02 2.62E+01 1.20E+01 0.00E+00 0.00E+00 0.00E+00 6.65E+02 Cu-64 0.00E+00 2.14E+02 1.01E+02 0.00E+00 5.40E+02 0.00E+00 1.83E+04 Zn-65 1.61E+05 5.13E+05 2.32E+05 0.00E+00 3.43E+05 0.00E+00 3.23E+05
/ 'N Zn-69 3.43E+02 6.56E+02 4.56E+01 0.00E+00 4.26E+02 0.00E+00 9.85E+01
'(_,) Br-93 0.00E+00 0.00E+00 4.80E+01 0.00E+00 0.00E+00 0.00E+00 6.91E+01 Br-84 0.00E+00 0.00E+00 6.22E+01 0.00E+00 0.00E+00 0.00E+00 4.88E-04 Br-85 0.00E+00 0.00E+00 2.55E+00 0.00E+00 0.00E+00 0.00E+00 1.19E-15 Rb-86 0.00E+00 1.13E+05 5.27E+04 0.00E+00 0.00E+00 0.00E+00 2.23E+04 Rb-88 0.00E+00 3.24E+02 1.72E+02 0.00E+00 0.00E+00 0.00E+00 4.48E-09 Rb-89 0.00E+00 2.15E+02 1.51E+02 0.00E+00 0.00E+00 0.00E+00 1.25E-11
'Sr-89 3.97E+E4 0.00E+00 1.14E+03 0.00E+00 0.00E+00 0.00E+00 6.36E+03 Sr-90 9.76E+05 0.00E+00 2.40E+05 0.00E+00 0.00E+00 0.00E+00 2.82E+04 Sr-91 7.30E+02 0.00E+00 2.95E+01 0.00E+00 0.00E+00 0.00E+00 3.48E+03 Sr-92 2.77E+02 0.00E+00 1.20E+01 0.00E+00 0.00E+00 0.00E+00 5.49E+03 Y-90 6.06E+00 0.00E+00 1.63E-01 0.00E+00 0.00E+00 0.00E+00 6.42E+04 I Y-91m 5.73E-02 0.00E+00 2.22E-03 0.00E+00 0.00E+00 0.00E+00 1.68E-01 Y-91 8.88E+01 0.00E+00 2.37E+00 0.00E+00 0.00E+00 0.00E+00 4.89E+04 i Y-92 5.32E-01 0.00E+00 1.56E-02 0.00E+00 0.00E+00 0.00E+00 9.32E+03 j 1
Y-93 1.69E+00 0.00E+00 4.66E-02 0.00E+00 0.00E+00 0.00E+00 5.35E+04 Zr-95 1.59E+01 5.11E+00 3.~46E+00 0.00E+00 8.02E+00 0.00E+00 1.62E+04 Zr-97 8.81E-01 1.78E-01 8.13E-02 0.00E+00 2.68E-01 0.00E+00 5.51E+04 Hb-95 4.~47E+02 2.49E+02 1.34E+02 0.00E+00 2.46E+02 0.00E+00 1.51E+06 Ho-99 0.00E+00 1.28E+02 2.43E+01 0.00E+00 2.89E+02 0.00E+00 2.96E+02 Tc-99m 1.59E-02 4.50E-02 5.73E-01 0.00E+00 6.83E-01 2.20E-02 2.66E+01 Tc-101 1.64E-02 2.36E-02 2.31E-01 0.00E+00 4.24E-01 1.20E-02 7.09E-14 Ru-103 1.10E+02 0.00E+00 4.73E+01 0.00E+00 4.19E+02 0.00E+00 1.28E+04 Ru-105 9.15E+00 0.00E+00 3.61E+00 0.00E+00 1.18E+02 0.00E+00 5.59E+03 6tia'5tum:HCGS ODCM 2.0-19 Rev. 1, 11/85
(q
'~'
/ SITE RELATED INGESTION DOSE COMMITMENT FACTOR, Table 2.2-1 A.
1
~(FISH AND INVERTEBRATE CONSUMPTION)
(mrem /hr per uCi/ml)
Page 2 of 2 NUCLIDE BONE LIVER T. BODY THYROID KIDHEY LUNG GI-LLI
.Ru-106 1.63E+03 0.00E+00 2.07E+02 0.00E+00 3.15E+03 0.00E+00 1.06E+05 Ag-110m 1.56E+03 1.45E+03 8.60E+02 0.00E+00 2.85E+03 0.00E+00 5.91E+05 Te-125m 1.19E+04 4.31E+93 1.59E+03 3.57E+03 4.83E+04 0.00E+00 4.75E+04 Te-127m 3.00E+04 1.0?E+04 3.66E+03 7.67E+03 1.22E+05 0.00E+00 1.01E+05 Te-127 4.88E+02 1.75E+02 1.06E+02 3.61E+02 1.99E+03 0.00E+00 3.85E+04 Te-129m 5.10E+04 1.90E+0'4 8.07E+03 1.75E+04 2.13E+05 0.00E+00 2.57E+05 Te-129 1.39E+02 5.23E+01 3.39E+01 1.07E+02 5.85E+02 0.00E+00 1.05E+02 Te-131m /.6/E+03 3.75E+03 3.13E+03 5.94E+03 3.80E+04 0.00E+00 3.73E+05 Te-131 8.74E+01 3.65E+01 2.76E+01 7.18E+01 3.83E+02 0.00E+00 1.24E+01 Te-132 1.12E+04 7.23E+03 6.78E+03 7.98E+03 6.96E+04 0.00E+00 3.42E+05 I-130 4.87E+01 1.44E+02 5.67E+01 1.22E+04 2.24E+02 0.00E+00 1.24E+02 1-131 2.68E+02 3.83E+02 2.20E+02 1.26E+05 6.57E+02 0.00E+00 1.01E+02 I-132 1.31E+01 3.50E+01 1.22E+01 1.22E+03 5.57E+01 0.00E+00 6.57E+00 1-133 9.15E+01 1.59E+02 4.85E+01 2.34E+04 2.78E+02 0.00E+00 1.43E+02 I-134 6.83E+00 1.86E+01 6.63E+00 3.21E+02 2.95E+01 0.00E+00 1.62E-02
( ,, 1-135 2.85E+01 7.47E+01 2.76E+01 4.93E+03 1.20E+02 0.00E+00 8.44E+01 Cs-134 3.33E+05 7.93E+05 6.48E+05 0.00E+00 2.57E+05 8.52E+04 1.39E+04 Cs-136 3.49E+04 1.38E+05 9.91E+04 0.00E+00 7.66E+04 1.05E+04 1.56E+04 Cs-137 4.27E+05 5.84E+05 3.83E+05 0.00E+00 1.98E+05 6.59E+04 1.13E+04 Cs-138 2.96E+02 5.84E+02 2.89E+02 0.00E+00 4.29E+02 4.24E+01 2.49E-03 Ba-139 1.34E+01 9.53E-03 3.92E-01 0.00E+00 8.91E-03 5.41E-03 2.37E+01 Ba-140 2.80E+03 3.52E+00 1.83E+02 0.00E+00 1.20E+00 2.01E+00 5.77E+03 Ba-141 6.50E+00 4.91E-03 2.19E-01 0.00E+00 4.57E-03 2.79E-03 3.06E-09 Ba-142 2.94E+00 3.02E-03 1.85E-01 0.00E+00 2.55E-03 1.71E-03 4.14E-18 La-140 1.57E+00 7.94E-01 2.10E-01 0.00E+00 0.00E+00 0.00E+00 5.83E+04 La-142 8.06E-02 3.67E-02 9.13E-03 0.00E+00 0.00E+00 0.00E+00 2.68E+02 Ce-141 5.56E+00 3.76E+00 4.26E-01 0.00E+00 1.75E+00 0.00E+00 1.44E+04 Ce-143 9.80E-01 7.25E+02 8.02E-02 0.00E+00 3.19E-01 0.00E+00 2.71E+04 Ce-144 2.90E+02 1.21E+02 1.56E+01 0.00E+00 7.19E+01 0.00E+00 9.80E+04 Pr-143 5.79E+00 2.32E+00 2.87E-01 0.00E+00 1.34E+00 0.00E+00 2.54E+04 Pr-144 1.90E-02 7.87E-03 9.64E-04 0.00E+00 4.44E-03 0.00E+00 2.73E-09 Nd-147 3.96E+00 4.58E+00 2.74E-01 0.00E+00 2.68E+00 0.00E+00 2.20E+04 W-187 2.98E+02 2.49E+02 8.70E+01 0.00E+00 0.00E+00 0.00E+00 8.15E+04 Hp-239 3.00E-01 2.95E-02 1.63E-02 0.00E+00 9.20E-02 0.00E+00 6.05E+03 i
7-
,,i Quantum: HCGS ODCM 2.0-20 Rev. 1, 11/85 e - , - - - - . - - - - - - - -- ,, , - - .,. ,,._,n- .-,,,..,-,,_-----n.,- - - - -
l .
Table 2.2-2 BIOACCUMULATION FACTORS (pCi/kg per pCi/ liter)*
ELEMENT. FISH INVERTEBRATES H 9.0E-01 9.3E-01 C -4.6E+03 9.lE+03 NA 1.0E+02' 2.0E+02 P 1.0E+05 3.0E+04 CR. .4.0E+02 2.0E+03
. MN 5.5E+02 9.0E+04 FE 3.0E+03 2.0E+04
- CO 1.0E+02 1.0E+03 NI. , 1.0E+02 2.5E+02 CU 6.7E+02~ 1.76+03 ZN 2.OR*93 5.0E+04 BR 4.2E+02 3.3E+02 RB- 2.0E+03 1.0E+03 SR 3.0E+01 1.0E+02 Y 2.5E+01 1.0E+03 ZR 2.0E+02 8.0E+01 NB 3.0E+04 1.0E+02 MO 1.0E+01 1.0E+01 TC 1.5E+01 5.0E+01
- p. RU l.0E+01 1.0E+03 RH 1.0E+01 2.0E+03
'Q AG** 3.3E+03 3.3E+03 TE 4.0E+02 6.lE+03 I 1.5E+01 5.0E+01 CS 2.0E+03 1.0E+03 BA 1.0E+01 2.0E+02 LA 2.5E+01 1.0E+03 CE 1.0E+01 1.0E+03 PR 2.5E+01 1.0E+03 ND 2.5E+01 1.0E+03 W 1.2E+03 3.0E+01 4 NP- 1.0E+01 , 4.0E+02
- -- V a l u e s in Table 2.2-2 are taken from Ref. 4, Table A-1, except as noted below. The more conservative of salt and fresh water values have been included in Table 2.2-2 for the purpose of liquid dose calculations.
- -- Values for Ag are taken from Reference 9.
O Quantum:HCGS ODCM 2.0-21 Rev. 1, 11/85
7 j Table 2.2-3 ADULT INGESTION DOSE FACTORS *
(mrem /pCi ingested)
Page 1 of 2 NUCLICE SONE t.IVER T.ROGY THYR 010 RIONEY LUNG GI-LLI H 3 NO DATA 1.05E-07 1.05E-0 7 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C 14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA 24 1.70E-06 1.70E-06 1. 70E-06 1. TOE-06 1 70E-06 1.70E-06 1.70E-04 P 32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR 51 NO DA)A NO DATA 2.66E-09 1 59E-09 5.86E-10 3.53E-09 6.69E-07 MN 54_ NO DATA 4.57E 8. 72 E-0 7 NO DATA 1.36E-06 NO DATA 1.40E-05 MN 56 NO DATA 1.15E-07 2.04E-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE 55 2.75E-06 1.90E-06 4.4 J C-0 7 NO DATA NO DATA 1.06E-06 1.09E-06 FE-59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO 58 NO DATA '7.45d-07 1.67E-0 6 NO DATA NO DATA NO DATA' 1.51E-05 CO 60 NO DATA 2.14E-C6 4.72C-06 NO DATA NO DATA .'NO DATA 4.02E-05
.NI 63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 NI 45 5.28E-07 6.86E-08 3.13E-0 6 NO OATA NC OATA NO DATA 1.74E-06 CU 64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 No DATA 7.10E-06 IN 65 4.84E-06 1.54E-05 6. 96E-0 6 NO DATA 1.03E-05 NO DATA 9.70E'-06 2N 69 1.0 3E-08 1.97E-08 1.37E-09 . No DATA 1.28E-08 NO DATA 2.96E-09 C 84 83 BR 84 NO DATA NO DATA NO DATA NO DATA
- 4. 02 E-0 8 NO DATA
- 5. 21 E -0 8 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.79E-08 4.09E-13 LT E-24 SR 85 NO DATA NO DATA 2.14 E-0 9 NO DATA NO DATA R8 46 NO DATA 2.11E-05 9. 83 E-0 6 NO DATA NO DATA NO DATA 4.16E-06
'R8 88 NO DATA; 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19
-RS 89 NO DATA 4.01E-04 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR 89 3.08E-04 NO DATA 8. 84 E-06 NO DATA NO DATA- NO DATA 4.94E-05 SR 90 7.58E-03 NO DATA 1.86E-0 3 NO DATA NO DATA NO DATA 2.19E-04 54 91 5.67E-06 NO DATA 2.29E-0 7 - NO DATA NO DATA NO DATA 2.70E-05 SR 92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 Y 90 9.625-09 NO DATA 2 58E-10 NO DATA NO DATA NO DATA 1.02E-04 Y 91N 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 Y 91 1. 41 E-0.7 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y 92 8 45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y 93 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05 2R 95 3.04E-08 9.75E-09 6.40E-09 NO DATA 1.53E-08 NO DATA 3.09E-05
- 2R 97 1.68E-09 3.39E-10 1.55E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 N8 95 4.22E-09 3.46E-09 1. 86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MD 99 NO DATA 4.31E-06 4.20E-07 NO DATA 9.74E-06 NO DATA 9.99E-06 TC 99M 2.47E-10 6.90E-10 8. 89E-09 NO OATA 1.04E-04 3.42E-10 4.13E-0T
- Values in Table 2.2-3 are taken from Ref. 4, Table E-ll.
Quantum:HCGS ODCM 2.0-22 Rev. 1, 11/85
l V Table 2.2-3 ADULT INGESTION DOSE FACTORS *
(mrem /pCi ingested)
Page 2 of 2
. NUCL1DE SONE LIVER T.800Y THYR 010 RIONEY LUNG GI-LL1 TC101 2.S4E-10' 3.66E-10 3. 59E-0 9 NO DATA 6.59E-09 1.87E-10' t.10E-21 RU103 1.85E-07 NO DATA 7.97E-08 NO OATA 7.06E-07 NO DATA 2 14E-05
- Rul0h 1.54E-08 NU DATA 6. 00E-09 NO DATA 1 99E-07 NO OATA 9.42E-06 4
TA RU106 2.75E-06 NO DATA 3. 48E-0 7 NO DATA 5.31E-06 NO DA 1.78E-04 AG110M 1.60E-07 1.48E-07 0.79E-08 NO DATA 2.9.1E-07 NO DATA 6.04E-05 ,
TE125M 2.68E-06 9.71E-07 3. 59E-0 7 0.04E-07 1.09E-05 NO DATA 1.07E-05 2.27E-05
! TEt27M- 6.77E-06 2.42C-06 8.25E 47 1 73E-04 2.75E-05 NO DATA 8.68E-06 TE127 1.10E-07 3.95E-08 2.38E-08 0.15E-08 4.48E-07 NO DATA 5.79E-05 TE129M 1.15E-05 4.29E-06 1. 82E-0 6 3 95E-06 4.80E-05 NO DATA TE129 3.14E-08 1.18E-08 7. 6'sE-0 9 2 41E-08 1.32E-07 NO DATA 2.37E-00 '
TE131M 1.73E-06 8.46C-07 7.05E-0 7 1 34E-06 8.57E-06 NO DATA' 8.40E-05 4 TE131 1.97E-08 8.23E-09 6. 22 E-0 9 1 62E-08 8.63E-08 NO DATA 2.79E-09 2.52E-06 1.63E-06 1. 53E-0 6 1.80E-06 1.57E-05 NO DATA 7.71E-05 4 TE132 1.92E-04 1 130 7.54E-07 2.23E-06 8. 80E-0 7 1 89E-04 3.44E-06 NO DATA 1 131 4.16E-06 5 95E-06 3. 41E-0 6 1 95E-01 1.02E-05 NO DATA 1.57E-06 1.90E-05 8.65E-07 NO DATA 1.02E-07 j
O 1 132 I 133 I 134 2.03E-07 5.43E-07 1.42E-06. 2.47E-06 1.06E-07 2.88E-07 1.90E-0 7 7.53E-0 7 1.03E-0T 3.63E-04 4.31E-06 NO DATA 4.99E-06 4.58E-07 NO DATA.
2.22E-06 2.51E-10 t 135 4.43E-07 1.16E-06 4. 2 0E-0 7 7.45E-05 1.86E-06 NO DATA 1.31E-06 C5134 6.22E-05. 1.48E-04 1. 21E-0 4 NO DATA 4.79E-05 1.59E-05 2.59E-06 C5116 6.51E-06 2.57E-05 1. 85E-0 5 NO DATA 1.43E-05 1.96E-06 2.92E-06
- C5137 7.97E-05 1.09E-04 7.14E-0 5 NO DATA 3.70E-05 1.23E-05 2 11E-06 C5138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.9tE-09 4 45E-13 l SA139 9.70E-08 6.9tE-11 2. 84E-0 9 NO OATA 4.46E-11 3.92E-11 1.72E-07 84140 2 05C-05 2.55E-08 1 33E-06 NO DATA 8.67E-09 1.444-08 4.18E-05 84141 4.71E-04 3.54E-11 1 59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 84142 2.13E-08 2.19E-11 1. 34E-0 9 NO DATA 1.85E-11 1 24E-11 3 00E-26 LA140 2.S0E-09 1.26E-09 3.33C-10 NO DATA NO DATA NO DATA 9.2SE-05 l
LA142 1.20E-10 5.82E-11 1.45E-11 NO DATA NO DATA NO DATA CE141 9.36E-09 6.35E-09 T.18E-10 NO DATA 2.94E-09 NO DATA 4.2SE-07 2.42E-05 l )
CEt43 1.65E-09 1.22E-06~ 1. 35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE144 4.RSE-07 2.04E-07 2.62E-0 8 NO DATA 1.21E-07 NO DATA 1.65 E-04 PR143 9.20E-09 3.69E-09 4 56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR144 3.01E-11 1.25E-11 1. 5 6E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 N0147 6.29E-09 7.27E-09 4. 35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 W 187 1.03E-07 8.41E-08 3.01E-08 NO DATA NO DATA NO*0ATA 2.02E-05 N#239 1.19E-09 1.17C-10' 4.45E-11 NO DATA 3.65E-10 NO DATA 2 40E-05 i
\
~*
Values in Table 2.2-3 are taken from Ref. 4, Table E-ll.
Quantum:HCGS ODCM 2.0-23 Rev. 1, 11/85
-3..-.-y _ _ . _ ,,.r.y. .-_..~,__,,__.m_.._.,,,___.,_m, , _ - _ _ _ _ _ , _ _,_.._,,,__,..,_.,____,_~m_, m_ ,_, .-,_..__,_,__m .m..
/
' \j\
2.3 DEFINITIONS OF LIQUID EFFLUENT TERMS-Section of
. Term Definition Initial Use A = Adj us t men t factor which will allow the' (2.1.1.1) setpoint to be established in a
. practical manner for convenience and to prevent spurious alarms.
Alt = the' site related fish and invertebrate (2.2) consumption dose commitment factor to the.
total body or any organ t for each identified principal gamma and beta emitter listed in Table 2.2-1 [ mrem /hr per uCi/ml].
f-s BFi = Bioaccumulation factor for radionuclide i, (2.2)
( ,j in fish [pci/kg per.pci/1] from Table 2.2-2.
BI i = Bioaccumulation factor for radionuclide i, (2.2).
in invertebrates [pci/kg per pCi/l] from i
Table 2.2-2.
c = the setpoint [uci/ml] of the radioactivity (2.1.1) monitor measuring the radioactivity con-centration in the effluent line prior to
~
dilution and subsequent release.
C, = the concentration of. alpha emitters in (2.1.1.1) liquid waste as measured in the most recent 4
QUARTERLY composite sample for the tank under consideration [uci/ml]. j l
(
Quantum: HCGS ODCM 2.0-24 Rev. 1, 11/85
[h a 1
- \/ Section of Term Definition Initial Use C
g
= the measured concentration of Fe-55 in (2.1.1.1) liquid waste as observed in the most recent QUARTERLY composite sample for the tank under consideration [uci/ml].
C = the concentration of each measured gamma (2.1.1.1) 9 emitter observed by gamma-ray spectroscopy of each waste sample [uci/ml].
-Ci =
the measured concentration of Cg,C a, Cs, (2.1.1.1)
C g and Ct.
Cil .. - the average concentration of radionuclide (2.2) i, in undiluted liquid effluent during time 4
]s s-j atl from any liquid release,[uci/ml].
CMPC = the effluent concentration limit (Speci- (2.1.1.1) fication 3.11.1.1) implementing 10CFR20 for the site, corresponding to the specific mix of radionuclides in the effluent stream being considered for discharge [uci/ml].
Cs = the measured concentrations of Sr-89 (2.1.1.1)
, and Sr-90 in liquid waste as observed i in the most'recent QUARTERLY composite sample for the tank under consideration
[uci/ml].
.Ct
= the measured concentration of H-3 in (2.1.1.1) l liquid waste as determined from analysis ,
l of the most recent QUARTERLY composite gg sample for the tank under consideration N._ [uci/ml].
Quantum: HCGS ODCM 2.0-25 Rev. 1, 11/85
Section of
~ Term Definition. Initial Use DF = dilution factor; ratio of total dilution -(2.1.1.1) flow rate to tank flow rate required to assure'that the limiting concentrations of 10CFR20, Appendix B, Table II, Column 2 are met at the point of discharge to the Delaware River.
DF' = the greatest value for DF from DF 1, DF2, (2.1.1.2).
DF 3 ..., used in the determination of the monitor setpoint when liquid radwaste tanks are releasing simultaneously.
DFi = Dose conversion factor for radionuclide i, (2.2) 73 for adults in preselected organ t [ mrem /pCi]
k-) from Table 2.2-3.
D't = the cumulative dose commitment to the (2.2) total body or any organ t, due to radio-activity in liquid effluents for the total m
time period Atl [ mrem].
{ ,
l=1 f = the flow setpoint as determined at the (2.1.1) radiation monitor location, in volume per unit time, but in the same units as F, below.
F '= the dilution water flow setpoint as (2.1.1) determined prior to the release point, in volume per unit time.
O Pd = the setpoint for minimum dilution flowrate (2.1.1.1)
Quantum: HCGS ODCM 2.0-26 Rev. 1, 11/85
b(,,/ Section of Term Definition Initial Use Fd' = the setpoint for minimum dilution flowrate, (2.1.1.1) considering the buildup of radioactivity from plant' operations in the Cooling Tower Blowdown Basin.
fe = maximum permissible effluent discharge (2.1.1.1) flow rate.
F1 = the near field average dilution factor (2.2) during any liquid effluent release
[unitless].
fs = the sum of the expected flow rates for (2.1.1.2) all waste tanks releasing simultaneously.
O v = the expected flow rate of liquid waste (2.1.1.1) ft tank discharge. The maximum discharge capacities for'the liquid waste tanks at HCGS are presented in Table 2.1-2.
Ko = Units conversion factor, 1.14 E+5 (2.2)
MPC = MPC g, MPCa, MPCs, MPCg, and MPCt are (2.1.1.1) limiting concentrations of the appropriate radionuclides from 10CFR20, Appendix B, Table II, Column 2. For dissolved or entrained noble gases, the concentration shall be limited to the specific MPC values presented in Table 2.1-1.
Quantum: HCGS ODCM 2.0-27 Rev. 1, 11/85
._g_ ,
, g ,4
, , . m.
- (
N s
\ w ,s
\s . . L
. -s .'s i
- (j .-. x
{ Section of Term Definition g .s Initial Use
- s s' .
SP = the safety. factor; a conservative 't ( 2. -l .1.1 ) s factor used to compensate for statistical, m fluctuationsanderrorsofmeasuremefts. g _
s.
. . s
, [* 1. ,
Atl= ,the length of the 1th. time period ,over . v (2.2) which Cil and F1 are averaged for all ,, s,;
liquid releases, [ hours]. ~ ,
~
UP = Adult fish consumption (21.kg/yr). .., :l:R.7)- 4
.. x UI = Adult' invertebrate consumption (5 kg/yr). (2.2)
% s 4
- l Z =~ 10, which is the applicable dilution (2.2) factor for the receiving water body al s the Hope Creek Generatir.g Station. .,' ,
. s s'
~' \
s L, s ,
h N 'w a s 'Oy
\
. t t,
k
- 4 4
s V .
Quantum: HCGS ODCM 2.0-28 Rev. 1, 11/85
, s N 4
_, ,--,a , - - . . ~ , -
f%
sV Section 3.0
)~ ROUTINE GASEOUS EFFLUENTS
- ;3.1 GASEOUS EFFLUENT MONITOR SETPOINT CALCULATIONS s Technical Specification 3.3.7.11 states, in part:
The radioactive gaseous effluent monitoring instrumentation channels shown in Table 3.3.7.11-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of Specification 3.11.2.1 are not exceeded.
Since, according to Section 5.1.1 of Ref. 6, "It is not considered practicable to apply instantaneous alarm / trip setpoints to integrating radiation monitors sensitive to radioiodines, radioactive materials in particulate form, and radionuclides other than noble gases," only noble gas monitor setpoints need be specified by the ODCM.
The. noble gas limits established by Specification-3.11.2.1 are quoted below in Section 3.2.1; they are instantaneous dose rates of 500 mrem /yr to the total body, and 3000 mrem /yr to the-skin at any point outside the Site Boundary. The three noble gas effluent monitors listed in Technical Speci-fication Table 3.3.7.11-1 are the following:
RE4811A - the Filtration, Recirculation, and Ventilation System noble gas monitor RE4814A - the South Plant Vent nobic gas monitor RE4875A - the North Plant Vent noble gas monitor The methodology of this Section applies to setpoints for
- w
! these three monitors. The setpo nts calculated according
.to this ' Section are regarded as upper bounds for the actual Quantum: HCGS ODCM 3.0-1 Rev. 1, 11/85
}
O( / monitor setpoints. That is, setpoint adjustments are not required to be performed if the existing setpoint level corresponds to a lower count rate than the new calculated value. If no radioactive di1 charge is planned for a given release point, the monitor setpoint for that release point should be established as close to background as pr'actical to prevent spurious alarms, and yet alarm should an,inad-vertant release occur. -
Two methods are given. The first (Section 3.1.1) is the method which is used normally. The second (Section 3.1.2) is used during startups when the concentrations of all plant-generated noble gases in the most recent sample for a given release point are all undetectable. Setpoints calculated by the two methods may be used on different monitors simultaneously; only those release points for which the most recent sample yielded no de'tectable plant-( generated noble gases will have their monitor setdoint established according to Section 3.1.2.
3.1.1 Normal Setpoint Method The following method applies to the normal circumstance that one or more plant-generated noble gases in the most recent sample for a given release point are detect-able. In this case, for the purpose of satisfying
-Technical Specification 3.3.7.11, the setpoints of each of the three station vent monitors are estab-lished as follows:
Sy = the lower of Svt or Sys, where 500 ay SF X gy 1
O S =
~
h F y (X/Q) 1
[K g X1y]
Quantum:HCGS ODCM 3.0-2 Rev. 1, 11/85
/ .
3000 ay SF [X gy i
S =
8 Fy (X/Q) [(Lg + 1.1 Mg) Xgy]
1 and where:
S = the candidate setpoint for vent v, based vt upon the total body dose rate limit of 500 mrem /pr [uci/cc].
S = the candidate setpoint for vent v, based ys upon the skin dose rate limit of 3000 mrem /yr
[uci/cc].
500 = the whole body dose rate limit [ mrem /yr].
ry d 3000 = the skin dose rate limit.[ mrem /yr]..
ay = the administrative allocation factor for vent v [unitiess], which'is the fraction of the station site boundary dose rate limit which is assigned to vent v. Allocation f actors may be changed as necessary. However, normally, each allocation factor should be between 0.0 and 0.5 inclusive, and the sum of the three allocation factors should be less than or equal to 0.5. (This limitation to 0.5 is to ensure that the combined releases from the Hope Creek and Salem Stations remain within the regulatory' limits at the common Site Boundary.) Any, increase in this total allocation factor above 0.5 will be coordinated
-Cs with the Salem Generating Station to ensure Quantum: HCGS ODCM 3.0-3 Rev. 1, 11/85
s,
)
1 / that the total allocation factor for all units does not exceed 1.0.
F = the expected flow rate in vent v [cc/sec].
y Flow rates in cfm may be converted to cc/sec by multiplying them by 472.
SF = the safety factor; a conservative factor used to compensate for statistical fluctuations and errors of measurements. The actual value will be determined in implementing procedures.
X/O = the highest annual average relative concentration at the site boundary in any sector.
=
7.0 x 10-6 sec/m3 (from Reference 8).
K = total body dose factor for gamma emissions i
from noble gas radionuclide i [ mrem'yr / per uCi/m3), from Table 3.1-1.
X = the measured concentration of noble gas iy radionuclide i in the last grab sample analyzed for vent v [uci/cc]. For the North Plant Vent and the South Plant Vent, such samples are taken at least monthly. For purges of containment through the FRVS, a grab sample will be taken prior to intentionally initiating each such release, or as soon as possible after such a release is initiated automatically.
L = skin dose factor for beta emissions from i
( noble gas radionuclide i [ mrem /yr per uCi/m3),
Quantum:HCGS ODCM 3.0-4 Rev. 1,.11/85
. .=. -.. - -. -. -- - . - - _ . -_ - - _
from Table 3.1-1.
1 M = . air. dose factor for gamma emissions from i- ,
noble gas radionuclide i [ mrad /yr per uCi/m 3),
from Table 3.1-1.
I i;
j 1.1 = a factor to convert absorbed dose in air due to gamma radiation, to dose equivalent in skin [ mrem /arad]. .
The monitor setpoint S y established by the method above shall be' entered into the radiation monitoring system, along with the sample assay data (the Xiy}
that were used to calculate it. The operational value of the setpoint should contain an allowance for the
~
monitor's background count rate and.its variation.
However, effluent monitors at the Station will be j maintained such that they are" sensitive'to radiation 4'
at'the levels at which it is emitted from the effluent streams.
3.1.2 Startup Setpoint Method The following method applies to the special circumstance that the assay of plant-generated. noble gases in the most recent sample for a given release point yields no detectable radionuclides. It is conservative because
- it assumes that all the noble ' gas detected by the monitor-is Kr-89, the most conservative radionuclide in Table 3.1-1. Thus, this method results in the overestimation of the true dose delivered by the actual _;
noble gas mixture being released. It is therefore recommended that this method not be used~except.when it is necessary due to the undetectability of the noole gases in the sample from a particular release Quantum:HCGS ODCM 3.0-5 Rev. 1, 11/85
77
-V point.
In this case, for the purpose of satisfying Technical Specification 3.3.7.11, the setpoints of any of the three station vent monitors may be established as follows:
S y. = the lower of Svt' or Sys', where 500 ay SF S ' =
Y F, (X/Q) K Kr-89 3000 ay SF 8
Fy (X/0) (LKr-89 + 1*1 "Kr-89}
where S e y l 's the conservative setpoint for startup
^
[uci/cc], L
/g Kr-89 and M K r-89 are dose factors for Kr-89 O from Table 3.1-1, and other terms are as defined above.
The monitor setpoint S e y established by the method above will be entered into the radiation monitoring system. For the sample assay dat'a, the LLD for Kr-89 in the most recent sample for the particular release point will be entered into the radiation monitoring system. The operational value of the setpoint should contain an allowance for the monitor's background count rate and its variation. However, effluent monitors at the Station will.be maintained such that they are sensitive to radiation at the levels at which it is emitted from the effluent streams.
O Quantum:HCGS ODCM 3.0-6 Rev. 1, 11/85
. - - . ~ - - ._ _ __
Table 3.1-1 DOSE FACTORS FOR EXPOSURE TO A SEMI-INFINITE CLOUD OF NOBLE GASES
- Dose to People + Dose to Air I Nuclide- Gamma-Body (K) Beta-Skin (L) Gamma (M) Beta (N)
Kr-83m 0.08 ----
19.3 288 Kr-85m 1,170 1,460 1,230 1,970 Kr-85 16.1 1,340 17.2 1,950 4
Kr-87 5,920 9,730 6,170 10,300 Kr-88 14,700 2,370 15,200 2,930 Kr-89 16,600 10,100 17,300 10,600 Kr-90 15,600 7,290 16,300 7,830 Xe-131m 91.5 476 156 1,110 Xe-133m 251 994 327 1,480
. Xe-133 294 306 353 1,050 Xe-135m 3,120 711 3,360 739 Xe-135 1,810 1,860 1,920 2,460 Xe-137
/ 1,420 12,200 1,510 12,700
(,,T/ Xe-138 8,830 4,130 9,210 4,750 Ar-41 8,840 2,690 9,300 3,280 Notes:
- -- Values taken from'Ref.- 4, Table B-1.
- -- mead /yr per uCi/m3
+ -- mrem /yr per uCi/m3
( \
\_) _
Quantum: HCGS ODCM 3.0-7 Rev. 1, 11/85
l' s~
3.2 GASEOUS EFFLUENT DOSE CALCULATIONS 3.2.1 Site Boundary Dose Technical Specification 3.11.2.1 states:
The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY shall be limited to the following:
- a. For noble gases: Less than or equal to 500 mrems/yr to the total body and less than or equal to 3000 mrems/yr to the skin, and 1
- b. F o r. iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than~8 days: Less than or equal to 1500 mrems/yr to any organ.
The following two subsections give the methods-by which dose computations are performed for the purpose of demonstrating compliance with this Technical Speci-G fication.
/
(
~
3.2.1.a Dose due to Noble Gases For the purpose of implementation of Technical Specifica-tion 3.11.2.1.a, the dose at the Site Boundary due to noble gases is calculated as follows:
t
= current site boundary total body dose rate [ mrem /yr]
=
X/O [K g h]1 i
D = current site boundary skin dose rate s
[ mrem /yr]
= X/Q [ (Lg + 1.1 Mg) h]g 1
Quantum: HCGS ODCM 3.0-8 Rey, 1, 11/85
where:
+
i
= the release rate of noble gas radionuclide i as determined from the concentration measured in the analysis of the appropriate sample required by the Technical Specification Table 4.11-2 [uci/sec].
X/Q = the highest annual average concentration in an? sector,'at the site boundary (for value, see Section 3.1.1) [sec/m3 3 For post-release computations, the actual X/Q
~
for the period of the release (calculated according to Section 3.3 of this ODCM) may be substituted for X/Q.
's 3.2.1.b Dose due to Radionuclides other than Noble Gases T For the purpose of implementation of Technical Specifica-tion 3.:11.2.1.b, the dose at the Site Boundary.due to radioiodines, tritium, and radionuclides in particulate form with half-lives greater than 8 days is calculated as follows:
Do sb = current site boundary dose rate to organ o [ mrem /yr]
= X/o [P h. O' i
]
i where:
- Q' i
= the release rate of non-noble gas radionuclide i as determined from the concentration measured in the analysis of the appropriate sample required by the Technical Specification Table 4.11-2 [uci/sec].
Quantum:HCGS ODCM 3.0-9 Rev. 1, 11/85
. . .. . - . . - . . _ . _ - - . . _ . - , . - ~ - _ _ _ . _ . _ _ _ . _ _ . _ _ . _ ..-,_ . - _ _ . . . - - . _ _ _ _ _ - - . _ . , - . --
O X/O = the highest annual average concentration in any sector, at the site boundary (for value, see Section 3.1.1) [sec/m3]. For post-release calculations, the actual site boundary X/Q in the affected sector for the period of the release may be substituted.
P = dose parameter for radionuclide i and organ o, io for ihhalation, from Table 3.2-1 [ mrem /yr per uCi/m3].
3.2.2 Air Dose Techni~ cal Specification 3.11~.2.2 states:
The air. dose due to noble gases" released in gaseous
~
effluents, from each reactor unit, to areas at and beyond the SITE -BOUNDARY shall be limited to the following:
n
- a. During .any calendar quarter: Less than or equal to 5 mrads for gamma radiation and less than-or equal to 10 meads for beta radiation, and
- b. During any calendar year: Less than.or equal to 10 meads for gamma radiation and less than x
or equal to 20 mrads for beta radiation.
For the purpose of demonstrating compliance with this Technical Specification, the air dose at the Site Boundary is determined as follows:-
U -8 X/O [Mgg ]
g = 3.17 x 10 i
D b
=- 3.17 x 10-8 X/O [N g Q ]
i a
Quantum:HCGS ODCM 3.0-10 Rev. 1, 11/85 ,
l
3_
where:
.D g = the site boundary air dose due to gamma emissions from noble gas radionuclides [ mrad].
D = the site boundary air dose due to beta emissions b
- from noble gas radionuclides [ mrad].
3.17 x 10-8 = the-fraction of one year which is one second.
i
= cumulative release of noble gas radionuclide i over the period of interest [uci].
X/O = the highest annual average concentration in any sector, at the site boundary (for value,'see Sec' tion 3.1.1) [sec/m3]. For post-release calculations, the actual site boundary X/O in the affected sector <for the period of the release may be substituted.
N = air dose factor for beta emissions from i
noble gas radionuclide i [ mrad /yr per uCi/m3], '
from Table 3.1-1.
3.2.3 Dose to a Member of the Public Technical Specification 3.11.-2.3 states:
The dose to a MEMBER OF THE PUBLIC from iodine-131, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released,.from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limited to the following:
- a. During any calendar quarter:
~
Less than or equal to'7.5 mrema to.any organ, and hV
- b. During any calendar year:
to 15 mrems to any organ.
Less than or equal Quantum:HCGS ODCM 3.0-11 Rev. 1, 11/85
.. ~- --.... . . . . . - - - . . , - . - . - , - . _ - - - . _ _ _ _ . . .- -_ ..- - - - -
G For the. purpose of demonstrating compliance with this Technical Specification, a Maximum Exposed Individual is defined. This person has those residence and consump-tion patterns of real. Members of the Population in the environment of HCGS which lead to the highest computed doses. Technical Specification 3.11.2.3 is then satisfied if the calculated doses for the Maximum Exposed Individual are less than the limits of the Tech Spec. The dose to the Maximum Exposed Individual is calculated as follows:
D mp = dose to organ o of a Member of the Public, from radioiodines, tritium, and radionuclides in particulate form with half-lives greater than-8 days C. [ mrem]
= 3.17 x 10-8 [R g3, wg). gi e
]
ij where:
W gj. = relative concentration or relative deposition for the Maximum Exposed Individual, as appro-priate for exposure pathway j and radionuclide
- i. W gj. is defined as follows, (where the specific numerical values are from Reference 8):
= X/Q' for inhalation and all tritium pathways, 2.1 E-07 sec/m3, and
= D/Q' for other pathways and non-tritium.
nuclides, 8.0 E-10 m-2 1
I G
Quantum:HCGS ODCM 3.0-12 Rev. 1, 11/85 l
[ R dose' factor for organ o due'to radionuclide ijo =
i and pathway j, from Table 3.2-2 [ mrem /yr L per uCi/m3 ,.or m2 - mrem /yr per uCi/sec]. !
Q' i
= cumulative release of non-noble gas radionuclide
'- i over the period of interest [uci].
l i
. l l
1-i i
, l l
l l
i l
l I
i i
i l 1 *j l I
Quantum: HCGS ODCM 3.0-13 Rev. 1, 11/85 l l
l
___l c ,
(v) PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b Table 3.2-1 l (P.lo)*
Page 1 of 7: Dose Factors for Total Body I 190TOPEI I H LATION I I ISOTOPEl INHALATION I i 190TOPEI I H LATION 1 IH-3 1 1.125E*03 I ISR-92 1 5.254E-01 I Il-131 I 2.727E+M I IC-14 1 6.734E+03 I IY-94 1 1.106E+02 1 11-132 1 1.876E+03 I
................... ... ..... ___...__... ___. . ==................
12-24 i 1.610E*H I lY i 1.843E-02 I Il-133 1 7.696E+03 I
. ..................... ___-91tl.....- ..... ... ..........- ..
IP-32 I 9.879E+44 I lY-91 1 2.438E+04 1 11-134 1 9.953E+02 'l ICR-51 1 1.543E+02 I lY-92 1 5.809E-01 1 11-135 I 4.144E+03 I It94 1 9.509E+03 I lY-93 1 5.106E+00 I 105-134 1 2.246E+05 I
. _-54 __............. . . .. .... .. ... ......_______..
It96-56 1 3.119E-Il i 12R 1 3.700E+04 I ICS 136 1 1.162E+05 I
. . . .. ... .. .___-95 --- -- ....... ____ ....... .__.. ..
IFE.55 1 7.770E+03 l~ 12R-97 l 1.598E+01 I ICS-137 1 1.284E+05 I IFE.59 1 1.669E+44 1 186 -95 1 6.549E+03 I ICS 138 I 5.550E*02 I 100-58 1 3.164E*03 1 1910 I 4.255E+fl1 I l % 139 I 5.365E-02 1
_ . . - .... . _-99__ ............. . .. ..... ......-
100-60 1 2.264E*H -- ... ..
I lit-99tl I 5.772E-02 1 104-140 l 4.329E+03 1
/N INI.63 I 2.797E+44-l 17C-101 1 1.077E-03 I 194-141 1 6.364E-03 I
(") ___....
lNI-65 l 1.643E-41 I 1110-103 1 1.073E+03 1 1 % 142 l
............. ..... . . ____...... .- .. ... 2.790E _03 I ICtF64 1 1.073E+49 l 11111-1 05 1 5.550E-01 I ILA-140 1 7.540E+01 1
....... . ..... ...... . ===- ... .......
12S65 I 7.030E+H I INU-106 1 1.691E*H I ILA-142 1 1.291E-01 I 12569 I 8.917E-03 I IAG-litrlI 9.139E+03 I ICE-141 1 2.897E+03 I 18R-83 1 4.736E+02 I ITE-125tlI 9.139E+02 I ICE 143 1 2.83E+01 I 18R.84 1 5.476E+02 I ITE-127tl1 3.019E*t3 I ICE-144 1 3.615E+05 I 151-85 1 2.531E+41 1 ITE-127 1 6.105E-01 l IPR-143 I 9.139E+02 1 115-86 1 1.143E+85 I ITE-129tl1 3.041E+03 I IPR-144 1 2.99?E-03 I 148-88 I 3.663E+02 I ITE-129 1 2.303E.02 I IN0-147 1 6.000E+02 I l119-09 1 2.897E+02 I ITE-131tf I 5.069E+01 I IW-107 I 4.320E+00 I
. . = .-- .____ .. ..___.......... ===__. .........
19R-89 l 1.724E+04 I ITE-131 I 6.586E-83 1 19-219 I 2.350E+01 I
.. ............. .... .... ........ __.... ................... =
ISR-90 1 6.438E+06 I ITE-132 1 2.634E+02 I ISR 91 l 4.589E+00 1 11-134 .I 8.436E+03 I
- -- See Note, page 3.0-21 p
Units: mrem /yr per uCi/m3 Quantum: HCGS ODCM 3.0-14 Rev. 1, 11/85
/ g\
'v/ Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (P.lo)*
Page 2 of 7: Dose Factors for Bone l ISOTOPEI Il4#tATION I I ISOTOPEI I M ATION I I ISOTOPEI I R ATION I
... ..... -- =.......... .............. ...
14 3 1 0.000E+09 I ISR 92 1 1.310E*01 I 11-131 1 4.818E*64 i
= _ .... ..... ..._.......__...........
IC-14 1 3.589E+44 I lY 90 - 1 4.107E+03 1 11 132 1 2.116E+03 I
. .. . .........= ....... ...... - _ - _ _ =--....
inn-24 I 1.610904 I lY-91M l 5.069E-01 I 11-133 1 1.658E+04 I IP-32 1 2.609E+06 I lY-91 1 9.139E+05 I 11-134 1 1.173E*03 I ICR-51 I 0.000E*00 1 *iY-92 1 2.035E+01 I 11-135 1 4.921E+03 i
..... .. .....__.. ..... .. ....... =.....
INN-54 I 0.000E+98 I lY-93 1 1.065E+02 I 10S-134 1 6.512E*05 I 1104-5 6 i O.000E+64 1 125t-95 l 1.099E+05 I 1C5-136 I 6.512E+04 I GE.55 I 4.736E+04 l 12R-97 I 1.876E+02 I ICS-137 l 9.065E+05 i ire.59 1 2.06BE*04 I 116 -95 1 2.350E+04 I ICS-138 1 6.327E+02 I
- - =- --...
100-58 I 0.000E+00 I 110 99 I 0.000E+00 1 184-139 1 1.843E*00 I 100-60 1 0.000E+00 l ITE-99N I 1.780E-03 1 194140 1 7.400E+04 I
( T lHI-63 1 0.214E+95 I ITE.101 1 0.163E-05 I 104-141 1 1.957E.01 1
- "/ .. ... . .. =_ ....- .. ..
INI-65 1 2.990E+00 l .1 6 103 1 2.794E+03 1 194142 3 4.995E-02 I 100-64 1 0.000E+08 I 1 6 105 l 1.520E+00 I ItA-140 I 6.438E*02 1
=_....._......
IN-65 I 4.25EE+04 I I E 186 I 1.362E+05 I ItA-142 1 1.295E+00 t
... . .. . . _ ..... ........ ... .......- =.....
IN-69 I 6.697E-02 1 14G-110N I 1.687E+04 I ICE-141 1 3.922E+04 ~l
.._-_ ._...... . . = ..... =.
19P-83 1 0.000E+00 I ITE-125N I 6.734E+03 I ICE-143 1 3.659E+02 I 10R-84 I 0.000E*06 I ITE-127N I 2.486E+04 I ICE-144 I 6.771E+06 I IFR-85 1 0.000E+06 I ITE 127 1 2.771E+00 I IPit-143 1 1.846E+04 1 1
.. __. .___ _ _ .... ... . . = -- - =. .. ;
190-86 I 0.000E+44 I ITE-129N I 1.920E+04 1 18R-144 1 5.957E-02 I l I
I 100-88 1 0.000E+00-1 ITE-129 l 9.768E-02 I 180-147 l 1.000E+n4 I
.._ ...=_ - ..... l 104-09 I 0.000E+04 I ITE-131N I 1.343E+02 I IW-107 I 1.632E*01 1 159-89 I 5.994E+05 I ITE-131 1 2.172E-02 I IMP-239 I 4.662E+02 I l 159-90 1 1.010E+08 I ITE-132 i.4.818E+02 I l
.... - ............ j 158-91 1 1.214E*82 l 11-139 1 0.177E+03 I
- -- See Note, page 3.0-21 D')
5 I
Units: mrem /yr per uci/m3 Quantum:HCGS ODCM 3.0-15 Rev. 1, 11/85 l
1
.. , , _ . - _ . - .-. - , - _ - _ - .i
g (V i Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (P.10}*
Page 3 of 7: Dose Factors for Liver 1 ISOTOPEI INHK ATION I I IS070PEI llH LATION I I ISOTOPEI IMOT10N I
.... ... .........=_- - ..... ........................
lH.3 I 1912-92 1 0.000E+00 I 11 131 1 4.01 @ 44 1
. ...=_ 1.125E+03'..I ........................ =............
Ir-14 5 6.734F+03 I lY-90 1 0.000E+00 1 11-132 1 4.070E+03 I
..... .... _....... . ==..=--- - =
IN4-24 1 1.410064 I lY.91M I 0.000E+0e i 11 133 1 2.031E+04 I
... .._.. ..... ..... ....... ...... . ====----_............
IP.32 I 1.143E+0E I lY.91 1 0.000E+64 I 11 134 1 2.161E+03 I ICit-55 7 0.000E+00 I ~5M I OIO90E+00 1 11-135 I 8.732E+033 1196-5 4 1 4.292E*04 I lY.93 1 0.000E+00 I 105-134 i % 014E+06 I
.......... . ... - =............ .. =_ .-:.. ...
1996-56 i 1.658E+44 1 13 95 1 4.181E+04 I ICS-136 I 1 M9E+05 I IIT.55 1 2.516E*t4 1 12R-97 1 2.716E+01 I ICS-137 I 8.251E+05 I ire.59 1 3.345E+44 1 15-95 I 9.176E+03 I 105-138 I 8.399E*02 I Ir0-58 1 1.772E+03 I 110-99 1 1.724E+02 I I6A.139 I 9.842E-04 I 100-60 l 1.314E+04 I ITC.99N I 3.482E.03 1 186-1 6 I 6.475E+01 1
== . ._.___...... .._ .. . -- . .
\
INI-63 1 4.625E+64 I ITC-101 I 8.510E-05 l 15-141 1 1.092E-04 I (Q ..
INI-6E I 2.956E-01 I
. . -- ===..... ....
t h 103 1 0.000E+08 i
. .....=
W 42' I 3.600E-05 1
_ =........... n.. ..-___ ......
ICU-64 1 1.994E+04 i 1110-1 05 1 0.000E+44 I ILA- N I 2.250E+02 1 12N-65 1 1.132E+0E I I E 106 1 0.000E+00 t ILA-142 l 4.107E-01 I 12H-69 I 9.657E-82 I idG-Ilon 1 -1.140E+04 I ICE-141 1 1.954E+04 1 19R-83 1 0.000E+00 I I)E.12EN I 2.327E+113 I ICE.143 1 1.987E+02 I
. . ......- . . .. .........= --
...............==
181t-84 1 0.000E+64 I ITE-127tt i 8.547E+03 I IE.144 1 2.116E*06 i
..=_ ....
15-85 1 0.000E+40 l 11E-127 l 9.509E.01 1 IPR.143 1 5.550E+03 I f.!_...f.. 2 ! .f....!f!b1!f..f f . f..f..b! !!~.!!..f I 1488 I 5.624E+t2 I ITE 129 I 3.497E-02 I IMO-147 I 8.732E+03 I l 106 09 1 3.452E+02 I ITE-131N I 5.920E+nt i IW-107 I 9.657E+00 i !
.= . =_ _
_............ ............._= =.... 1
.ISR-89
... ..= .000E+44 I 0 I ITE-131 1 8.436E-fl3 I IW-239 I 3.345E+01 I l
..=- . .... .=== _......... ... ..... .===- ..
I 15R 9n 1 0.000E+00 I ITE-132 1 2.723E+02 I l
.=== . ....... 1 ISR.91 I 4.000E+00 I 11 130 1 1.63 0 04 I
- -- See Note, page 3.0-21 g
Units: mrem /yr per uCi/m3 Quantum:HCGS ODCM 3.0-16 Rev. 1, 11/85 l
l
lp_ 1 AJ Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (P.lo)*
Page 4 of 7: . Dose Factors for Thyroid I ISOTOPEI IM R ATION I i 190ftFEl INHALATION I I ISOTOEl ImlALATION I IW.3 1 1.125E+03 1 19R.92 1 0.000E+04 I 11 131 1 1.624E+07 I 10-14 1 6.734E*03 I lY.90 1 0.00nE+00 1 11-132 1 1.935E+ns 1 INA.24 I 1.610E+44 I lY.91N I 0.000E+00 1 11 133 1 3.840E+06 i IP-32 1 0.000E+44 l' lY-91 1 0.000E*60 1 11 134 1 5.069E+04 I 100-51 1 0.547E+01 I lY-92 1 0.000E+09 I 11 135 l 7.910E+05 I 1 % 54 1 0.000E+00 I lY.93 1 0.000E*00 1 10S-134 I 0.000E*00 I 1 % 56 I 0.000E+H I 13 95 1 0.000E+tt i 1C5 136 1 0.000E+00 I
. . ....==_
ire-55 1 0.000E+84 1 13 97 1 0.00E+H I 105-137 I 0.000E+00 I IFE-59 I 0.000E+00 1 1495 1 0.000E+H I ICS_138 1 0.000E*00 I 100-50 l 0.000E+44 I lie.99 1 0.000E+00 l 19A-139 1 0.000E+00 I 100 60 1 0.000E*00 l ITC.99N I 0.000E*00 1 104-140 1 0.000E+00 I
/ IN!.63 1 0.000E+00 -1 IK_191 1 0.000E+H 184 141 1 0.000E+00 1
\ '
- -.... . . _ _ _ . = ... .1 .......__ ..- ---===...
lHi-65 1 0.000E+44 I 1810 103 1 0.000E+00 1 684 142 1 0.000E+00 I -
100-64 1 0.000E+00 I 1110 105 1 0.000E+00 I ILA-140 1 0.000E+00 1 12465 1 0.000E+04 I 1115-106 1 0.000E+00 1 ILA-142 1 0.000E+00 1 15-69 I 0.0ikIihi I h 110M i ~ hIh5k hh i ick 545 I 0.000EA00 I
-.199 83 1 0.000E+00 I 'ITE.125N I 1.924E+03 I ICE-143 1 0.000E+00 I 189-84 1 0.000E+44 1 IE 127N I 6.068E+03 I ICE.144 1 0.000E+00 I 19R.85 1 0.000E+M i ITE.127'i 1.961E+00 I If4t.143 1 0.000E+00 1 199 86 1 0.000E+M i IE.129M i 6.327E+03 I IPR.144 1 0.000E+00 I 199 88 1 0.00nE+00 t ITE.129 I 7.141E-82 I IMO.147 1 0.000E+00 I 119-09 1 0.000E+04 I IE.131M i 9.768E+01 I IS187 1 0.00nE+00 I 158 09 I 0.000E+00 I 1E-131 1 1.69RE.92 I l@-219 I 0.000E+00 I 15#.94 I 4.94E+00 I ITE.132 1 3.175E+02 I Ice.91 1 0.00K+00 l 11 134 I 1.84E+46 I
- -- See Note, _ page 3.0-21 1
n\
O Units: mrem /yr per uCi/m3 Quantum:HCGS ODCM 3.0-17 Rev. 1, 11/85
m
/T l
(_)
(
Table 3.2-1 PATHWAY DOSE' FACTORS FOR SECTION 3.2.1.b (P.lo)*
Page 5 of 7: Dose Factors for Kidney
.. ....- =. ....... ............... ... ...........- ....
I ISOTOPEI IM41LAT10N I I ISOTOPEI IIMILATION I I ISOTtPEI llHILATION I 164 3 1 '1.125E+03. I ISR.92 1 0.000E+44 1 11-131 1 7.891E+04 I 1C-14 I 6.734E+03 I lY.90 1 0.000E+04 I 11-132 1 6.29E*03 I
....- ........= . _............
INA-24 1 1.610E+04 I ly.91n 1 0.00DE+06 I 11-133 1 3.3?RE+04 1 IP-32 1 0.000E+00 I ly.91 1 0.000E+00 I 11 134 I 3.300E+03 I
..--. ........................ ......====
ICR-51 1 2.431E+01 1 4Y-92. 1 0.000E+00 I Il-1M i 1.339E+04 I IMN-54 i 1.003E+64 I lY-93 1 0.000E+88 I 105-134 1 3.304E+05 I INN-54 i 1.672E+60 1 12R 95 1 5.957E+td i ICS.136 I 9.546E+04 I IFE-M I 0.000E+00 I 12R-97 1 3.895E+st i 105-137 I 2.823E+05 I IFE.59 .I 0.000E+00 1 1 4 95 I 8.621E+03 I ICS-118 1 6.216E+02 I
.......-- .. .. == _ - - -.....
ICn EB I 0.000E+00 I IMO 99 I 3.922E+02 1 184-139 1 8.621E-04 I tr0-60 1 0.000E+H l ITC-99N I 5.069E-02 1 134-140 l 2.113E*01 I fy INI-63 1 0.000E+#8 I ITC-101 1 1.450E-83 I 184 141 1 9.472E-05 I V) t IN1 65 1 0.000E+H I kl.la3 I 7.030E+03 1 18A-142 1 2.912E-05 I 100 64 1 6.031E+H I 1n0 195 l 1.343E+08 I ILA-140 1 0.000E+00 I IN68i I 7.141E*l4 1 111U-106 1 1.839E+05 I ILA-142 1 0.000E+04 I
- IM69 I 5.044E.82 1 14110N I 2.124E+94 I ICE-141 1 0.547E+03 I 198 83 1 0.000E*00 I ITE-125M I 0.000E+08 I ICE.143 1 8.362E+01 I
..._ ....... ... ..... ........_ _ ___ ........... .= = .
190-84 1 0.000E*00 t ITE-127M I 6.364E+44 I ICE-144 1 1.173E+06 I
.... .....- _ .. . . ~ . . - - ......
191585 I 0.000E+06 l ITE.127 I 7.067E+08 I IPR-143 1 3.001E+03 I 1566 -1 0.000E+H I ITE-129M i 5.032E*84 I IFR-144 I 9.768E-03 I 148A i 0.000E+H I 'lTE-129 I 2.569E-61 I 1 6 147 1 4.81AE+03 I 1818 69 I 0.000E+00 1 ITE-131M i 3.996E*02 I IW-107 1 0.000E*00 I 1 9 -89 I 0.000E+H I ITE.131 1 5.003E-02 I lHP-219 I 9.731E+01 I 199 A I 0.064E+80 I .lTE.132 1 1.772E+03 I 150.91 1 0.00AE+99 I it.134 1 2.446E+44 1 I
1
- -- See Note, page 3.0-21 (d
\
Units: mrem /yr per uci/m3 Quantum: HCGS ODCM 3.0-18 Rev. 1, 11/85
m
-/ i V. PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b Table 3.2-1 (P.lo)*
Page 6 of 7: Dose Factors for Lung 1
1 ISOTOPEI IpeelLATION I I ISOTOPEI I H LATION I I ISOTOPEI INNALATION I IN.) I 1.125E+03 1 19 92 1 2.401E+04 I 11-131 1 0.0nnE*00 i 10 14 1 6.734E*03 I lY 90 1 2.616E+05 I 11-132 1 0.000E+00 I
..._ . . - . . . ..........==_ _..... .. ........- __-
lNA 74 l 1.610E*H I IY.91M i 2.012E+03 I 11-133 1 0.000E+00 I 18 32 1 0.000E+04 I lY.91 1 2.62?E+06 I 11-134 1 0.000E+00 I Ir.9-51 1 1.690E+44 I .IY.92 1 2.390E+04 1 11-135 1 0.000E+no I
.== .. ..._ ..........._ ... .. ._...........
Ift6-54 1 1.576E*06 I lY 93 1 7.437E+04 I ICS-114 1 1.210E+05 I
.=__ . ...... . ....... _... ................ _...
lit 6-56 1 1.314E+04 1 1R.95 1 2.231E+96 I ICS-136 1 1.454E+04 I
..... =- -
IFE.55 1 1.110E+05 1 _ IR-97 1 1.132E*05 I 1C5-137 1 1.04nE+05 I
. .....- .. . . .. _......... . ...= _ _. ..........
IFF.59 I 1.269E+06 1 1 4 95 1 6.142E+04 I irs-IT9 I 6.009E+01 1 ICO-5A i 1.106E+46 i ' Ift)-99 I 1.354E+n5 I 1(%-139 4 5.77?E+03 I 100-60 1 7.06?f+46 I ITC-99n i 9.500E+02 I 104-140 1 1.743E+06 1
,q IN1-63 1 2.749E+0E I ITE-In1 1 5.846E+02 I. 104-141 1 2.910E+03 i
- .. .. _ . . .. _.... .. ... .. ........__ _ =.
\.. INI-64 I 8.177E*03 I IllU-int i 6.623E+05 I 134-142 1 1.64TE+03 I
..- . -- _ ~.... _ .- ......_ ..
lCU-64 1 9.583E+03 I i b in5 1 1.591E+64 I n 4 140 1 1.029E+05 I
. _=... .. ..... .. -- .... ... ..........
12N.65 I 9.953E+05 I l b l06 1 1.432E+07 I flA-142 1 0.695E+03 I 17N-69 1 1.421E*03 I IAG-110M i 5.476E+06 I ICE-141 1 5.439E+05 I
. .- _ ..... . _ ... .= _ - - . .......... .
IEG-03 1 0.000E*00 l ITE-125M I 4.773E45 I trE-143 1 1.154E+05 I
.._ - ... ...- ....... . .... ........ .-= ...
198-04 1 0.000E+M i ITE-127N I 1.400E+96 I ICE-144 1 1.195E+07 I 1118-8 9 I 0.000E40 l ITE-127 1-1.003E+04 I Ip8t-143 L 4.320E+ns I
.. .. ..... .. ..__ . . . . . ... ==_=......... .
IM 1 0.000E*00 1 ITE-129M i 1.761E+06 I IPW-144 I 1.565E+03 i
_ -86 -
1119- 8 9 1 0.000E+9t I ITE-1?9 l 2.934E+03 I IND-147 1 3.202E+n5 I 109-89 1 0.000E+00 l ITE-131n i 2.0S?E+05 IW-197 I 4.107E+04 I
......_ .. . .- _= =- --- ... ............... ....
1 9 -89 1 2.157E+06 I ITE-111 1 2.054E+03 I INA.239 I 5.009E+64 I
............_...... . .. ............... ......-- __= . 1 19 94 1 1.476E+07 I ITE-132 1 3.774E+05 1 19-H I 5.128W 04 I ll-139 i S.890E+04 I
- -- See Note, page 3.0-21 d Units: mrem /yr per uCi/m3
-Quantum:HCGS ODCM 3.0-19 ~Rev. 1, 11/85
73
-f \
V Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (P.lo)*
Page 7 of 7: Dose Factors for GI-LLI I ISOTnPEI I H LAfl0N I i 190TOPEI I H LAil0N I I ISOTOPEl I H LATION l 8H 1 1.125E+fl3 I ISR e 2. 424E+ M i 11-131 1 2.042E+03 i
___-3 __............... .. ..._-92 -
IC-14 I o.734E+03 I ly.90 I 2.679E+05 1 11-132 1 3.201E+0} I INA-24 1 1.610E+04 I tv.91n i 1.717E+03 I 11 133 I 5.4hE+03 1
_ ---- ===..... .. ... .......... ... .. ........ ..............
IP-32 _l 4.219E+H I lY 91 1 1.839E+05 I 11-134 1 9.546E+02 I ICR-51 1 1.004E+03 I iY 92 1 2.390E+05 I 11-1 % I 4.440E+03 I
.. .........._ _.... _____............ ...._= ......._......
1 % 54 1 2.290E+04 I ly.93 i 3.095E+05 I 1C5 134 1 3.840E+03 I
. ......- - ..... . __.=-_ . . .. _....
1 % 56 1 1.232E+05 1 179 95 1 6.105E+04 I ICS.136 I 4.101E+03 I
- -- - .== . . ..... _...___.... . ....__.....=- ..
IFE-55 1 2.860E+a) i 13 97. I 3.511E+05 l 10S-137 1 3.619E+03 I
-...._=- ..............- ..__ ....... - .....
IFE 69 1 7.067E+04 I l B.95 l 3.700E+04 i trS.110 1 2.697E+02 8
--- -- =. .'....................... .........==-
100-50 1 3.437E+N i iM0 99 1 1.265E+05 1 604 139 I 5.772E+04 I
.-- - === ......___
..u _ __ __.. ..... __ .-
100-60 1 9.620E+04 I ITC.99N I 4.910E+03 i 194 140 1 1.018E+05 I
.....== .. .- -
[n')j INI.63 I 6.327E+03 I ITC.101 1 1.632E+01 1 194-141 1 2.753E+02 1
.....=- .
INI 65 I 0.399E+04 I IRU-101 1 4.477E*84 1 194142 1 2.742E+00 I ICU-64 1 3.670E+N I Illy-1M i 9.953E+N I ILA.140 1 2.257E+05 I
. . . . . - . __=.__....... ... _ _.
I?*4-65 i 1.632E+04 I 1110 106 i '4.292E+05 i lle.142 I 7.505E+04 I
~12H-69 I 1.010E+04 I IAG.110M i- 1.003E+05 I ICE-141 I 5.661E+04 I IBP-83 1 0.000E+99 I ITE-125M I 3.378E+04 I ICE-143 1 1.271E*05 I IBR-04 1 0.000E+04 I ITE.127M i 7.141E+04 I ICE-144 1 3.805E+05 I IBR-85 1 0.000E*06 I ITE-127 I 5.624E+04 I IPR.143 1 9.731E+04 I IRB-86 1 7.992E+03 I ITE.129M I 1.817E+05 I IPR.144 i 1.968E*02 I IR9-08 1 1.724E*01 1 ITE-129 I 2.549E+04 I l @ -147 1 0.214E+04 I
. ......===------ _.. ..........--- . - ............
109-89 1 1.091E*04 I ITE- U1H I 3.079E*05 I IW-107 I 9.10?E+n4 1 ISR-89 1 1.672E*05 I ITE-131 1 1.332E+03 I l*-219 I 6.401E+04 1 l @ 90 1 3.434E*I6 I ITE.132 1 1.376E+05 I 15R 91 1 1.739E+05 I 11-130 1 5.1HE+03 I
- -- See Note, page 3.0-21
- Q V Units: mrem /yr per uCi/m3 Quantum: HCGS ODCM 3.0-20 Rev. 1, 11/85
1 4
- 1. NOTE:' The Pi o values.of Table 3.2-1 were calculated according to the methods of Ref. 6, Section 5.2.1, for the child
- f. age group. The values used for the various parameters, j and the origins of those values, are given below in
-Table 3.2-3.
1 l
l 1
I l
1 1
I 4
s Quantum: HCGS ODCM 3.0-21 Rev. 1, 11/85
I \
V Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rigg)*
Page 1 of 21: Dose Factors for Total Body I ISOTOPEI I n t.ATION I 910180 PUWEI GRS/ Coll /ti!LKI 14 1 1 6.469F+02 I I.000E*66 1 2.353E+03 I 10-14 I 5.106E+01 1 0.000E+00 1 7.940E+08 i
.................. ........-_ - .=== =_
INA-24 8 1.056Ed4 1 1.194E+07 1 2.453E+07 I IP-32 1 7.742E+04 1 0.000E*00 1 9.000E+99 I O -51 1 0.946E+01 1 4.659E+06 1 2.565E+05 I It94-54 I 4.984E+03 1 1.306E+09 1 1.406E+07 I It94-4 I 2.212E-01 1 7.J35E*05 I 8.641E-43 I IFE-% 1 3.332E+03 I li.000E+00 1 3.712E+07 1.
= ......
IFE 59 I 9.479E+01 1 2.727E+08 1 2.457E+06 I 100 58 l 1.020E41 1 3.011E+09 I 9.634E+07 I 100-60 l 1.157E+64 1 2.152E+10 1 3.311E+08 1 f~'so t
INI-63 I 1.161E+44 1 0.00nE+00 I 1.929E+09 I O
. ....=--_- - __
INI-65 l 1.231E-91 1 2.970E+05 1 2.071E-01 I 108-64 1 7.742E-91 1 6.0+7E+05 1 1.366E+05 1:
12N-65 1 3.100E+44 I 7.463E*08 1 1.39?E+18 1 124-69 I i 182E-03 1 0.000E+00 1 5.596E.12 I
.................. ................. =. .....
iM.01 1 3.800E+42 l 4.071E*03 1 1.406E+00 1
_=
IRD-R4 1 4.004E+02 1 2.026E+05 1 1.990E-22 I 19R A5 1 2.044E+01 1 0.000E+00 1 0.000E+00 I 111B-86 I 8.020E+84 1 9.904E+06 1 1.749E+10 1 IRB-BR I 2.970E*02 1 3.307E+04 1 1.634E-44 I
.......- --___ _... .............=_ ....
IR9 A9 1 2.059E+82 1 1.23hE+n5 l 3.741E-52 I
.................. ...........=_ - .......
19-89 1 1.141E44 1 2.162E+04 1 5.741E+99 I-
.. ......=_ . _ -- ..._.- -- ==..
ISR-9n i 2.590Ed6 1 0.00nE+no I 4.925E+10 I
_ _ = = _ - ___ - ==.-
158 91 1 3.450E+44 1 2.144E+46 1 1.564E+04 I
- -- See Note, page 3.0-43
^
/s Units: Inhalation - mres/yr per uCi/m3 Others -
m2 arem/yr per uCi/sec )
1 Quantum: HCGS ODCM 3.0-22 Rev. 1, 11/85 !
7.
Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R L.
30)*
Page 2 of 21: Dose Factors for Total Body I 191TOPFI Im ATirst I (J0lM) PLANEl GDS /C0lutilLKI 188 92 1 3.984E-01 1 7.760E*05 1 2.74?E-01 1 lY-90 I 8.020E*01 1 4.491E*03 I 2.90AE+01 1 I'V-91M i 1.1AAE-02 1 1.002E+65 I 3.051E-26 I lY-91 1 1.5e0E+04 1 1.073E+06 1 3.104E+03 I IA92 15'4.606E-01 1 1.50'E*05 4 1 2.404E-09"I
.... .= - ..== _ - .....
lY-93 1 4.074E*00 1 1.652E+05 I 9.745E-02 I 179 95 l 2.03nF+04 1 2.446E+0A 1 1.871E+03 1 17R-97 1 1.170E+01 l 2.960E+06 1 5.065E-81 I I A 05 i 3.78nE+03 1 1.4A9E*09 1 2.27nE*05 I IMO-99 I 3.23#+01 1 3.995E+06 1 6.453E+07 I Ifr.99n 1 3.724E-02 1 1.041E*05 I 1.161E+03 1
.m s ITC-101 1 0.120E-04 1 2.034E+44 I 4.525E 58' I
- (d '
imi-1CI i 6. 790E+02 1 1.084E+08 1 4.615E+03 I tmkl05 8 4.102F-01 1 6.363E*05 1 4.315E-03 1 18tb106 1 1.000E+04 1 4.200E+09 1 3.781E+04 I lag.110M i. 4.990F+03 1 3.445E+09 1 2.96'E*66 I
....--- _=. =-_
!~ 125N I 6.5ADE+02 1 1.552E*06 1 3.243E+3~/ I ITE.127tl i 2.072E+03 I 9.165E+04 I 0.10AE+07 I ITE-127 1 4.006E-01 1 2.994E+03 1 2.214E+03 I ITE-129fti 2.226E+03 1 1.972E+07 1 1.364E+08 I ITE-129 l 1.076E-82 I 2.600E+04 I 7.79AE.16 I N I 8.526E+06 1 1755E+06 I iib 53I'.'.I"3326E+Al sTE-131 1 4.990E-01 1 2.919E+04 1 1.53nE-32 I ITF-132 1 1.764E*02 1 4.223E+06 I 1.546E+67 I 88-130 1 5.572F+03 8 5.911E*06 1 4.99T+96 I
.-- See Note, page 3.0-43 o i f Units: Inhalation - mres/yr per uCi/m3
-v Others -
m2 mrem /yr per uCi/sec Quantum: HCGS ODCM 3.0-23 Rev. 1, 11/85
p) i V Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*
Page 3 of 21: Dose Factors for Total Body
.1...190T0pEl IHLATION I GROIDO PL4El GRS40Millifl.81-131 1 1.96eE*04 I 1.721E+07 1 2.24?E+09 I 11-132 i 1.?59E+03 I 1.245E+D6 1 1.648E*00 1 11-133 1 5.60DE+03 1 2.451E*06 1 2.460E+07 I 11-134 1 6.650E*02 1 4.467E+05 1 2.039E.11 1
=_== . . --- _. - .__
it.135 1 2.7??E+03 1 2.526E+06 i 1.296E+95 I
.. .. .= _.......- .........- ......
10S-134 1 7.449E+04.I 6.963E+09 1 1.093E+10 I 10S-136 1 5.299E+04 1 1.50?E+08 I 3.44?E+09 I 1C5-137 1 4.55GE+04 1 1.030E+10 1 6.792E+89 I 105-130 1 3.976E+02 1 3.509E+05 l 1.051E-22 I 104-139 4.29 AE-02 i 1.061E+05 1 2.089E.08 i
.... - = .........- ----
184-140 1 2.R90E+03 1 2.053E+07 1 1.976E+07 I (s-)
Lj 114-141 1 4.970E-03 1 4.172E+04 1 2.00EE-46 i 484-142 8 1.960E 83 1 4.44;E+nd 1 0.000E+00 I ILA-len 1 5.152E+01 1 1.921E+07 1 6.551E*00 I ILA-142 1 9.044E-02 1 7.60?E+05 1 2.418E-11 I
...... = -
___ =.... ... .
ICE-141- t 1.900E+03 1 1.366E+07-1 4.953E+03 I
.. =....... ._ ..........
ire-143 1 2.212E+01 1 2.312E+06 1 4.779E+01 I ICE-144 1 1.764E+05 l 6.946E+07 1 2.073E+95 I IPil-143 1 6.986E+02 1 0.000E+A0 1 1.172E+02 I 1811-144 1 2.400E.03 1 1.837E+03 I 5.215E-54 1 14 147 1 4.oSPE+02 1 8.460E+06 1 0.033E+01 I 166-107 1 3.122E+00 1 2.360E+06~ l 2.340E+04 i
=.. .......-
IMP-739 1 1.876E+01 1 1.786E+46 1 2.923E+00 I l
l l
I
- -- See Note, page 3.0-43 Inhalation - mrem /yr per uCi/m3 h)
Units:
others - m2 mrem /yr per uCi/sec Quantum:HCGS ODCM 3.0-24 Rev. 1, 11/85
l l
l i
1 (v) Table 3.2-2 l
PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R i j.o)*
Page 4 of 21: Dose Factors for Bone
. . . . . . . . . . . . . . . . . . - _ =___ _- ..................
I 190T0pEl INHALATION I 910lM) PueEl GRS/C0blotlLi(1
-lH-3 8 0.n00F+ne 1 0.000E+06 1 0.00nE+00 t IC-14 1 2.64AE*04 1 0.00nE+00 1 3.722E+09 I 11 # -2 4 1 1.056E+64 1 1.194E+07 I 2.453E*07 I IP-32 1 2.030E+06 1 0.000E+00 1 2.549E+11 i ICR-51 1 0.A01E+00 1 4.6SSE+06 1 0.000E+00 I
..... ..... ......_ ....... = .....
Ir96-54 1 0.000E+00 1 1.386E+09 1 0.000E+49 I 1194-56 1 0.000E+00 1 9.035E*05 1 0.000E+44 I IFE-56 1 1.074E+44 1 0.000E+00 1 2.15aE+00 I IFE 99 I 1.357E+94 1 2.727E+08 1 3.569E+00 l I 5 hh'"I h hone +00 1 3.811E+68 0.000E+00~I ICO-60 I 0.000E+00 1 2.15?E+10 1 0.000E+00 I INI.63 1 3.388E+05 1 0.000E+00 1 5.558E+10 1 (r')
'V INI.4%
i 2.304E+#9 I -2.970E+05 1 5.576E+06 i E ICU-64 l ~hIbh0E+00 1 6.b67E+05 1 0.00bEhh"I
............._ =- ==
17N-65 1 1.932E+64 1 7.461E+08 1 0.833E+09 I 174-49 I 5.39nE A2 1 0.00flE* 00 1 4.177E-11 I
. . . . . . . . . . . . . . . . - - =- _ .. -- ........ ._
18R-93 1 0.000E+40 1 4.871E+03 1 0.000E+00 I 199-84 1 0.000E+ta i 2.026E+05 1 0.000E+00 I
...........=_ ...- .== _..........
IIIR-85 1 0.000E+48 1 0.000E+00 1 0.000E+04 I
. tllbe6 1 0.000E+99 1 8.994E+06 1 0.000E+00 I
[U l 6[5hnE+00"I~3.367E+04 I h.000E+00 i 1119-99 1 0.000E+0a I 1.230E*05 I 0.00nE+00 I
... .- ===............................
1 9 -09 I 3.076E+s5 1 2.162E+04 1 2.002E+10 I
. .........._..- =..............
19 96 I 4.090E+47 1 0.000E+00 1 1.934E+11 I
................. -=..-=- z.......- -....
19 91 1 9.56?E+01 1 2.la0E+06 4 4.320E+A4 I
- -- See Note, page 3.0-43 s
Units: Inhalation - mrem /yr per uCi/m3 Others - m2 arem/yr per uCi/sec Quantum:HCGS ODCM 3.0-25 Rev. 1, 11/85
i I
I m
l V) Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION'3.2.3 l
( Ri ].o)* !
i Page 5 of 21: Dose Factors for Bone I ISOTOPEl llemLATION l GBOUND PLANEl G85/C0iktilLKI 158-92 I 1.050E+01 1 7.76aE*AE ' 7.385E+00 I lY 90 1 3.290E+03 1 4.4*lE+03 I.1.004E*03 I 4Y 91M i 4.074E-01 1 1.0n2E+ns 1 8.994E-10 I iY-91 1 5.000E+05 1 1.073E*06 1 1.165E+04 I lY.92 l l.630E+01 I 1.0n4E*05 I 8.554E-04 I lY-93 4 1.49PE+02 1 1.852E*05 1 3.677E+00 1 179-95 1 1.154F+05 1 2.44AE*00 .I 1.00?E*04 I 129-97 1 1.490E*02 1 2.960E*06 1 6.462E+00 I 1 4 95 i 1.660E+04 1 1.460E*04 I ~9.932E+05 -I
.IEis95~~I~0I000E+00 I 3.995E+06 1 0.00aE+00 I
- TC-9sn i 1.397E-03 1 1.041E+05 1 4.372E+01 I
.....- _.- = . - - .
.. A ITr-104 1 6.510E-05 1 2.034E+04 1 3.630E-59 I l .. .-
\.. Ikt-Is1 1 2.016E+03 1 1.094E+08 I 1.38nE*04 I Imi.10s i 1.224E+00 1 6.341E*05 1 1.291E-02 I l#tt-1M i 8.600E+04 I 4.2 NAE +00 1 3.027E+04 I ter.-110M l 9.9A2E+03 I 3.449E+09 I 6.130E+06 I ITE.12CH I 4.760E+03 1 1.55?E+n6 I 2.390E*08 I ITE.127tt i 1.666E+04 1 9.165E+04 1 6.70nE+0A I ITE-127 1 2.226E+00 1 2.994E+03 1 1.030E+04 I ITE-120M i 1.414E+04 -l 1.972E+07 1 0.854E+08 i ITE-120 1 7.0A?E-02 1 2.600E+04 1 3.340E-04 I ITE-131M i 1.n6?E*02 1 0.02er+0A I 5.372F+06 I ITE-131 1 1.716E-02 1 2.910E*04 1 5.49?E-32 i ITr.137 1 3.724E*02 1 4.223E+06 4 3.346r+07 8 ar.13n 1 6.356E*03 I 5.511E+06 1 5.646E*66 1
- ~- .See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others - m2 mrem /yr per uci/sec Quantum: HCGS ODCM 3.0-26 Rev. 1, 11/85
. // ,%
-\s l
'"f Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..130)*
Page 6 of 21: Dose Factors'for Bone
.............. ...................... =.....
I 190TOPEI IIMILATION I 910t90 PueEil GIS/Cini/filLXI it_111 8 3.794E+04 1 1.721E*07 I 4.327E*09 I 11 132 1 1.694E+03 1 1.245E+06 1 2.200E+00 I 11 113 1 1.124E+04 I 2.451E*06 1 5.768E+07 I
................ ............=_-- .......11-134 1 9.21?E*02 1 4.467E+05 1 2.799E.11 l
............_..=--
tI-115 I 3.964E+03 1 2.576E+06 1 1.786E+D5 I ICS.134 1 3.962E+A5 1 6.863E+09 I 5.003E+10 I
.........._.........._ =- ........ .............
Irs.1% i 4.n3nE*04 1 1.502E+08 I 3.135E+09 I
...... _ ..==- -.
8C5-137. I 5.400E+05 1 1.030E+10 I 9.187E+10 1 ICS-139 8 5.056E*02 1 3.509E+05 1 1.334E-22 I 134-139 1 1.404E+00 l 1.061E+05 l 7.219E-07 I
. l94-140 1 5.600E+04 4 2.053E+07 1 3.035E+04 I p) g
~.
194-141
___ _ = . ..._....
1- 1.568E nl I 4.17?E+04 I 6.611E-45 i
. .........................._..== --- ........ .
= - . . . . .
194-142 1 3.976E-02 l 4.445E+A4 1 0.0C0E+00 I ILA-14h i 5.054E+02 1 1.921E+07 1 6.460E+01 I ItA-142 1 1.030E+00 1 7.602E+05 1 2.751E-10 I ICE-141 1 2.772E+h4 1 1.366E+07 1 6.099E+04 I ICE-143 1 2.926E+0? I 2.31?E+06 I 6.311E+02"I ICE-144.I 3.192E+06 i 6.946E+07 I 3.699E+06 I 189-143 1 1.400E+04 1 0.0nnE+00 1 2.365E+03 I IPII-144 I 4.700E-02 1 1.837E+03~l 1.035E-52 I
. ............... ........ .............=
14-147 I 7.939E+03 I 9.468E+06 1 1.404E+03 I
.......- .__................. .....= _....
1 1.296E+61 1 2.360E+06 I 9.739E+04 I
.' W...187 INA-239 I 3.710E+02 1 1.706E+06 1 5.784E*01 I 4
- -- See Note, page 3.0-43 m
). Units: Inhalation - mrem /yr per uCi/m3 Others - m2 arem/yr per uCi/sec Quantum:HCGS ODCM 3.0-27 Rev. 1, 11/85
-. - - _ _ . . , - ,- _ _ _ _ . = -- -
q v
t
(. \
V Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 -(Rt. )*
Page 7 of 21: Dose Factors for Liver I ISOTOPfl 14KAT10N I GROUM) PL# del G8S/C0lutilLKI
'H-3 1 6.468902 1 0.000D04 ! 2.361903 I IE-14 i 5.306E+03 1 0.000E+0A i 7.94AE+0B I 168-24 8 1.056E+04 1 1.19/.D07 1 2.453E+07 I
.'...-8-321 1.124E+05 1 0.000E+00 1 1.499E+16 I
=
fr#.51 (r.00nF+00 1 4.659E+04 I 0.000E+60 1 1 % 54 I 2.534E+04 1 1.386E*09 I 6.205E+07 I 1 % 56 3 1.540D00 1 9.035E+05 I 5.013E-82 I IFE-55 1 1.i75D04 1 0.000E+0A i 1.309E+09 I IFF.co i 2.35?D64 1 2.727E+0A I 4.234D9R I tro.5p i 1.210F+A3 1 3.A11E+na i 3.n6?E+07 I trn.6A I 6.027D03 1 2.152E+10 l 1.402E+06 I f'3 tNI.63 i 2.044F*04-_l 0. A03DO A I 3.43AE+69- I
- d' IN!_65
= - - ...
....==-
l ' 2.842E-01 1 2.970E*05 1 6.312E-41 I 1011-64 i 1.076D00 I 6.047E+06 1 2.951E+05 1 12H-65 1 6.259E+64 1 7.463E+n0 1 3.029919 I I5A^l~E554E-02 10.00i!+0A I-7.521E-11 1 tre-83 1 0.000F+00 1 4.871903 1 0.000E+98 l 198-04 1 0.000E*00 1 2.026E+05 1 0.00nDgg i 198 85 1 0.000D0A 1 0.000E*00 1 0.000E+06 I 119 44 1 1.904E+65 I 8.904E+06 I 3.540E+10 I 19R.40 l 5.57?D02 1 3.307E+04 1 2.9A?E-44 I IPit-89 I 3.206E*02 i 1.230E+06 I 5.43tE-62 I 44 69 1 0.00nE+0a i 2.167E+04 1 0.0nnE+A9 I 158-9A i 0.000D9A I 0.000E+00 1 0.00nD00 I 158.91 I 8.000E 80 1 2.148D66 I 0.lgnDg6 I
- -- See Note, page 3.0-43
^
(' Units: Inhalation - mrem /yr per uCi/m3 Others -
m2 mrem /yr per uCi/sec Cuantum: HCGS ODCM 3.0-28 Rev. 1, 11/85
l l
1
'O Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*
Page 8 of 21: Dose Factors for Liver I 190TM. ItemMIGi 6 m PUIEl IM/ Chi 410LXI l@ 92' I 0.000E+n0 1 7.768E+05 1 0.000E+H I lY 90 1 0.000E*00 1 4.491E+03 1 0.00nE+H I lY.91M i 0.000E+00 1 1.002E+05 1 0.00f(+M I lY-91 1 0.000E+08 l 1.073E+06 1 0. 00f(+M i tY.92 I 0.000E+00 1 1.8n4E* 05 I 0.000E+H I
......- -- .. - ...__ - ==.
lY.93 1 0.000E+00 1 1.852E+05 1 0.000E*H I
........._ ..==- . . . .
129-95 1 2.786E+04 1 2.444E+nP i 2.63aE+43 I 17P-97 1 2.562E+01 1 2.960E+' 6 1 1.10*E+86 I tie M i 6.426E*03 1 1.409 1 3.926E+05 1
_..... _ _.......'+n8 __._ __ ...
IMI) 09 1 1.652E+02 1 3.9'4E+06 I 3.309E+R8 1 ITE-MM i 2.884E-03 1 1,841E+05
..___ .. ... ' I _9.017E+01 _.. .....1
/< ,' ITC-101 1 0.232E-n5-l 2.034E+04 1 4.573E-59 I Q __ =.- .. _=
1830-103 1 0.00nE+00 1 1.084E+08 1 0.000E+M l 14195 1 0.000E+R0 1 6.361E*05 1 0.000E+M i
-.... . ...... ==-....... .... _.....
Ib1H I 0.000E+00 1 4.200E+08 1 0.000E+00 t IAG-110M i 7.224E*03 1 3.445E+09 I 4.481E+W I
.....__....==__ --
..==----- _ .......
ITE-125M I 1.988E+03 1 1.552E+06 I 8.019E*I7 I ITE-127M i 6.902E+03 1 9.165E+04 I 2.222E+N l ITE-127 8 9.534E-81 1 2.994E+03 1 3.450E+03 I ITE-129N I 6.090E+03 1 1.972E+07 1 3.030E+00 t ITE.129 1 3.472E-n2 1 2.600E+04 1 1.151E-89 I ITE-131M i 5.502E+01 1 8.026E+n6 I 2.163E+06 I ITE-131 1 0.218E-03 1 2.910E+04 1 2.013E-32 I ITE-112 1 2.366E*02 1 4.223E+06 I 1.6PE*07 I 11 136 I 1.HPE+04 1 5.511E+% I 1.242E*07 8
- -- See Note, page 3.0-43 Units: Inhalation - mrom/yr per uCi/m3 (mV) Others - m2 arem/yr per uCi/sec Quantum: HCGS ODCM 3.0-29 Rev. 1, 11/85
,m
/ \
Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*
Page 9 of 21: Dose Factors for Liver i ISOT0PEI lotal ATION I GilOIM) PLeff GIPS /COMllLKI Il-131 i 4.43aE+04 l 1.721E+07 I E.09'E+09 I 11-132 I 1.542E*03 1 1.246E+0A I 4.629E+00 1 11-133 4 1.918E+04 1 2.451E*06 I 8.399E+07 I Il-134 1 1.R76E+03 I 4.467E+05 I 5.733E-11 I 11 136 I ).602E+03 1 2.524+06 1 3.953E+05 I 1C5-134 I 7.028E+09 I 6.861E+09 l 1.002E+11 I 105 136 i 1.349E+05 1 1.502E+08 I 9.219E+09 I -
IES.137 1 6.11aE+05 1 1.030E+10 1 9.983E+16 1 les.13n I 7.n12E*02 1 3.589E+05 1 2.169 E-27 I lPA-139 I 9.847E-04 1 1.061E*05 I 4.705E.10 I 11414a I 5.600E+01 1 2.053E+07 1 3.835E+05 I in)
,v 111A-141 1 1.n?8E-04 I 4.172E+04 1 4.520E-48 I llA 147 1 3.Ta4E-05 1 4.449E+04 1 0.nonE+00 1
............... ~ ...... ._. .- ..__.
IIA.len i 2.002E*02 1 1.923E+07 1 2347E+01 I ILA-147 1 3.766E-01 1 7.602E+05 I 1.010E-10 I IEE-141 1 1.666E*04 1 1.366E+07 1 4.207E+04 I ICE-141 1 1.932E+02 l 2.312E+06 1 4.199E+05 I ire.144 1 1.211E+06 I 6.946E+07 1 1.914E+06 I IM-143 1 5.23AE+03 1 0.000E+00 1 8.844F+02 I IM.144 1 1.048E-02 1 1.837E+0.1 1 4.006E-53 I 16147 I 6.134+03 I 8.400E+06 1 1.442E+03 ..I IW-187 8 9.016E+00 1 2.360E*06 1 6.772E+04 I IW-239 1 3.11AE+01 1 1.746E+66 1 5.174E+00 i
- -- See Note, page 3.0-43 ;
n I
() Units: Inhalation - mrem /yr per uCi/m3 j
~.-
others -
m2 mrem /yr per uci/sec ;
Quantum:HCGS ODCM 3.0-30 Rev. 1, 11/85
/# \\
/
r )
L' Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R )*
Page 10 of 21: Dose Factors for Thyroid t ISOT0pEl liotHTION I GIEpG PLMEl GIIS/OnletLKl.
lH t 6,469E+02 1 0.000E+00 1 2.353E+03 'l
............................... _ __ = =.......
I 5.306E+03 1 0.000E+00 1 7.940E+00 I
.'C.14
.............. ..............- =-=.... ........
6424 1 1.056E+04 l 1.194E+07 1 2.453E*07 I IP-32 1 0.000E+no I 0.000E+00 1 0.000E+H l ICR-51 1 5.75 0 01 1 4.659E+n6 l 1.674E+05 I 1 % 54 1 0.000E+00 1 1.306E+n9 1 0.000E+H I IE56 1 0.000E*00 1 9.035E+05 1 0.00nE+H I IE-55 1 0.000E+00 1 0.000E+00 I 0.000E+H I IFE 59 1 0.00AE+00 1 2.727E+09 I 0.000E+00 I iCb.'kk"~i 0.00 0 00 1 3.Bi5E+n8 I OIO90E+00 I ICO.60 l 0.009E+00 1 2.152E+10 1 0.000E+00 I INI-63 1 0.000E+00 - I 0.000E+00 1 0.000E*00 I
[y~)T ........_...... .-
INI.65 1 0.00 0 00 1 2.970E+05 1 0.000E+00 I 10.1-64 1 0.00aE+00 1 6.067E+05 1 0.000E+H I
..=== _ _= ...... ........................
12N-65 1 0.00 0 00 I'7.463E+09 1 0.000E+00 I I59 1 0.00RE+00 1 0.000E*00"i"0.000E80~'I
.-=- .
109-03 1 0.00f(+00 I 4.871E+03 I 0.000E+00 I
..........=- - ... ....__ ........... .
1119 0 4 1 0.000E+00 1 2.026E ^ l 0.000E+00 t IIM-65 1 0.00 0 00 1 0.000E+00 1 0.000E*H I
...== ....- .. .. ... ..
189-06 1 0.000E*00 1 8.984E+06 1 0.000E*H I L
1839 8 8 1 0.00aE+no i 3.3n?E+04 1 0.00nE+At I IRS-09 i 0.000E+00 1 1.23nE+05 1 0.000E+00 I ISR-09 I 0.00 0 00 1 2.lo?E+04 I 0.000E+00 .l 199 90 I 0.00aE+00 1 0.0nnE+00 I 0.000E+00 I 198-91 I 0.00 0 00 1 2.1MIE+M i 8.000E+00 t
- -- See Note, page 3.0-43 (mv) o Units: Inhalation - mrem /yr per uCi/m3 Others -
m2 mrem /yr per uCi/sec Quantum:HCGS ODCM 3.0-31 Rev. 1, 11/85 1
p' Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rg3g)*
Page 11 of 21: Dose Factors for Thyroid i 1911TOPFI Imot ATION I G80VW Plae(I GPS /COMill(I 1 9 t 0.000E+60 I 7.768E+05 1 0.000E+08 I IV.96 0.000E+00 I'4.49tE*03 1 0.000E*00 I IV-91N I 0.000E+08 1 1.002E*04 1 0.00nE+00 I lY-91 1 0.n00E+99 I 1.073E+06 1 0.036E+96 I lY-92 i OiO0nE+96 1 1.9n4E+05 I 0.0nnE+66 I lY.93 1 0.00nE+g6 1 1.952E+05 l 0.000E+06 1 129-94 1 3.000F+94 1 2.446E+09 1 0.000E+64 1 55h7 I 1
0.00hk th I 2.960E*05Ih.000Ehi'.~.I
_...__= ___ ........ _ .
1 4 -94 1 0.n00E*06 1 1.409E+09 I 0.00nF+00 I Infi-99 1 0.0nnE*06 1 3.995E+06 I 0.nnnE+46 I ITC-99N I 0.000E+99 1 1.941E+05 1 0.000E+44 1
'(, ,) ITC-101 1 0.600E+00 1 2.034E+04 1 0.000E+46 i 100-103 1 0.000E+04 1 1.004E+09 1 0.000E+00 I iml-105 l 0.000E+80 1 6.363E+05 1 0.000E+00 1 IIR)-10A I 0.000E+89 I 4.200E*00 1 0.000E+00 I IAG-linn I 0.000E+89 1 3.445E+09 1 0.000E+00 1 ITF-125M i 1.624E+03 1 1.552E+06 l~ 9.071E+07 I ITE.127N I 4.972E+93 1 9.165E+04 I 1.935E*06 I ITE-127 1 1.040E+tt i 2.994E+03 I 9.392E+03 I ITE-120N I 5.474E+03 1 1.972E+07-1 3.401E+06 I ITE-129 I 6.740F-82 1 2.600E+04 I 2.799E-09 I ,
ITE-131M i 9.932E+61 1 0.026E+06 I 4.303E+06 I ITE-131 I 1.5n2E-42 I 7.919E*04 I 4.963E-32 I
..._= ........ .._
ITE-132 1 2.706E+42 I 4.223E+06 1 2.44EE+47 I
. ............. _=.____. .- ._
tI-13n i 1.44E+96 1 5.511E+n6 1 1.193E+99 I l
- ~-- See Note, page 3.0-43 l n
Inhalation - mrea/yr per uCi/m3
(])
~.
Units:
Others - m2 arem/yr per uci/sec Quantum:HCGS ODCM 3.0-32 Rev. 1, 11/85
m j h, t f L/ Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..2.]o)*
Page 12 of 21: Dose Factors for Thyroid I 1810TOPEI lleetAfif1N I GilotND PLANEl GitS/COMILKl II.lli i 1. 48/.E* 07 1 1.7?)E+67 i 1.675E+12 I 81-132 1 1.694E+ns 1 1.24;E+n6 1 2.170E+02 I 11-111 1 1.556E+n6 1 2.451E+06 I 1.527E+10 I
.. _.............................= _ ... .
11 134 I 4.45?E*04 I 4.467E+05 1 1.337E-09 I
...........................= .............._.
11 135 ' 1 B.958E*n; I 2.5?6E+06 1 3.105E*07 I
............................... = .... ........
105 134 1 0.00nE+00 1 6.8^1E+09 I 0.000E+00 I 105-136 1 0.00nE+no I 1.50?E+n8 1 0.000E+00 I 105-137 1 0.00nE+00 l 1.03nE+10 4 0.00nE+00 I
... ............... .......=--- -
105-118 1 0.00nE*00 1 3.99E+05 I 0.000E+00 I 194 110 i 0.00nE+no i 1.041E+0i 1 0.000E+00 I 196-140 1 0.00nE+00 1 2.05'IEf07 1 0.000E+00 1 n .....................
( \ 194-141 1 0.000E+00 1 4.172E+A4 I 0.000E+00 I
.\~ ) .............................
194 142 1 0.000E+00 1 4.44.;E+04 1 0.00nE+09 I ILA.140 1 0.00nE*00 1 1.923E*07 I 0.000E+00 t ILA-142 1 0.00nE+n0 1 7.607E+05 1 0.000E+00 1
___---- =.._ .............
ICE-141 1 0.00nE+00 l 1.366E+07~l 0.000E+00 I ICE.143 I 0.00nE+n0 1 2.317E*06 1 0.000E+00 I ICE-144 1 0.00fE+00 1 6.946E+07 I 0.000E+68 1 IPit.143 1 0.00nE+00 I 0.000E+no I 0.000E+00 l 1911 144 1 0.00nE*00 I .1.817E+03 1 0.00l(+00 I 410-147 1 0.00nE+00 1 8.468E+06 1 0.000E+00 I
.' IW.187 l 0.0gnE+00 I 2.3^0E+n6 I 0.00nE*00 I INA.239 1 10.0nflE+n0 1 1.7n6E+66 1 0.000E+00 I s-
- -- See Note, page 3.0-43
/n) Units: Inhalation - mres/yr per uCi/m3
\ ",
Others - m2 arem/yr per uCi/sec Quantum:HCGS ODCM 3.0-33 Rev. 1, 11/85 v
,a Table.3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*
Page 13 of 213- Dose Factors for Kidney I ISflTOPEI l
...'e#t
..... ATION I G80UM) PLM(I GPS /C0wflII.KI _ _ _ . . . . _ _ -
I 6.46AF+02 1 0.000F+00 1 2.353E+43 I
' .IH.3
=.........- ..._.......
IC-14 1 5.306E+03 1 0.00nE+00 l 7.94AE+88 1 Iw24 4 1.056E+04 1 1.194E+07 1 2.453E*07 I IP-32 1 0.n00E+00 I.0.000E+00 1 0.000E+00 I 108.51 1 1.323E+01 1 4.659E+06 1 3.657E+94 I
.........=
l % 54 1 4.98 0 03 I 1.386E+09 1 1.375E+67 I-1 % 56 I 1.10nE+00 1 9.035E+04 I.4.300E-92 I IFE-55 1 0.000E*00 l 0.000E+00 1 0.000E+00 I IFE-59 1 0.000E*00 1 2.727E+00 1 0.000E+46 I Ifib99 1 0.000E+00 1 3.811E+00 1 0.000E+00 I 100-60 1 0.000E+00 1 2.152C+10 1 0.000E+40 t INI-63 1 0.000E+00 1 0.000E+00 1 0.000E+00 1
- {}, .
......- .. . .=--
'U INI-65 1 0.000E+00 I 2.970E+06 1 0.00E+00 1 101)-64 1 3.974E+00 1 6.067E+05 1 4.990E+95 I 17I6 45 -1 3.240E+04 I 7.463E+08 1 1.469E+14 I I?W-69 1 4.010F-02 1 0.000E+00 1 3.12SE.11 I IP8-63 1 0.000E+00 1 4.071E+03 1 0.00E+40 I 1118- 0 4 1 0.000E+00 'l 2.026E+09 1 0.000E+00 I Ill8-85 I 0.000E+00 1 0.000E+00 1 0.00K+99 1 108-06 1 0.000E+60 1 0.984E*06 1 0.00K+00 1
_= ___..............- ..._ _ ......
199-89 1 0.000E*00 1 3.307E+04 1 0.000E+00 I ISB t 0.000E40 l 1.230E+05 1 0.00AE+00 I 158-80 -l 0.000E*00 1 2.162E+04 1 0.00E+90 I ,
)
a 198-90 1 0.000E+00 1 0.000E+00 1 0.t/00E+00 t
=-
158 91 I 4.80E*00 1 2.14RE+96 I 8.0nnE+04 i '
k
/
- -- See Note, page 3.0-43 (A
'w) t Units: Inhalation - arem/yr per uci/m3 Others - m2 mrem /yr per uCi/sec Quantum: HCGS ODCM 3.0-34 Rev. 1, 11/85 i
/"N%
\ \
V Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..13o)*
Page 14 of 21: Dose Factors for Kidney I 190TOPEI IHLATION I Gil0lMD PUWEl GIIS/E0lkfilu(I 191P.92 ' l 0.000E10 1 7.768E+es 1 0.00eE+00 I iv.9* i '0.00nE+no i 4.491E+03 1 0.000E*00 I
....._ __ .._ ..................... =_ _
IY.91rt t 0.000E+00 1 1.002E+05 1 0.000E+00 l iY.91 1 0.000E+00 1 1.073E+06 1 0.00nE+00 I
................. ............. ....... = .....
tY.92 1 0'.nonE+00 1 1.004E+05 1 0.000E+00 I iY.93 'I 0.000E+00 l 1.052E+05 1 0.00nE+00 I IN 95 I 3.100E+n4 1 2.446E+00 1 2.943E+93 I IM.97 I 2.590E+01 1 2.960E+06 1 1.110E+00 I INB 95 1 4.71aE+03 1 1.400E+00 1 2.614E*04 I
...........= _.. __ ___=.
IMO 99 8 2.646E+02 1 3.99;E+06 I 4.944E+08 i ITE.99M i 3.1n4E-02 I 1.041E+05 I 9.700E+02 'l n ......_ _ _ =-- . ... - ... .
( ) ITC 101 1 9.706E-04 1 2.034E*n4 1 5.437E-50 I v .............. -- - ... ............
8110 1n3 1 4.242Ed3 1 1.004E+08 I 2.871E+04 I 1130- 1 05 I 9.90AE-01 1 6.363E+05 I 9.420E-02 i
'1110-106 I 1.065E+05 1 4.20aE+n8 1 3.500E+05 I
............ =........ ..............
IAG-110M i 1.09?E+04 1 3.445E+09 I 6.41nE+08 1
........__ . ...- ..- ._=
ITE.1?SM i 0.00nE+00 1 1.552E+n6 1 0.000E+00 I ITE-127M i 3.752E*04 1 9.165E+04 1 1.649E+49 I ITE.127 1 4.95aE+00 1 2.994E+03 1 2.513E*84 I
...._= _ _ . - _ _ . ........ ....
ITE.129M i 3.170E+04 1 1.972E67 ' I 2.214E*09 I ITE-199 I 1.7snE-01 1 2.ianF**4 I 0.315E-09 I
...............- _ =......- ............
ITE-131M i 2.644E+n2 I 8.026E+n6 1 1.40kE+07 I ITE-111 I 3.99hE n2 1 2.919Ed,4 1 1.394E-11 1 ITE.132 l 1.035E+03 l 4.223E+06 1 1.03AEet i II.130 1 1.524E+64 1 5.511E*06 1 1.364E*07' I
- -- See Note, page 3.0-43
[mT
\ }
Onits: Inhalation -mrem /yr per uCi/m3 Others -
m2 mrem /yr per uCi/sec Quantum: HCGS ODCM 3.0-35 Rev. 1, 11/85
s O f Table 3.2-2 U
. PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*
Page 15 of 21: Dose Factors for Kidney I 150T0pel INieLATION I GNOLBC PL8MEl GPS / COW /ttit.Kl
...... _ = ... . ....
Il-131 1 5.19AE+94 1 1.721E+67 I 5.95(+0* I 11 131 8 3.94AE+03 1 1.249E+06 1 5.169E+66 I If.131 i 2.?4nE+04 1 2.491E+06 I 9.876E+47 I II-134 1 2,086E+03 1 4.467E+05 1 6.410E-11 I II-135 i 8.47nE+03 1 2.526E+06 1 3.961E*05 1 109-134 1 1.004E+05 I 6.963E*09 1 2.796E+18 I trS-136 I 5.642E+04 1 1.502E+08 1 3.674E+89 I Ir4137 8 1.722E*05 1 1.030E+10 1 2.572E+10 I arS-13A I 4.10?E+02~l 3.509E+05 1 1.00?E-22 I 604-139 I 5.'22E-04 1 1.061E+09 ~I 2.976E-10.I
.= --
It%-140 l 1.343E+61 1 2.093E+07 I 9.104E+04 i
/7 .....--- - ..... . ..
t ; ire-141 1 6.494E.05 I 4.172E+04 1 2.72X-48 i A_/ ...== ...- ... ..
104-147 1 1.904E 05 1 4.445E+04 1 0.000E+99 I
-...... .. ..-- =- ___......
ILA 140 1 0.000E+00 1 1.923E+07 1 0.00AE+08 i ItA.142 1 0.0anE+00 1 7.602E+05 1 0.000E+00 I
,. ICE-141 1 5.250E+03 1-1.366E+07 I 1.294+04 I
.= _ .... ... .. ......
erf.141 1 5.64?E*01 I a.312E+06 1 1.220E+02 I
..... ...... _.=_ . ......... .
ire-142 1 5.376E*45 I 6.946E+07 .I 6.120E+05 I IM.141 1 1.974E+03 1 0.000E*00 1 3.2RM+02 I sm.144 1 6.720E-03 1 1.037E+03 1 1.451E.53 I -
...... =...19-147 I 3.150E*03 1 0.408F+06 1 5.55'E+62 1 eu-167 1 0.00er+64 1 2.360E+06 1 0.0nnE+00 1 18-23' I 6.622'+41 1 1.704E+96 1 1.632E+61 1 <
1 I
1
- '-- See Note, page 3.0-43 p, Units: Inhalation - mren/yr per uCi/m3 -
h Others -
m2 arem/yr per uCi/sec Quantum:HCGS ODCM 3.0-36 Rev. 1, 11/85 1
1
~- , . _ . . ~ . , _ . . _, .---.,x , - - ~ , . - - -- , . - - , _ . .- - - . .-- '
m
[V\ PATHWAY DOSE FACTORS FOR SECTION 3.2.3 Table 3.2-2 (R..1]o)*
Page 16 of 21: Dose Factors for' Lung I 190TOPEI INNN.ATION I CJOND PLNEl GRS/ColMilLKI
. = . . . . . . . . . . . . . . . ~ ==....... .....
lH-3 1 6.469E*02 l 0.nn0E+no 1 2.351E+01 I
.......................... .=------ .........
IC.14 1 5.306E+03 I 0.00nE+00 1 7.948E+n6 I
................... _ - ... = ........
IMA.24 1 1.056E+04 1 1.194E+07 1 2.453E+07 I IP.12 -1 0.000E+00 1 0.000E+0b I 0$ih5k hi"I Irp.51 1 1:28 @ 04 1 4.659E+n6 1 3.25?F+05 i
...........=--- _ .....-- ...... . ..
4196 5 4 1 0.996E+n5 1 1.386E+09 I 0.000E+M i
... .......-- ......= ........ ..... ..
I W.56 1 1.253E+44 l' 9.035E+05 1 0.000E+H I IFE 55 I 0.694E*ad I 0.000E+no ~l 6.789E+07 I
._ _ ....... .........._ --- _=. .......
14 59 1 1.015Ed6 1 2.72?E+08 1 1.042E+08 1 1C0 58 1 7.77AE+05 I 3.811E+08 1 0.000E+00 I
..........................= .. ..
ICO.60 1 4.50RE+06 1 2.152E*10 'I 0.000E+00 I f) g"f INI-63 1 2.086E+05 1 0.000E+00 1 0.000E+00 I
--- - .= - -=...........
INI.45 I 9.12nE+03 1 2.970E+05 1 0.090E+H I 100-64 I 9.29eE+03 1 6.06'E+05 1 0.000E+00'I
...........= .
12W65 1 6.46AE*05 1 7.461E+08 1 0.000E+H I
................. _......= ..................
12N.69 1 1.47AE+03 1 0.00nE+00 1 0.000E+00 l IBR-83
. . . - -I h$555EI55".I7bhiE55"..I0.0bbE+55"..I IM-84 1 0.000E+00 1 2.026E+05 I 0.000E+00 I 1 9 -85 1 0.000E+00 1 0.000E*00 1 0.000E+00 I
. ...... ..... ...===- ........... ...
1118 9 6 1 0.000E+A0 1 8.994E+n6 1 0.000E*B0 I IIIB.89 1 0.00nE+ne 1 3.307E+04 1 0.000E+00 I
......._____= = =- _ _........= .......
1819 6 9 1 0.ngnE*00 l 1.230E+05 1 0.000E+00 t 19 69 I 2.030E+n6 I 2.167E+n4 1 0.00nE+00 I 1c0.90 1 1.124E*07 1 0.000E+00 ~I 0.000E*00 I 6991 1 5.264E*04 1 2.149E+86 1 0. 0HE* H I
---See. Note, page 3.0-43 p Units: I'nhalation - ares /yr per uCi/m3 V Others - m2 arem/yr per uCi/sec Quantum:HCGS ODCM 3.0-37 Rev. 1, 11/85
p
. Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]O)*
Page 17 of 21: Dose Factors for Lung I 191T0f*1 14W ATI0re 191GJMO PLAIEl G8S/C0lvfl!LKI IG8-97 I 2.30AE+04 I 7.768E+0E I 0.000E+00 I lY.90 8 2.e0V+05 1 4.491E+03 1 0.000E+00 t IV.91N I 2.70aE+n) I 1.007E*05 1 0.000E+00.I iY-91 1 2.460D06 1 1.073E+06 I 0.000E+00 I IV.97 I-2.4snE+04 1 1.004E+05 1 0.000E+00 I IV 93 i 7.644E+04 1 1.052E+05 1 0.000E*00 I 1718-96 8 1.790D06 1 2.446E+00 1 0.000D00 1 129-97 1 1.103E*05 1 2.40E+06 1 0.000E+00 1 14 95 1 4.78GF+44 1 1.409E+00 1 0.000E+00 1 8 MIL 99 I 1.148D05 1 3.995E+06 1 0.000E+00 I ITC-94N I R.106E+02 I 1.041E+05 I 4.713E+01 1
/ '\ ITC-101 I 5.030E+02 l 2.034E+04 I 2.494E-59 i
\") .....- ...._...
190-101 I 5.516D05 l 1.004E+00 1 0.000E+00 I
-190-105 1 1.4e0D64 I 6.363E+05 I 0.000E+00 1 15H-106 i 1.156E+07 I 4.200E+00 1 0.nU0E+00 I
, IAG 110rl I 3.660E+06 1 3.449E*09 1 0.000E+00 l ITE-125N 1 4.466D05 I.1.552E+06 1 0.000D00 t ITE-127Ni 1.312906 I 9.165E+04 1 0.000E+00 1 ITE-127 1 1.0MD64 1 2.994E+03 1 0.000E+00 l ITE-120N I 1.690E+06 1 1.972E+07 I 0.00nE+00 I ITE-129 1 2.996E+03 1 2.600E+04 1 0.000E+00 t ITE.131Mi 1.009E+06 1 0.026E+06 1 0.000D00 I 170 131- l 2.050E*03 1 2.919904 1 0.000E+00 1 ITE-131 1 3.402E+09 I 4.223E+06 1 0.000E+00 I Il_138 i 6.00E+0A I 5.511D06 I 0.000E+00 I
- -- See Note, page 3.0-43 O Units: Inhalation - mrem /yr per uCi/m3 Others -
m2 mrem /yr per uCi/sec Quantum:HCGS ODCM 3.0-38. Rev. 1, 11/85 l
l
, . /m .
) l
(_/ Table 3.2-2 PATHWAY DOSE FACTORS FOR .9ECTION 3.2.3 l (Ri ].o)* -
Page 18-of 21: Dose Factors for Lung I 190TOPEI limLATION I GilotPC PLelEl GRS/ Cal /ttiLirl s ;
i 11-111 i 0.000E+nn i 1.721E+07 1 0.00nE+n0 1 '
I
...........===- =................................
11 112 1. 0.00nE+n0 1 1.245E+06 1 0.00nE ne i 11 111 1 0.00nE+no 1 2.451E+n6 I 0.00nE+00 I
. . _ ... ........=- _ ........ ....11-134 1 0.00nE*00 1 4.467E+n5 1 0.00nE+08 i
..===_ ___........................................
11 115 1 0.00nE+00 1 2.52AE*06 1 0.00nE*00 I ICS-134 1 7.96eE+04 I 6.863E+09 l 1.142E+18 1
..... ................... ......... ....... 1 105 136 1 1.176E+#4 1 1.50?E+08 1 7.51?E+00 I l
.. ............................................ l l
109-137 1 7.126E+nd I 1.03nE+10 1 1.041E*10 I
.................................==- - =....
105 139 1 6.53AE+61 I 3.509E+n5 i 1.689E-23 I
...............== _ __ ___ =....=-- - -
IRA-119 I 5.950E+n) I 1.061E*05 1 2.901E-18 i
...............= --
194-14n i 1.596E*06 1 2.053E+07 1 2.355E+05 I
-_% ..............= - ------- .....................
(v ) 194-141 1 2.96BE+03 1 4.172E+04 1 2.754E.40 I 194.la? I 1,554E*D3 1 4.44;E+04 1 0.00nE*06 i ILA-140 1 1.680E*n5 l' 1.921E+07 1 0.000E*60 I ILA-142 l 8.219E+01 1 7.602E+ns 1 0.000E+04 .I
. .............. .....................= ===
ICE-141 I 5.16AE+05 1 1.366E+07 1 0.00nE+ng
.............. = . . _....-.....- - -- =...
ICE-141 I-1.162E*05 1 2.31?E*06 1 0.00nE+00 'I ICE-144 'l 9.042E+66 I 6.946E+07 1 0.00nE*00 I Ipe.143 I 4.32eE+05 1 0.0nnE+00 l 0.000E+00 I
. ===__- .._ ==..==- = =-- _===....
Ipsi-144 1. 1.610E*03 i 1.037E+03 1 0.000E+04 I
=................
IND.147 I 3.220E+ns 1 8.4n8E+n6 1 0.000E+06 I 114 197 1 3.962E+ad i 2.360E*06 1 0.00nE+ns I
. . . . . . . . - = = = - - = - - ...............................
lHP.219 I 5.95nE+#4 1 1.706E+86 1 6.00AE+08 I
- -- See Note, page 3.0-43
' (-) Units: Inhalation - mrem /yr per uCi/m3
%"/ Others -
m2 arem/yr per uCi/sec Quantum:HCGS'ODCM 3.0-39 Rev. 1, 11/85
/ \.
/ 4 5
Vl- Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*
Page 19 of 21: Dose Factors for GI-LLI
, .. .=__ . . .. . . ..
i ISOT0Pri ImaLATION l GH0 lac PLM(i GOS/CN/filuf f
=......_
1H.1 8 6.46A r+02 1 0.0nnr+00 l 2.3s3E+03 I
..=_ .... __ - ___
ir.14 i s 10AE*A3 1 0.000E+00 1 7.940E+06 I
.. .... .....=-
in-24 1 1.A66F+04 I 1.194E+07 4 2.453E*07 I IP.32 1,,AlnE *04 1 0.000E+00 I 3.44aE+49 I IfD.El t 3 E70F+02 1 4.659E+06 I 7.474E+84 I It I 7.04AF*03 1 1.3A6E*09 I 2.279E*07 I
_'s. E4 .. ..... . ..... - ...
Iros Ed i 7.169E+04 I 9.035E+05 1 4.554E+04 I trr.ss : 1.n9CE*03 1 0.0nnE+00 1 1.761E+A7 I trE-59 .I 2 47Gr+04 1 2.727E*08 i 2.979E+00 t ten.se i 1.113E+04 I 3.811E+09 I 9.423E+07 I t
rm 5 tro.60 i 3.192E+04 1 2.152E+10 l 3.337E+66 I V INI-63 t 2.422E+03 1 0.000E+00 1 1.709E+00 1 INl.6E I 5.Al?E+04 l 7.97QE+0E I 4.005E+01 1
- = _ - -
a rt)-64 6 1.490F+04 i 6.0e?E+05 1 6.056E+06 1 17N-65 I (13AF+04 1 7.463E+00 1 2.560F+10 I 17te-69 I 1.322E*04 1 0.000E+04 I 6.133E-89 I ice.83 1 0.0AAE+0A I 4.871E+03 1 0.000E+00 I IA8-84 1 0 n00E*00 1 2.026E+05 1 0.00nE+00 I 190-44 1 0.nonr+00 1 0.0noE+00 1 0.00nE+08 1 199-86 1 3.030E+03 1 0.984E+04 1 9.059E+99 I toe ea i 3.tnaF*n2 1 3.107E+04 1 2.904E-44 I Iff-89 I 4.418E+01 1 1.23nE*05 1 1.68CE-52 I sco.ag i 6.ToAE+a4 1 2.162E+04 1 4.lleE+09 i
=_ _- - =.................- ..=== -- ........
14p.on i 1.310E*05.l 0.0n0E+00 1 2.415E+99 I 148 91 I 7.316E+44 1 2.140E+06 1 5.11 0 05 I
- -- See Note, page 3.0-43
(^) Units: Inhalation - mrem /yr per uCi/m3 others -
m2 mrem /yr per uci/sec Quantum: HCGS ODCM 3.0-40 Rev. 1, 11/85
m s-
'i s
) Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o),
Page 20 of 21: Dose Factors for GI-LLI
......................= ....- - ..........
I 15r1TrtPEl IMHALATION i GROUfo PLAIEl GIIS/ Coll /flitKI
.- =...........................---- .....
i5p.92 i 1.4nnE+n5 i 7.769E+n5 1 7.962E+61 I
............................ =- - .........
lY 9n i 1.040E+ns i 4.491E*03 1 1.496E+06 I lY 91M i 2.35?E+03 1 1.00?E+05 1 2.985E-15 I
.............................- _ = _ _..............
lY 91 1 7.029E+04 1 1.071E+06 I 8.354E+N I lY.97 l 1.2e4E+ns i 1.go4E+n5 1 1.631E+01 I
.....................= = -
= ..............
lY.9) i 1.AAAE+n5 1 1.85?E+05 1 2.826E+44 I 1/9.95 1 2.170E*04 1 2.44AE+n0 1 1.314E+86 I 179.97 1 1.4pnEen5 1 2.96nE+46 1 7.073E+04 I INB.95 l 1.?67E+n4 1 1.409E+00 1 3.314E+09 I IMO.09 I 4.872E+04 1 3.995E+06 1 1.070E+#9 I ITC 99M i 2.03nE+03 1 1.041E+05 1 2.610E+04 I p .....................-----
iTE-101 I 8.44?E*02 1 2.034E+h4 I ?.771E-57 I s_s .
..........................- - - =.........
19tl.103 i 1.61nE+04-I'1.084E+08 1 1.67AE+ns I ilM.i-185 I 4.844E+n4 I 6.361E+05 1 5.096E+00 I lilu.in6 t 1.6PE+n5 1 4.2 NAE +09 1 2.299E+N I
............. .... ...........__ =
lag.linN I 1.304E+04 1 3.445E+49 1 2.324E+10 I ITE-125M i 1.291E+nd i 1.55?E+06 1 1.143E+ng I ITE.127M i 2.730E+04 I 9.165E+04 1 2.703E+00 I ITE-1?? I 2.41AE+nd I 2. 4E+83 1 I
............................ "__..........--2.16?E+n5 .
ITE-129N I 6.90?E*04 1 1.9??E*07 1 5.207E+08 I ITF.129 I~ 2.63?E+nd i 2.6nnE+n4 1 2.67hE.07 I ITE-131M i 1.191E+iiG I 0.07^E+n6 1 3.640E+07 I ITE-111 1 8.219E+ni i 2.910E+nd i 2.20?E-30 8 ITE.117 I 4.410E+nd i 4.221E+p6 I 6.130E+07 I 11 114 1 1.994E*05 I 5.511E+86 1 2.641E+n6 I
- -- See Note, page 3.0-43 A Units: Inhalation - mrom/yr per uCi/m3 O Others -
m2 mrem /yr per uCi/sec Quantum:HCGS ODCM 3.0-41 Rev. 1, 11/85
o m
i x Table 3.2-2 PATHWAY' DOSE FACTORS FOR SECTION 3.2.3 (R 1 3o)*
Page 21 of 21: Dose Factors for GI-LLI I lainTOPfl fleetATION I rJ0lMi Pt AMEi IPS/Coli/filll(i
. . .. . ____.==
11 131 i 1.050E*03 1 1.771E+47 1 1.020E+08 i 11 132 e 1.904E*63 1 1.245E+06 1 3.750E+09 I
. ..=== .__ .-
11 133 1 2.154E+03 1 2.45tE+06 I 1.421E+07 I 11 134 1 1.?A9E+63 1 4.467E*05 1 5.927E-11 I 11-135 1 1.034E+03 1 2.526E+06 1 1.296E+99 I irs.134 ' i 1.334E*03 1 6.963E+09 I 2.9anE+46 I irs-134 1 1.420E+03 1 1.5n2E+09 1 1.400E+00 1 105-137 1 1.334E*03 1 1.030E*10-l 2.996E+00 t ifs-13A I 9.76K+02 1 3.599E*05 1 3.46AE-22 I 104-139 I 5.096E*04 1 1.061E+05 1 4.572F-09 I m 194 144 1 3.816E+H I 2.093E+07 I 9.410E+07 1
(,},
/
194 141 1 4.744E+03 1 4.172E+04 I 8.075E-44 I 1H4-149 I 6.93RF+02 1 4.449E+04 1 0.000E+99 I il4-140 1 9.4A4E+44 1 1.923E+07 I 2.991E*05 I liA 142 1 5.950E+A4 I .7.602E+05 i 1.716E-99 I ire.141 1 2.196E+04 1 1.366E*07 1 2.174E*47 I tEF.141 1 4.970F+64 ' I 2.312E+06 1 2.444F+ N I ICE-144 1 1.464E+05 1 6.944E+07 1 2.123E+08 1 IP#.141 1 3.724E+H I'O.000E+00 1 1.249E+N 1 IPU.144 I 4.2A4E+03 1 1.037E*03 1 1.863E-40 I 64-147 1 3.122E*H I 0.4NE+06 I 9.137E+05 I
. . . . _ _ _ _ . . . . . . . . . . . - - =.............. .__
lW.197 6 3.556F+Aa 1 2.3A0F+06 1 3.979F+N I INP 239 l 2,492(+$4 1 1,7h(+$6 1 1.4%E*05 I
- -- See Note, page 3.0-43 (o) Units: Inhalation - ares /yr per-uCi/m3 v
Others -
m2 mrem /yr per uCi/sec Quantum: HCGS ODCM 3.0-42 Rev. 1, 11/85
I O
\s NOTE: The R ijo values of Table 3.2-2 were calculated according I to the methods of Ref. 6, Section 5.3, for the pathways and age-group of the. designated Maximum Exposed. Indi-vidual.. The values used for the various parameters required for the calculations, and the origins of those-values, are given below in Table 3.2-3. .
l n
v l-
-(
Quantum:HCGS ODCM 3.0-43 Rev. 1, 11/85 r- y w-e- - y r---g , - - - + , e ,- w--e r--, w e ym ww-rw y s-e . y-w3.cm.,,.w,n ,w- w-e wwww w ,-wy---%-, e r v*e,---,,.m.--.--wm----.,- -
z:
'I .
'Pable 3. 2-3 PARAMETERS USED IN DOSE FACTOR CALCULATIONS-Page 1 of 4 Orgin of Value Table in Section of Parameter 'Value- R.G. 1.159 NUREG-5133
- For P ***
f DFA Each Radionuclide E-9 BR 3755 m'/yr E-5
- For R1 (Inhalation)***
BR" Each age group E-5 DFA Each age group, nuclide E-9 and f
and organ E-15 s
- For Ri (Ground Plane)***
SF 57 E-15
.DFG Each radionuclide E-6 f
(Note 4) t 4.73 E+78 sec 5.3.1.2 O
Quantum:HCGS 3.(-44 Rev. 1, 11/85
1 t -
Table 3.2-3 PARAMETERS USED -IN DOSE FACTOR CALCULATIONS Page 2 of 4 Orgin of Value Table in Section of Parameter Value R.G. 1.179 NUREG-7133
- For R f (Vegetation)***
- r. . Each element type E-1 Yy 2.s kg/m* E-15 lNw 5.73 E-7lsec -1 5.3.1.3 DELg. Each. age group,. organ, E-1,3 and, , 1 and nuclide
- E-14 .
U,L Each age group E-5 (O.,,) f 1. 5.3.1.5 L
tg 8.6 E+#4 sec E-15 US a Each age group E-5 f
g 5.76 5.3.1.5 th 5.18 E+06 sec E-15 H 8.'l gm/m' *** Note 1***
- For Ry (Grass / Cow / Milk)***
QF_ 55 kg/ day E-3
'U,p. E&ch age group E-5
~
kw 5.73 E-g7' sec 5.3.1.3 F, Each element E-1
,O -
V
-Quantum:HCGS ODCM 3.0-45 Rev. 1 11/85 f
t
Table.'3.2-3
- PARAMETERS USED IN DOSE FACTOR CALCULATIONS Page 3 of 4 Origin of Value Table in Section of Parameter Value R.G. 1.109 NUREG-0133
. r. Each element type E-15 t
h 5.18 E+06'see E-15 H 8.1 gm/m3 *** Note 1***
DFL Each age aroup, organ, E-13 and i
and nuclide E-14 Y 2 *** Note 2***
p 0.44.kg/m ,
~Y 2 E-15 s 2.0 kg/m tg 1.73 E+05 sec E-15 f
p 1.0 5.3.1.2 f
s 1.0 5.3.1.2
- For Ri (Grass / Cow / Meat)*** ,
. *** Note 3***
OF 50 kg/ day E-3 U
ap Each age group ' E-5 F Each element E-1 f'
r Each element type E-15 t
h 5.18 E+06 see E-15 i H 8.1 gm/m3 *** Note 1***
DFL Each ace group, organ, E-13 and i
and nu6 lice E-14 Y
p 0.44 kg/m 2 *** Note 2***
Quantum: HCGS ODCM 3.0-46 Rev. 1, 11/85 0
- ...,.w ,---n.,r.< ,,---v,.n-,.--nn -, .,--,,...,nn.v,.,,ny, <<,,n, ,,.n.~,.rnw,w.-,~,ge-,w,-..v,, e ,e.--,- -,-,v----,,--,.----,-...
l
~
Table.3.2-3 PARAMETERS USED IN DOSE FACTOR CALCULATIONS l
Pcge 4 of 4 Origin of Value Table in Section-of Parameter ' Value R.G. 1.109 NUREG-0133 Y
a 2.0 'kg/m 2 E-15 tg 1.73 E+05 aec E-15 f 1.0 5.3.1.2 p
f s 1.0 5.3.1.2 hw -1 5.3.1.3
- 5.73 E-07 sec Notes
( 1. Site-specific' annual average absolute humidity, from Ref.
' 3, Section 2.1.3.4.
- 2. Site specific areal productivity of pasture feed grass, from Ref. 3,.Section 2.1.3.4.
- 3. 'No evidence was found in any land use or demographic information that animals are kept for meat withi'n 5 miles of the Station.
These values are included for reference only, should the need for them arise.
- 4. The " Total Body" dose factors from the referenced. table were applied to all organs.
O Quantum:HCGS ODCM 3.0-47 Rev. 1,*11/65
=4.-,y s 9 ..w+yy--..y., ewww-,. --9.,w,y, y,,es,,-wnv,,p ,y,-.-,-g.nc- yy,hyun-.,,=.,ww,wwwww-g-y--ee.-9,e--,y-v-w,,,.,y-,9-v,%mww--..-w-m,.-,y v. - . - -
- . - - . _ _ - =. . -. . - _ - _ _-- .
(O). 3.3 METEOROLOGICAL MODEL i
- The dose calculation methods for gaseous effluents described j .in Section 3.2 6 squire the use of annual average relative dispersion-(X/Q) and relative deposition (D/Q) parameters.
When new or revised values of these parameters must be computed, the method detailed below will be used. All release points.are treated as ground level. The computation i of-the dispersion.and deposition parameters is based on the onsite meteorological data, the configuration of the sources, and-the terrain surrounding the Station, and is
-implemented in a sector-averaged diffusion model, 3.3.1 Meteorological Input Joint frequency distributions of wind speed and direction
! by atmospheric stability class are used for the diffusion
, calculations. The meteorological tower is located
. approximately'l.0 mile southeast of HCGS. All meteoro-logical data are from the Artificial Island meteorological tower.. The flat, uncomplicated terrain that surrounds the site for a considerable distance in every direction, ensures excellent representation of the regional airflow by the Artifical Island meteorological tower measurements.
j Wind speed and direction data from the'33-foot tower level are used as input for the joint frequency distri-butions.
Joint frequency distributions of wind speed and direction by atmospheric stability calsa are computed for 22.5 l ' degree sectors using the wind speed groups and atmospheric stability classes suggested in Regulatory Guide 1.23.
Joint frequency distributions of wind direction, speed, and stability from the 33-foot level are used as input
' for both vents.
Quantum: HCGS ODCM 3.0-48 Rev. 1, 11/85 i
c-, ...<,.,..-.w....._...,____.x_._,,, ,,.m.. _ , _ . . . _ ,_,_.,_,._,,,,m.m_,_ . , . . , _
. , , . .._m.,,_.._,__,_____.,,_,,,.,,-
- ./%
b, With the exception of the calm and the 25+ mph grom.,,
the median speed from each wind speed group fx used to represent _the group in the diffusion calculations.
For conservatism, a wind speed of 0.38 mph, equal N to one-half of the highest threshold of the vane and propeller, is assigned to the calms. A wind speed of 26 mph is used to represent the 25+ mph group.
3.3.2 Source configuration Radionuclides are routinely' released from two sources, the south and north vents. Their source characteristics are given as follows:
Parameter South Vent North Vent
- M tg Height above grade, m. 35.05 35.05 Exit diameter; m, the i
equivalent cire diam for for rectangular vents 4.13 2.23 Exit velocity, m/s Summer (Apr - Sept) 15.54 5.08 i-Winter (Oct'- Mar) 10.82 5.08 Both vents, pointing upward, are adjacent to the tops of the turbine buildings, below the level of the reactor contalment dome. Therefore, the vents are affected by the nearby building aerodynamics with moderate to strong winds.
1 The release is assumed to be at ground level, and a
[ building wake correction factor (reactor building height squared) of 3819 m2 is used in accordance with the methodology of Regulatory Guide 1.111, Revision 1.
Quantum:HCGS ODCM 3.0-49 Rev. 1, 11/85
I
- en
.(V) The building wake correc; ion f actor takes into considera- l tion the initial mir.ing of the plume within the building cavity.
The exit. velocities for the south ~ plant vent are signif-icantly higher than those for the north plant vent.
The assumption made in Regulatory Guide 1.111 (Revision 1) about the height of adjacent solid structures (i.e.,
reactor building dome) is simplistic in the case of effluents released at high exit velocities from vents oriented upward (versus horizontal). With the considera- i tion of the reactor building dome as an adjacent. structure,,
the projected effluent path becomes complicated because the transport wind and associated entrainment will be sector dependent. Therefore, the X/0, depleted X/Q, and D/Q values (HC FSAR Tables 2.3-31, 2.3-32 O and 2.3-33) are conservative when based on a ground level release.
3.3.3 Site Impact on Vent Releases The effect of the cooling tower on the relatively low-level vent releases during neutral and unstable atmospheric conditions would be to enhance the vertical diffusion through increased mechanical turbulence, and thus reduce ground-level concentrations. Therefore, to be conservative in the estimation of ground-level concentrations for neutral and unstable conditions, the wake effect of the cooling tower has been neglected.
3.3.4 Diffusion Model The sector-averaged Gaussian plume equation, as expressed h in Regulatory Guide 1.111, Revision all X/O calculations.
1, is used for Quantum:HCGS ODCM 3.0-50 Rev. 1, 11/85
_--*ert -rFpw*ry--$-'vW-*w'-tm --e-'-Tv- m- "'m--M7 '-'T-4M'+We-- e v m-w --*"-""r=vvw-'* '-
- IV 3.3.5 Terrain Correctors Changes.in terrain elevation, though very small~in
.the immediate vicinity of the plant, are applied at each receptor. Terrain heights above plant grade, which is 4 meters mean sea level (MSL), are used in the calculations, where applicable. The terrain height correction applied to any particular receptor is the highest terrain between the source and the receptor.
3.3.6 Atmospheric Stability Atmospheric stability classes are determined using the vertical temperature difference between the 300 and 33-foot levels of the Artificial Island tower.
The seven lapse rate classes for stability classification are those recommended.in Regulatory Guide 1.23.
3.3.7 Dispersion Coefficients The horizontal and vertial dispersion coefficients,
~
sigma y and sigma z for each turbulence class, are computed using analytical approximations to the P-G sigma curves given in Regulatory Guide 1.111, Revision 1.
These dispersion coef ficients were developed for flat to rolling terrain, similar to that surrounding the Hope Creek site.
3.3.8 Deposition Relative depletion by dry deposition is estimated in accordance with Regulatory Guide 1.111, Revision 1.
The depleted by deposition X/Q values are obtained from the X/Q values by multiplying the X/Q values i 1
Quantum:HCGS ODCM 3.0-51 Rev. 1, 11/85 l
i
.kOj . by the fraction remaining in the plume. These fractions
.are determined from Regulatory Guide 1.111, Revision 1, Figures 2 through 5.
Relative dry deposition is estimated in acordance with Regulatory Guide 1.111, Revision 1. The relative deposition rate per unit area, D/Q, is obtained by:
- a. Determining the relative deposition rate at each receptor, which is a function of distance from the source, source height, and atmospheric stability.
This rate is obtained for- Regulatory Guide 1.111, Revision 1, ground releases.
- b. Multiplying the relative deposition rate by the fraction of the release transported into the q sector.
- c. Taking this product and dividing by the appropriate crosswind distance, which is the arc length of the sector at the point being considered.
I w/ :
Quantum: HCGS ODCM- 3.0-52 Rev. 1, 11/85
/^
3 3. 4 ' DEFINITIONS OF GASEOUS EFFLUENTS TERMS
\~
Section of Term Definition Initial Use a
v = the administrative allocation factor (3.1.1) for vent v [unitiess], which is the fraction of the station site boundary dose rate limit which is assigned to vent v.
D b = the site boundary air dose due to beta (3.2.2) emissions from noble gas radionuclides
[ mrad].
D g = the site boundary air dose due to gamma (3.2.2) emissions f rom noble gas radionuclides
[ mrad].
\_
D mp = dose to organ o of a Member of the (3.2.3)
Public, f rom radioiodines, - tritium, and radionuclides in particulate form with half-lives greater than 8 days [ mrem].
D/Q= the annual average relative deposition (3.2.3) at the location of the Maximum Exposed Individual [m-2],
Fy = the expected flow rate in vent v (3.1.1)
[cc/sec].
- K i
= total body dose factor for gamma (3.1.1) emissions from noble gas radionuclide i
[ mrem /yr per uC1/m3], from Table 3.1-1.
-l
. Quantum: HCGS ODCM 3.0-53 Rev. 1, 11/85
/
w/ . Section of Term Definition Initial Use L = skin dose factor for beta emissions (3.1.1) i from noble gas radionuclide i
[ mrem /yr per uCi/m3], from Table 3.1-1.
M i
= air dose factor for gamma emissions (3.1.1) from noble gas radionuclide i 3 ], from Table 3.1-1.
[ mrad /yr per uCi/m N = air dose factor for beta emissions from (3.2.2) i noble gas radionuclide i
[ mrad /yr per uCi/m3], from Table 3.1-1.
P io = dose parameter for radionuclide i and (3.2.1.b) organ o, for inhalation, from Table
[] 3.2-1 [ mrem /yr per uCi/m3],
V .
Qi = the release rate of noble gas (3.2.1.a) radionuclide i as determined from the concentration measured in the analysis of the appropriate sample required by the Technical Specification Table 4.11-2 [uci/sec].
I'-
= the release rate af non-noble gas (3.2.1.b) radionuclide i am determined from the concentration measured in the analysis-of the appropriate sample required by the Technical Specification Table 4.11-2 [uci/sec].
Quantum: HCGS ODCM 3.0-54 Rev. 1, 11/85
- ? '
Section of Term Definition Initial Use
. i
= cumulative release of noble gas (3.2.2) radionuclide i over the period of interest [uci].
i'
= cumulative release of non-noble gas (3.2.3) i radionuclide i over the period of interest [uci].
R ijo = dose factor for organ o due to (3.2.3) radionuclide i and pathway j, from Table 3.2-2 [ mrem /yr per uCi/m3, or
, m2 - mrem /yr per uCi/sec].
S y = the normal radiation monitor setpoint (3.1.1)
) for vent v [uci/cc].
S ye =
the. conservative radiation monitor (3.1.2) setpoint for vent v, assuming all noble gas is Kr-89 [uci/cc].
S ys = the normal candidate setpoint for vent '(3.1.1) v, based upon the skin dose rate limit of 3000 mrem /yr.[uci/cc]. i S ys' = the conservative candidate setpoint for (3.1.2) vent v, based upon the skin dose rate limit of 3000 mrem /yr, and assuming all noble gas is Kr-89 [uCi/cc].
S vt = the normal candidate setpoint for vent (3.1.1) v, based upon'the total body dose rate 1 1 O) limit of 500 arem/yr [uci/cc].
Quantum: HCGS ODCM 3.0-55 Rev. 1, 11/85
. _ _ - _~ . ~ . , _ . _ . _ _ _ _ . - - _ _ _ . . . _ . _ _ . . . _ . , - . . ___ _._ _ _ _ . . _ . _ . . _
Ap)g s._ Section of Term Definition Initial Use S
y e. = the conservative candidate setpoint for (3.1.2) vent v, based upon the total body dose rate limit of 500 mrem /yr, and assuming all noble gas is Kr-89 [uci/cc].
SF = the safety factor; a conservative factor used to compensate'for statistical fluctuations and errors of measurements.
W ij' = relative concentration or relative (3.2.3) deposition for the Maximum Exposed Individual, as appropriate for exposure pathway j and radionuclide 1. Its value is X/Q' or D/Q', as appropriate.
IsV) X iy = the measured concentration of noble gas (3.1.1) radionuclide i in the last grab sample analyzed for vent v [uci/cc].
X/O = the highest an1ual average relative (3.1.1) concentration at the site boundary in any sector [sec/m3]. For post-release calculations, the . ual site boundary X/Q in the affected sector for the period of the release may be substituted.
X/Q' = the annual average relative (3.2.3) concentration at the location of the Maximum. Exposed Individual [sec/m3].
i
%/
Quantum:HCGS ODCM 3.0-56 Rev. 1, 11/85
~
v O
Section.4.0 ,
SPECIAL DOSE CALCULATIONS
-Sections 2.0 and 3.0 described calculations which are made in connection with each effluent release. In addition to these calculations, the Technical Specifications (Reference 1) require
, or imply'that certain other~ types of dose calculations shall be specified in the ODCM. , These special dose calculations are
' described in the present section.
4.1 NECESSITY OF OPERATING EFFLUENT TREATMENT SYSTEMS "
4.1.1 Liquid Radwaste Treatment System Technical Specification 3.11.1.3 reads:
. The LIQUID RADWASTE TREATMENT SYSTEM shall be used to reduce the radioactive ~ materials in liquid wastes E prior to-their discharge when the projected doses due to the liquid effl'uent, from each reactor unit, to UNRESTRICTED AREAS would exceed 0.06 arem to the total body or 0.2 arem to any organ in a 31 day period.
The surveillance requirement f or this Specification, which is Technical Specification 4.11.1.3, reads:
Doses due to liquid releases from each reactor unit to UNRESTRICTED AREAS shall be projected at least once per 31 days in accordance with the methodology and parameters in the ODCM.
The Liquid Radwaste Treatment System to which this decision process applies consists of the filters and domineralizers shown schematically in Figure 4.1-1.
Prior to rendering the system inoperable, and at least once each 31 days while the system remains inoperable, doses due to liquid effluents shall be projected according O to the following guidance:
Quantum: HCGS ODCM 4.0-1 Rev. 1, 11/85
p
(
- l. Doses from all liquid effluents from all liquid radioactive waste management components shall be inclu'ded. For the Hope Creek Generating Station this shall include releases ~ from the Waste Sample Tanks, Floor Drain Sample Tanks, Detergent Drain Tanks, Condensate Storage
~ Tank,- and any radioactivity in the Cooling Tower Blowdown Line.
- 2. The projected release rates used in the dose calculation shall be appropriate to the projected modes of operation of all the liquid radwaste streams. That is, release rates from liquid effluent streams which are projected not to be treated must be based on the analysis of pretreatment samples, and not of samples taken from those streams when the treatment systems are in operation.
- 3. Doses due to radioactive materials in liquid effluents shall be computed according to the methods of Section 2.2.
- 4. The projected dose from Step 3 shall be compared to the Technical Specification limits above (0.06 mrem to the total body or 0.2 mrem to any organ). If the projected dose does not exceed the limit, the systems may be operated as assumed in tIie projection. If the projected dose does exceed the limit, one of two alternative courses must be implemented: a) the treatment systems on some of the streams must be brought into operation until the projected dose does not exceed the limits; or b) all of the Liquid Radwaste Treatment System at the Hope Creek Station must be brought into operation.
O Quantum:HCGS ODCM 4.0-2 Rev. 1, 11/85
' Ventilation Exhaust Treatment System 4.1.2 Technical Specification 3.11.2.5 reads:
The VENTILATION EXHAUST TREATMENT SYSTEM shall be used to reduce radioactive materials in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, from each reactor unit,- to areas at and beyond the SITE BOUNDARY would exceed 0.3 meem to any organ in a 31 day period.
The surveillance c'equirement for this Specification, which is Technical Specification 4.11.2.5.1, reads:
Doses due to gaseous releases from the site shall be projected at least once per 31 days in accordance with the ODCM, when the VENTILATION EXHAUST TREATMENT SYSTEM is not in use.
The Ventilation Exhaust Treatment System to which this decision process applies consists of the charcoal and particulate filters shown schematically in Figure 4.1-2. Prior to rendering the system inoperable (other than for routine maintenance), and at least once each 31 days while the system remains inoperable, doses due to gaseous effluents will be projected according to the following guidance:
i
- 1. All gaseous effluent pathways from the Hope Creek :
Station must be included (including those from the Gaseous Radwaste Treatment System).
- 2. The projected release rates used in the calculation l shall be appropriate to the projected modes of operation of all the ventilation exhaust and gaseous radwaste treatment systems at both Stations.
That is, release rates from effluent streams which are projected not to be treated must be based.on the analysis of pretreatment samples, and not of samples taken f rom those streams when Quantum:HCGS ODCM 4.0-3 Rev. 1, 11/85
i the treatment-systems are in. operation.
! 3. Dose rates at the Site Boundary shall be computed
-according to the methods of Section 3.2.1, and.
multiplied by (31/365 = ) 0.0849 to convert them to a projected cumulative dose for 31 days. Doses i to the Maximum Exposed Individual shall be computed according to the methods of Section 3.2.3.
- 4. The projected dose from Step 3 shall be compared to the Tech Spec limit above (0.3 mrem). If 1
the projected dose does not exceed the limit, the systems may be operated as assumed in the projection. If the p'rojected dose does exceed
.the limit, one of two alternative courses must i be implemented: a)the treatment systems on some' of the streams must~be brought into operation
}_
- until the projected dose does not exceed the limit; or b)all of the Ventilation Exhaust . Treatment
- System at the Hope Creek Station must- be brought into operation.
l 4.1.3 Gaseous Radweste Treatment System i Technical Specification 3.11.2.4 reads:
i The GASEOUS RADWASTE TREATMENT SYSTEM shall be in operation.
The APPLICABILITY of this Specification is "Whenever the main condenser air ejector system is in operation."
The Gaseous Radwaste Treatment System is shown in Figure 4.1-3. No dose projections are required prior to rendering this system inoperable, but this shall not be done unless the main condenser air ejector system is rendered inoperable at the same time.
i
i i
m
/
\
Figure 4.1-1 LIQUID RADWASTE TREATMENT SYSTEM t
- *5 o *-
1.,
a
=g h E
=
pu iI: -
~
o j 5 o
o g
o V : :
3:
2 2 l .2 r: r 1a : :
(A-
_.: g2-
';3
!2 23 o o
.& g* 13 g*
a o a f, 'Tf .% . . 1
- : 8 :
1 :*
- k/ :
8% :*
3 I
.& 8 . .
i 3
8 8 8
- - o o a :
I: j : : :
5 Ei 5
~s x s o o :
- a j
s.- - . :
- : : : :: ~
C- 1 g 3 .
- t : : 2 a: -
8
} }"
- s:- 1 o * . s !" ;
_} } _
o o n 3, o
i
. 3 1 .
7 : I 1-g :. .
- : : . p ya : -
\ b $ ; $ 5b b$ l w) i Quantum:HCGS ODCM 4.0-5 Rev. 1, 11/85
\.s) Figure 4.1-2 VENTILATION EXHAUST TREATMENT SYSTEM Gaseous Radwaste h I _ M as Treatment System ~
(from rigure 4.1-3) O North Plant Vent Untreated Ventilation -
Air Sources Radweste Decon. m Evaporator '
Reactor Building - -
Purge Air R H ~
(Typ. of 3)
- p) Auxiliary Building Redweste Area R H E Rs k' (/ ,,
Ventilation Air g,yp, ,g 3)
. South
' Plant Vent Condensate Domineralizer Room Air Pipe Chase Air : R H C H +
reedwater Heater _
~
Room Air Untreated Ventilation -
Air Sources l
(Recirculation) ,,
Reactor f -
db ik FRVS i suilding Air - H C H " C H _
^ System Vent l (Typ. of 6) (Typ. of 2)
Legendt R = Roughing Filter C = Charcoal rilter i H = HEPA Filter I RE = Effluent Radiation Monitor
- -- This Post-Treatment Monitor is not an effluent monitor as designated by the RETS.
/
(
Quantum HCGS ODCM 4.0-6 Rev. 1, 11/85
(
' Figure 4.1-3 GASEOUS RADWASTE TREATMENT SYSTEM Main or Aus111ery Steam SJAE
- offgas _ - - _ -------_-- .
g com "'
Preheater Recombiner , n er Condenser~
Offges l_ _ _ _
_ _ IXpic,gl of,2 2ec @ iner Peckges a _l jf i Holdup Pipes C I I
! Guard !
_ Cooler Reheater _
Bed
- g. " Condenser l
i _ _ _ _ _!
To North m HEPA' Filter Adsorber Train-
~
II Plant Vent (Figure 4.1-2) '!
I I r
l__ _ _
$2bi g t garco,alJ ystem _ l 1
t i
l Quantum HCGS ODCM 4.0-7 Rev. 1, 11/85
- b '4. 2 TOTAL FUEL CYCLE DOSE Technical Specification 3.11.4 reads in part:
The annual dose or dose commitment to any MEMBER OF THE I
PUBLIC due to releases of radioactivity and to radiation ,
from uranium fuel cycle sources shall be limited to less than or equal to 25 mrems to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 meems.
The total annual dose or dose commitment to a Member of l the Public will be computed as the sum of the doses due i to three components: doses due to radioactivity released
] in effluents from the Hope Creek Station, doses due to
'i effluents from othe uranium fuel cycle sources, and doses t
due to direct radiation from fuel cycle sources. When
- it is necessary to perform an evaluation of the total fuel cycle dose (see Technical Specification 3.11.4.a), it shall
, be performed according to the following guidance:
- l. Doses due to liquid effluents from the Hope Creek Station shall be calculated according to the methods of Section 2.2 of'this ODCM, using total releases for the year from all release pathways at the Station.
$ 2. Doses due to gaseous effluents from tho Hope Creek j Station shall be calculated according to the eethods of Section 3.2 of this ODCM, using total releases for the year from all release pathways at the Station.
t
- 3. Effluent doses from the Hope Creek Station shall be summed with those from the Salem Station to determine the total dose due to ef fluents f rom the uranium fuel cycle.
- 4. Direct radiation doses from the fuel cycle will be inferred from the evaluation of readings from environmental I monitoring devices (see Section 5.1).
l Quantum HCGS ODCM 4.0-8 Rev. 1, 11/85 i
l 1
^
-t V 4.3 INITIAL EVALUATION OF UNPLANNED GASEOUS RELEASES For the purpose of initial assessments of the impact of unplanned gaseous releases, dose calculations for the critical receptor in each af fected sector may be performed as follows.
For each location, X/Q' and D/Q' will be calculated according to the methods of Section 3.3 of the ODCM, using the measured meteorological parameters for the period of the unplanned release. The location of the critical receptors and the pathways j which should be analyzed for each critical receptor may be obtained from the most recent land use census.
The R ij for the appropriate exposure pathways and age groups
'will be selected from Tables 4.3-1 and 4.3-2.
O O
Quantum HCGS ODCM 4.0-9 Rev. 1, 11/85 9
.g.
ix
~)' Table 4.3-1
- INFANT PATHWAY DOSE FACTORS FOR SECTION 4.3 g (R ))
Page 1 of 3: Dose Factors for Composite Worst Organ I ISOTUPEI IHLATISI 1910 LAG PUIEl WE/ESMllLX1 NTl W ETATISI I lH-3 1 6.46tE*02 1 0.etW+00 l 2.353E+05 1 4.ettE*00 1 0.00E*40 t 1C-14 1 2.646E+04 I 0.000E+00 1 3.722E+09 1 0.000E*00 1 0.000E+00 t l % 24 1 1.056E*04 1 1.385E*07 1 2.453E+07 1 0.000E+00 1 0.000E+00 I IP-32 1 2.030E+06 1 0.000E+00 1 2.549E*ll 1 0.000E+00 1 0.000E+00 I ICR-51 1 1.294E+04 1 5.506E*06 1 7.478E+06 1 0.000E+00 1 0.000E+00 I 1 % 54 i 9.996E*05 1 1.625E+09 I 6.20$E*07 1 0.000E+00 1 0.000E*00 I If9M6 1 7.168E+04 1 1.06E+06 1 4.554E+00 1 0.000E+08 1 0.00E*00 t IFE-55 1 8.694E+04 1 0.000E+08 1 2.150E+06 I 0.00K+00 1 0.00E+00 t IFE-59 1 1.015E+06 1 3.204E+00 1 6.234E+00 1 0.000E*00 1 0.00E+00 I 1C0-59 I 7.770E*05 1 4.464E+03 1 9.634E*07 1 0.000E+00 1 0.00E*00 I 1C0-60 1 4.500E+06 1 2.532E+10 1 3.337E+09 1 0.000E+00 1 0.000E+00 I lHI-63 1 3.300E+05 I t.000E*00 1 5.558E+10 1 0.00E*00 1 0.000E*00 1
[_)
\j INI-65 1 5.012E+04 1 3.451E+05 1 4.905E*01 1 0.000E+00 1 0.0C0E+00 1 ICU-64 1 1.490E*04 1 6.876E+05 1 6.056E*06 1 0.000E*00 1 0.00E*00 I 12N65 1 6.469E+05 1 8.583E+00 1 3.029E*10 1 0.000E+00 1 0.00K+00 1 12N69 1 1.322004 1 0.000E*00 1 6.133E-09 1 0.000E*00 1 0.000E*00 I Illt-83 I ).000E*02 1 7.079E+03 1 1.486E+00 1 0.000E+00 1 0.000E+00 I.
IE04 1 4.004E+02 1 2.363E*05 1 1.998E-22 1 0.000E+00 1 0.000E*00 t 1M 85 1 2.044E+01 1 0.000E*ll 1 0.000E*00 1 0.000E+00 1 0.000E*t0 I 15 96 1 1.904E+05 1 1.027E+07 i 3.54E+10 ! 0.000E*00 1 0.000E*t0 t 1 5 -08 1 5.572E+02 1 3.779E+44 1 2.98?E-44 1 0.000E*00 1 0.000E*00 I 1118-8 9 1 3.206E*02 1 1.476E*05 1 5.431E-52 1 0.000E+00 1 0.000E*00 I 1 5 09 1 2.030E*06 1 2.509E+44 1 2.002E+10 1 0.000E+00 1 0.000E*00 t IE90 1 4.09E* 07 1 0.000E+04 1 1.934E+11 1 0.000E+00 1 0.000E*00 4 IE91 1 7.336E*04 1 2.511E*06 1 5.115E*05 1 0.000E+00 l 0.000E+00 I
- -- See Note, page 4.0-i6 (3 Units: Inhalation - arem/yr per uCi/m3
'V I Others - m2 mrem /yr per uCi/sec Quantum HCGS ODCM 4.0-10 Rev. 1, 11/85
n %
!' Table 4.3-1
'" )
INFANT PATHWAY DOSE FACTORS FOR SECTION.4.3 (Rg)*
Page 2 of 3: Dcse Factors for Composite Worst Organ I 190f0PEI IIMILAfl0M i sicuMD PIAEl ERS/Obfill.Kl EM/UWIGil UEEETATION l 15R.92 1 1.440E+05 1 8.6)lE*M I 7.96K+01 1 8. MK+M I 8.MK+04 I IV-96 1 2.600E*05 I 5.300E+0) i 1.496E+06 1 0.000E*00 1 0.000E*04 I lY-91M i 2.796E*0) I 1.161E*05 1 2.995E.15 1 0.000E*00 1 0.000E+00 I lY-91 1 2.45E+06 1 1.207E*06 I 8.354E+M i 0.000E+00 1 0.000E+M i lY 92 1 1.266E*05 1 2.142E*05 l 1.63)E*01 1 0.000E+00 1 0.00E+M i
. ......................s..... .......... ....... . ....................
IV-9) I 1.666E*05 1 2.534E*05 1 2.826E*04 1 0.00K+00 1 0.000E*00 I IZW-95 I 1.750E*06 1 2.937E+00 1 1.314E*06 1 0.000E*00 1 0.000E*M i 12R-97 1 1.400E+05 1 3.445E+06 1 7.07)E+04 1 0.000E+00 1 0.00K+00 I 114-95 1 4.784E+05 l 1.657E*06 1 3.)l4E*06 I 0.000E*00 1 0.000E+M i IMO.99 l 1.340E*05 1 4.626E*06 1 4.944E+06 1 0.000E+00 1 0.000E+M i ITE.99M i 2.030E*0) I 2.109E*05 1 2.618E*04 1 0.000E+00 1 0.000E*H I ITC.101 1 8.44?t+02 1 2.260E*04 1 7.771E.57 1 0.000E*00 1 0.000E*tt I (m T Im).10) 1 5.516E*05 1 1.265E*06 1 1.678E*05 1 0.000E*00 1 0.000E*tt I s
")
1111). 1 05 1 4.944E*04 1 7.212E*t5 1 5.096E+40 1 0.000E+00 1 0.00K+M i 1814106 1 1.156E*07 1 5.049E+M i 2.299E*06 1 0.000E*00 1 0.00E+M i IAG-Iten I. 3.669E+06 1 4.019E*09 8 2.324E*10 1 0.000E*00 1 0.000E*H I ITE-129N I 4.466E+05 1 2.12K+46 1 2.199E+09 1 0.00K+00 1 0.000E*t0 I ITE.127M i 1.312E+t6 1 1.M)E+05 1 1.649E+09 1 0.000E*00 1 0.00K+M 1 ITE-127 1 2.436E*04 1 J.29)E+t) I 2.162E*t5 1 0.00K+00 1 0.00 E + M i iTE-129M i 1.660E+86 1 2.305E*t7 1 2.214E*09 1 0.00K+00 1 0.000E*H I ITE-129 1 2.6)?E*04 I ).076E*t4 1 2.67E 07 1 0.000E*00 1 0.000E+tt i ITE-131M i 1.999E+05 I 9.459E*H I 3.640E*07 1 0.000E*00 1 0.00K+40 1 ITE-1)I I 8 218E*0) 1 3.45K+07 1 2.202E 10 1 0.000E*00 1 0.000E+tt i ITE-132 1 3.402E*05 1 4.96K+96 1 1.036E*06 1 0.000E*00 1 0.000E*M i 11 130 1 1.5%E*t6 I 6.69X+N I 1.19M+99 1 4.ttK+44 1 8.tME+M I
............................... ................~............................
- -- See Note, page 4.0-16 1
g Units: Inhalation - arem/yr per uCi/m3 h Others - m2 mrem /yr per uCi/sec Quantum HCGS ODCM 4.0-11 Rev. 1, 11/05 l
f
/
/' %
! - Table 4.3-1 v
INFANT PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rg)
Page 3 of 3: Dose Factors for Composite Worst Organ ,
AGE Gil0UP ( IWMT ) ( N.A. ) ( IWMT ) ( IWMT 1 (IWMT)
I ISOTOPEI IINILATISI I ElllMO PullEl ERS/C0HlU(I GRS/ColufEATI WETAfl0M 1 11-131 1 1.484E*07 1 2.089E+07 1 1.675E+12 1 0.000E*00 1 0.000E+44 I 11-132 1 1.694E*05 1 1.465E+86 1 2.170E+02 1 0.000E*00 1 0.000E*tt I 11 13) 1 J.556E+06 1 2.981E+46 1 1.527E+10 1 0.000L+00 1 0.000E+04 I 11-134 1 4.452E*04 I 5.305E*t5 1 1.337E-09 1 0.000E+00 1 0.000E+H I 11-135 1 6.959E+05 1 2.947E*06 1 3.185E*07 1 0.000E+00 1 0.000E*t0 I 105-134 1 7.028E+05 1 8.007E+09 1 1.002E*11 1 0.000E*00 1 0.000E+H I 105-116 1 1.345E*05 1 1.702E*00 1 9.219E*09 1 0.000E*00 1 0.00 E+ H I 105-117 I 6.l!8E*05 1 1.201E+10 1 9.58)E*10 1 0.000E*00 1 0.00E+H I 1C5 138 I 8.764E*02 1 4.102E+05 I 3.468E-22 1 0.000E+00 1 0.000E+H I 194-119 I 5.096E*04 1 1.194E*05 1 4.572E-05 1 0.000E+00 1 0.000E+06 I 106140 1 1.596E*06 1 2.346E+07 1 1.835E+08 1 0.000E+00 1 0.000E+H I
[s) s,
194141 1 4.746E+ 0) 1 4.754E*t4 I 8.075E-44 1 0.00K+00 1 0.000E+04 i 104 142 1 1.554E+0) 1 5.044E+44 1 0.00E+00 1 0.000E+00 1 0.00E* H I ILA140 1 1.680E+05 1 2.180E*07 I 2.991E*05 1 0.000E*00 1 0.00E+H I ILA142 1 5.950E+04 1 9.122E*05 i 1.716E 05 1 0.000E*00 1 0.00E*00 I ICE-141 1 5.166E*05 1 1.540E+07 1 2.174E*07 1 0.000E*00 1 0.000E*00 I ICE-14) I 1.162E*05 1 2.627E+46 1 2.444E*06 1 0.000E*00 1 0.000E*00 I ICE-144 1 9.842E*06 I t.032E*t7 1 2.12)E*08 1 0.000E+00 1 0.00E+04 I IPlble) i 4.326E*05 1 0.00E*44 1 1.240E*06 1 0.00 E+00 1 0.000E*00 I IPil-144 1 4.244E+1) I 2.ll2E*0) i 1.863E-48 1 0.000E+00 1 0.000E*00 I 166-147 1 1.220E*05 1 1.009E+07 I 9.137E*05 1 0.000E*00 1 0.000E*04 I 13107 1 3.96M*t4 1 2.740E+46 I ).979E*06 1 0,000E+04 1 1.4HE*10 I IIP-719 I 5.99tt+44 1 1.97K+46 1 1.494E+45 1 0.00E*H I 0.tHE*H I
- -- See Note, .page 4.0-16 g Units: Inhalation - arem/yr per uci/m3 U Others - m2 mrem /yr per uCi/sec QuantumallCGS ODCH 4.0-12 Rev. 1, 11/05
/
m v)
\
t Table 4.3-2
- CHILD PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rig)
Page 1 of 3: Dose Factors for Composite Worst Organ I 150TOPfl IMeLAtlel 1 Gilon#G PLAlti GNS/Coli/filu(I GRS/Cill/fEAtl UEGETATION
......... .... . . ...... ..... . ...... ....... ..... ...I lH-3 1 1.129E+03 1 0.040E*00 1 1.551E+03 1 2.312E+02 1 3.959 I
...................................................... ............ ...E*03 IC-14 1 3.589E+04 1 0.000E+00 1 1.901E+09 I 6.100E*00 1 8.894E*M
.................................................................i INA-24 1 1.610E+04 1 1.305E+07 1 1.400E+07 1 2.744E-03 1 I
.......................................... ............ ......3.729E+05 IP.32 1 2.605E+06 1 0.000E*00 1 1.237E+11 1 1.179E+10 1 3.366E+
IER-51
...................... .. ............. 49 I 1 1.699E+04 1 5.506E+N I 8.588E*04 1 7.415E*05 1 6.213E+06
.......................6.....................................I 1 % 54 1 1.576E+N I 1.625E+49 I 3.336E+07 1 1.275E*07 I 6.640E*
1 % 56
..... .... .... . . .. ... . 00 t ..
1 1.232E+05 1 1.060E+06 1 2.966E+00 1 3.077E-51 1 2.723E+ 03 1 IFE-59 1 1.11E+05 1 0.00K+00 1 1.770E*00 1 7.273E*06 I 1
.. ..... .... ............... ........................ ........9.012E*00 ...........
IFE 50 1 1.269E*06 1 3.204E*00 1 3.221E*08 l 1.009E+09 I I
.. .............................. ........ ......... ...........6.693E+00 IE0-59 1 1.106E+06 1 4.464E*06 1 1.126E+00 1 1.527E*08 1 3.771E+
.....................................................................00 100-64 I
1 7.067E*06 1 2.532E+10 1 3.805E+09 I 6.105E*00 1 I
.. .... ....................... ....................... ........2.095E*09 INI-63 1 8.214E*05 1 0.000E*00 1 4.716E*10 1 4.633E+10 1 A ....... ................................................... .....3.949E*10 ...........l
/ INI-64 I 8.399E+04 1 3.451E+05 1 3.037E*01 1 6.460E-51 1 a ................ ................................ .. ............1.211E*03 . ........
I ICU-64 1 3.670E+04 1 6.876E+05 1 5.572E*06 1 2.216E 05 1 5. I 12449
..................................159E*05 .... .
I 9.993E*05 1 8.503E*00 1 1.752E+10 1 1.591E*09 1 1
............................ ... .................................2.164E+09 ......
12469 1 1.018E+04 1 0.000E*00 1 1.786E-09 1 0.000E*00 1 9.
................................... .................................993E-04 I
108-01 1 4.736E+02 1 7.079E+03 1 6.999E 01 1 1.514E-56 1 108-04
............................... 5.369E*00 ............ I 1 5.476E*02 1 2.36fE*05 1 1.035E-22 1 0.000E*00 1 1W-05
............. ............. .............................. 3.822E ........11. I 1 2.531E+01 1 0.00K+00 1 0.00K+00 1 0.00K+00 1 18606
.......... .. ............................... 0.00 ....... K+00 .. I 1 1.99)E*05 1 1.027E+07 1 1.395E+10 1 9.171E+08 I 4.
189 08
......................52 K+00 ......... I I 5.624E+02 1 3.779E+04 1 1.130E-44 1 0.000E+00 1 4. I
......................................................................374E.22 18609 I 3.452E*02 1 1.476E*09 1 2.222E-52 1 0.000E*00 1 4 198-99
...... ..... .......................... 695E 26 I 1 2.157E*06 1 2.509E*04 1 1.053E*10 1 7.661E+08 1 I
....................................................................3.593E*lo 158 90
.......... 1 1.0lE*00 1 0.00K+00 l 1.777E+11 1 1.654E*le i 1.243E*12 I
.... ~ ... _ .. .................................... .....
198-91 1 1.739E+05 1 2.511E*h I 4.579E+05 1 0.419E 10 1
..............................................................1.157t+N ...........
1 l
- -- See Note, page 4.0-16 g] Units: Inhalation - arem/yr per uci/m3 l
V Others -
m2 mrem /yr per uC1/sec :
l Quantum: HCGS ODCM 4.0-13 Rev. 1, 11/85
>-r m
\
U/ Table 4.3-2 ,
CHILD PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rg ))
l Page 2 of 3: Dose ~ Factors for Composite Worst Organ I 190TIFEl lleRATIGI I GIDise PUWEl GIS/CIN/filLXI GIS/CIN/fEATI IKEETATisti 1911-92 1 2.424+05 1 8.631E+05 1 6.577E+01 1 5.554E-48 1 1.379E*04 I lY.90 1 2.679E+05 1 5.300E+03 1 1.459E+06 1 7.76?E*05 1 6.569E*07 I lY-91M i 2.812E*03 1 1.161E+05 1 8.269E.16 1 0.000E+00 l 1.737E-05 I lY.91 1 2.627E*06 1 1.207E*06 I 8.272E+04 1 3.818E+08 1 2.484E+09 I lY-92 1 2.390E*05 1 2.142E*05 i 1.163E+01 1 1.10 4 -34 1 4.576E+64 I lY-93 I J.80SE+05 1 2.53E+05 1 2.502E*04 1 2.461E-07 1 4.482E*06 I 1211-95 1 2.231E*06 1 2.837E*06 1 1.390E*06 I 9.715E*06 I 8.843E+08 1 17A-97 I 3.511E*05 4 3.445E*86 I 6.680E+04 1 1.116E*00 1 1.240E*07 I 14 95 l 6.142E+05 l 1.65N+08 1 3.677E*06 1 3.621E+09 I 3.070E+08 1 IMO-99 1 1.354E+05 1 4.626E+06 1 2.76E*06 1 3.907E*05 1 1.647E+07 I ITC-99N I 4.810E*03 1 2.109E*05 1 2.345E+04 1 1.100E.17 1 5.255E+03 i (O
Vl ITC.101 1 5.846E*02 1 2.260E+04 1 3.054E-58 l 0.000E*00 1 2.414E-29 I 1810103 1 6.623E*05 1 1.265E*08 1 1.762E+05 1 6.379E*09 1 3.971E+08 1 1 5 105 I 9.953E+04 1 7.212E*t5 1 3.966E*00 1 9.36?E.25 1 5.981E*04 I 1110 106 1 1.432E+07 1 5.049E*08 1 2.286E+06 1 1.090E*ll l 1.159E*10 I 14G-110N I 5.476E*06 1 4.019E+09 1 2.669E*10 1 1.073E*09 I 2.581E+09 1 ITE.125M i 4.773E*05 1 2.120E*06 1 1.17E* 08 1 9.052E*00 1 3.506E*00 i ITE.127tli 1.400E*06 1 1.083E*05 I 9.437E*08 1 8.050E+09 1 3.769E*09 l 111 127 I 5.624E+04 1 3.293E+03 1 1.895E+05 1 2.557E-06 1 3.903E*05 I lit-129M i 1.761E+06 1 2.305E*07 1 1.264E*09 1 8.345E*09 1 2.460E*09 I ITE 129 1 2.549E+04 1 3.076E+44 I 9.809E-08 1 0.000E*00 1 7.204E-02 I ITE.131M i 3.078E+05 I 9.459E*06 1 3.570E*07 1 1.562E*04 1 2.161E*07 I ITE.131 1 2.054E*03 1 3.450E*t7 1 1.350E-31 1 0.000E+00 1 1.349E 14 I ITT-132 1 3.774E*05 1 4.969E+06 I 7.240E+07 1 1.484E*07 1 3 lllE*07 I 11 130 1 1.846E*04 1 6.692E*86 1 4.ll?E+00 1 1.075E-03 1 1.370E+08 I
)
- -- See Note, page 4.9-16 O
U Units: Inhalation - arem/yr per uCi/m3 Others - m2 mrem /yr per uCi/sec Quantum HCGS ODCM 4.0-14 Rev. 1, 11/05 i
(
l i
,V Table 4.3-2 CHILD PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rg ))*
Page 3 of 3: Dose Factors for Composite Worst Organ I ISOTOPEl (NNILAil0N I ElllDe PUIEl UlkColMilu(I ErkColMOTI UEGETAil0N I
..... ......... ....... . . . ..........~ .....................
11 131 1 1.62(+07 1 2.009E+07 1 6.994+11 1 0.755E*09 I 4.754+10 I 11 132 1 1.935E*05 1 1.465E*06 I 9.368E*01 1 1.421E-% 1 7.869E+03 I (
11 133 I 3.840E*06 1 2.941E*H I 6.276E+09 1 2.07E+02 1 8.113E+48 i 11 134 1 5.069E+04 1 5.305E+05 1 5.766E.10 I 0.00E+00 1 6.622E-03 I 11-136 1 7.91K+ 05 I 2.947E+M i 1.369E*07 1 1.653E 14 1 9.973E+H I 1r5 134 l 1.014E+06 I 8.00M+49 1 5.910E+10 l 2.40 4+09 1 2.631E+10 1 ICS-136 I 1.709E+05 1 1.702E+00 l 4.412E+09 1 7.041E+07 1 2.24K+49 I ICS-137 I 9.065E*04 1 1.201E*10 1 5.129E+10 1 2.122E*19 1 2.392E+14 I IC4130 1 9.399E*02 I 4.102E+49 I 9.794E-23 1 0.000E+00 1 9.133E.11 I 194139 I 5.772E*04 1 1.194E+05 1 1.959E-05 1 0.00K+00 1 2.95K+00 I 196-140 1 1.743E*06 1 2.346E+47 1 1.663E*00 1 6.975E*07 1 2.76?E*08 1 p') ...... ........................ .............................................
104 141 1 2.919E*03 1 4.75E+44 1 3.112E-45 1 0.000E*00 1 2.042E-21 i x"/ 196-142 1 1.643E*03 1 5.N E+44 1 0.00E*00 1 0.00K+00 1 4.105E-39 I ILA-let i 2.254+05 1 2.180E+07 I 3.01?E*05 I 8.73N+02 1 3.166E+07 I IL6142 1 7.585E*04 1 9.122E+05 1 8.278E.06 1 0.00E*00 1 2.141E+01 I IEE-141 1 5.43*E*05 I 1.54K+07 1 2.165E+07 1 2.19K+07 I 4.002E+00 I
, ICE.143 1 1.273E*05 1 2.627E+N I 2.360E*06 1 4.003E*02 1 1.364E*t7 I ICE.144 1 1.195E*07 I 8.032E*t7 1 2.11E*09 1 3.011E*06 1 1.039E*10 1 1 5 143 1 4.329E+05 1 0.00K+00.............................. 1 1.2)dE*06 1 5.742E*07 1 1.575E+48...... ....
i l IP8 144 1 1.%5E*03 1 2.11?E+t3 1 3.246E-50 1 0.00K+00 1 3.829E.23 i j .................. ........... .......... .................................
%-147 1 3.292E*05 l 1.009E*07 I 9.00M*05 1 2.394E+07 I 9.194+07 1 IW.167 I 9.102E+04 1 2.74E*H I 3.850E+06 I 4.4)9E+00 1 5.300E*W I l*.239 I 6.401E*t4 l 1.9?d+M i 1.454+05 1 3.551E+03 1 1.39 4 47 i
- -- see Note, page 4.0-16 hx'y Units: Inhalation - arem/yr per uCi/m3 Others - m2 mrem /yr per uci/aec Quantum HCGS ODCM 4.0-15 Rev. 1, 11/85
l I
'n NOTE: The R ij values of Tables 4.3-1 and 4.3-2 were calculated according to the methods of Reference 6, Section 5.3.
.The values used for the various parameters and the origins of those values are given above in Table 3.2-3, with the following exceptions:
- 1) Rather than being organ-specific, the ingestion ,
and inhalation dose conversion factors (DFL and DFA) were chosen for a composite worst organ.
That is, for each age group and radionuclide, the dose conversion factor used was the highest of any for that age group and radionuclide.
- 2) The ground plane dose factors (DFG) used were the higher of those given for the total body and the skin in the referenced table of Reg. Guide 1.109.
t These R i values are therefore conservative and are most appropriate for initial or rapid assessments.
1 O
Quantum HCGS ODCM 4.0-16 Rev. 1, 11/85
4.4 DOSE TO A MEMBER OF THE PUBLIC DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY f
In the event that the annual land use census or other informa- <
tion should indicate that individual members of the public may be inside the site boundary for more than a few hours !
each year, doses to such members of the public shall.be j calculated according to the methods of Sections 2.2 and 3.2.
f i
i l
l
! l k
i l
Quantum HCGS ODCM 4.0-17 Rev. 1, 11/85 l
1 (J
A, Section 5.e RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Technical Specification 3.12.1 states, in part:
The radiological environmental monitoring program shall be conducted as specified in (RETS) Table 3.12.1-1.
A description of the Radiological Environmental Monitoring Program i thus specified is presented in this section.
5.1 SAMPLING PROGRAM The radiological environmental monitoring program will
.; be conducted in accordance with Table 5.1-1 at the locations specified in Figures 5.1-1 and 5.1-2.
i NOTE: For the purpose of implementing Technical Specifi-cation 3.12.2, sampling locations will be modified as required to reflect the (indings of the Land Use Census.
1 J
4 6
!O 5.9-1 Rev. 1, 11/85 QuantumtHCGS ODCM i
,,- ,- ,m t
3 s
s v/
C C
f7 3 .
r' Esposuat Station Turt amo resousucv f* PaTemar coce Locattom cottsettom maTmoo or huatusts U
- 3. atascent
() (al P art S.S et a of went continuous low values air Crosa beta analyste on each weekly a sampler. Sample collected sample. Camme spectrometry shall y a 252 8.4 et nut of vent every week along with filter be performed it gross beta exceeds >
O f.),
g T change. ten times the yearly mean of H 2F2 4.7 et met of poet Control Stettee value. O I p e O Cross beta analysis performed > 24 O
U 3a38 118 et ut of Station g L hr. efter saapling to a!!Ow for sadon a 1sc1 3.9 mi SSe of west and Theson daughter activity decay. 29
- CC E 16El 4.1 et new of went Comes isotopic analysis on quarterly Z s composite. g m wn un
. 6 Oe a (b) I 1r1 S.S et u et vent a Ttca-lapregnated flow-through Iodine-131 analysis performed on g gy ch- co.1 c-trid,. . ..ch ..e u , .. a g; o 2,2 ... . t of ve.t 7
m . 2,2 ... . m.E .t o.at co.a.o to air ,-tic.lat. ~ z 2 3m39 110 et ut of Station sampler and is collected g [
m 1801 3.9 et Ssw of went weekly at filter change. M FW 8
2 16t1 4.1 et new of vent m gg O
3 Z H
n
- 11. SotL O S.a et a of went Sott easples taken in general Cassa spectroscopy on each sample A3 1r1 H 232 9.4 et uut of went accordance with procedures out- at time of collection. g 11aed in WaSL-300 (new. 5/73): O 231 4.4 et mut of went 2r1 5 et mmE of vent- 18 soit plegs to a depth of 6* Sr-98 analysts on one sample from m 2F2 9.7 si mME et went over en area of 25 ft2, compos- each location at time of collection. O 3G10 16.6 et ut of went ited and sealed in a plastic bag O 23 %
O 3m3e 11e si ut of Station at each location. a sample will y 4 '
- Sol 3.5 mi E of went be collected from each location p 1801 3.9 es S5W of went once every 3 years. It a mult-
' 4.1 mi umw of vent able sample cannot be obtained at 16t1 y a location, a sample sha!! be &b-H tanned from a new location. and N
CD mac shall be notitled in writing of the new sample locat10a.
O Centret Station
( -
.s Y LA I
o C
t*
3 6
C EEPOScat STATION TYPE AND FAtQUENCY
{3 P&Temat CODE LOCATToel CotttCTIOe atTWOD OF ANALYSIS
' 2 111. Drare?
I l (O ) trl 5.8 et u of went 2 TLD's collected from each Comma done quarterly 8 1G30 14.5 m1 m of west location quarterly.
lO 2s2 e.4 et met of went S
'S 3 281 4.4 et nut or went O.
r 2r2 a.7 al mut et went o l 2r5 7.4 at uut of went O .
l 2 1. 34 et - t o, v.at n .
351 l
4.1 et he of went h
3r2 5.1 et ut of vent l 3F3 8.6 et et of went , h 3G19 16.6 ma ut et went <
M 3 ale 32 et at of west U e-3 a'O gg 3 3. n. ei - e,went
,o, g 402 3.7 et East of sent 4 %H (TJ G 8 551 1.8 el e of went y z 501 3.5 et t of went I
O +
Sri S.8 et t et went eg t* H
.., . 2 et ot e, ve.t Gr1 6.4 o! Est et went O
! Z 751 S.12 mi SE of went M 7F2 9.1 o! st of vent 951 4.2 o! 3 of went ;U 1.s1 .. . mi n. ., went ;;;
1801 3.9 el Ssw of vent O Aer2 5.8 m1 Ssu of went 'O tog 1. n.. et .. ., vest g 1831 0.99 et su et went O N n t, 5.. . e, went ;
[ 11r1 5.2 et su or went 3 l 1281 4.4 et use of went
[ 12r1 9.4 mi usw of vent '
13t1 4.2 at u of went w
i w 13r1 9.8 o! u of went l g 13,, . 5 1 . e, v.at Ut 13r3 9.3 et W of vent t Centrol stettes
<m
\% kw/ l
+
C c
i) -
3 h
g SIPOSUSE Patuenar Sta?!Om coor Location COLLECTIOm atteOO TYPE AND FAEQUSNCY OF am& LYSIS 3 III. ClaECT O (coat'd) 1401 3.4 of usw of went 2 TLo's collected from each ceana does quarterly. 30 14F2 6.6 o! uses of vent location quarterly. >
g ISf3 S** "I "" *I '**E H C
O 16t! 4.1 et mens of went h g
1.,, .1. of t 16C10 14.8 et muu of vent M O
Iv. teaTEe ta (a) S 781 1 et u of ned sorse Two-gallon semple,to be collec. Comma isotopic analysis monthly, m O Crk.1 4.5 el se of vent ted monthly, providing winter .
Z R telag conditlose allow sample M F 1141
- 658 2t ses of veet collection. . N g
e . . ze y e ne2. 2.5 1 . = of .e.t
- g;
& E W Z
>3 tri 16r1 C&D Canal
- O >+
6.9 mi unt8 of vent M F t!i 3W
(.i . 2,3 m.ite rv.-,.11o. ,r .. 1. coll.c- .-> .m.1,.i. o. .ont.1,...,1.. g
. ted t.1y. o.1, if . em. 1. -
>3 0 3tte 4.1 at NE of went likely to be affected. Comme isotopic analysis on quarter 1, O O composite. N g
. z D
O m
W (c) 0 2r3 salee teater Co. traw); 58 at aliquot taken delly and Cross beta monthly. O a a mi mut of went compoetted into a monthly O
- E O I 2 galloa sample. Gamma isotopic analysis on >
3 a monthly composate.
p a
' M-3 on quarterly compoalte, I
w a W
\
CD Ut 8 Control Stataon
m s (~g w
C C
t) 1)
rv C
y sapos::st STATION TYPE AND FREQutNCY
., paTsuar cose Locattom coLLaction meTwoo or Analysts E
o v. aQuatre (3 8 7El 1 si is or ned norme Sample of benthic orgeaisas N Gamma $sotopic and 3r-98 analyses M E Crt.; . 5 et 58 of vent and associated mediment, taken on each sentamanal sample, >
g . . ....a u ,. -
g 0 T 1141
- 454 ft Su of west 0 3 t"'
. O o 12:18 2.5 mi WSu et went O M
ta fr3 v1. IncesTross %
(a) n 2F4 6.3 at uut of west Four-gallom grab sample of Gamma isotopic and Iodine-131 4
M
,UI i
L x10 Se2 1... .i .. .t .e.t 7.8 el a of went
, re.. .u co u.m ed .i.ont i, when cows are on pasture, 1, . o. ...pl.. o. ; gg collection. d). 2 O' 5,
. In> ... .i . or .e.t . 1, .t ot..r u ..
- g;r 14,1 s.s .i - .t .e.t = Z
. n v.
O >+
(b) r 1141 outtell area; N 1
- 655 ft Se of went Two key samples of tien sealed in pleetic bag or jar and comme isotopic analysis on edible Py portion, on collection. Ut 3 6-*
3
. uc18 .est ..... o,,os u .
trases, seelannually or when in
.e..o..
h Artificial Island; R O
2.5 m1 wSu of went 3 M
Z (b) C 1141 outtall area; Two key samples of crab sealed Comme isotopic analysis on edible a
- e.58 ft SW et w'est in plastic bag or jar and portion, on collection. T a frozen, semiannually or when ta w O
3 a 12C18 west Sant, opposite season, O O y Artificial ! stand; >
e 2.5 mi WSu et went 3
=
N M
8 Contre! Stattee N
CD Un
ch # D i
\ \
D t
O
'. t; I fe 1 3 tv C
h asFoSuat PaTamar STkTION coot TYPE AND FREQutuCY g Locations coLLtcTIces atTuoo or amatusts VI. rectsTrou gg (cont'd) ,
0 0 C3 (d) FRUITS 1G10 g
15.2 mi N of went Samples collected during normal Radio!Odine determination on green ca O
normal harvest season, sealed leafy vegetables, on collection.
.t tT._
2t1 ... .! ..t of .e.t i. ,1.. tic, .nd ,ro... if if an, ar.. i. irriget.d ., w.t.t c3 Tions perishable. Sufficient sample into which plaat liquid wastes 2F1 S.O et Isms of veet co!!ected to yield See grams have been discharged. >
l of dry weight.
Gamma isotopic analysis on j Q
, collection, if any area is irrigated <
by water into which plant 11guld g g l
- Lft w..to. h..e en di.cha,g.d. ., O o,
- C Z t7 e
t 2-l f (e) c sas Station vicinity, mostrate skinned and Gamma isotopic analysis on edible l @ & E side of eetmary frozen seelannually. portion (only), upon collection.
]8 Hm
, O >*
E anst
'TJ t" H u side of estuary, 8 3 - S et froe went O
Z sus H withis le mi of Seef portion of cow sempted and 8 Station frozen seelannually, subject to availability of slaughtered cow. M Z
. o
- 13 lI3 e control station JO ses - Location to be given at time of collection.
8 0 :x2 i
e E N
m M
N N
CD Un
-6 *-
eem eu*ee he. >ww- e upe - p w pe__ m- e
/ >
\ / Figure 5.1-1 ONSITE SAMPLING LOCATIONS ARTIFICIAL ISLAND
/ , ' ,
l- l a
b
, r I > I
\
- )
. l O, f '
l 6
\ s I-
- a d.Y_y 5
pe
\f A .:
l! Allow ,\
y s'
- g Q SS ' 3 ** 152( ,
6 yI '
% a . l4 Y t4R 4g 53 r Y e 451 3
13 51 2
N ll 7 '
\
10 ,
\
! \
n
~
QuantumtllCGS ODCM 5.0-7 Rev. 1, 11/85
1 1
I Q
k/
I Figure 5.1-2 )
OFFSITE SAMPLING LOCATIONS l ARTIFICIAL ISLAND w.gf @ ** ge.
G 1 S.
16
\Y J
e(** M ,
j ,
e.t a. "
\
3 f 15
- '" ~
L l 6 ,
4 i "
r _, @ .
1 34 .
4
)
@us gun,
- a e P
,, N e.os A
f.88 .,s 5 13 maastome J **' 3 4,
2 .,
/ %. e I
""e, , , , " * 'e, ,.
,si 6 l 12 ,,
I i
..) (
g-. ,,,
I
%,+ '
\
1 p
, k I
.it . .
, _ kd...e..i.a..&.
l L g $ L". T. O "J"a" %
e O
Quantum HCGS ODCM S.0-8 Rev. 1, 11/85 l
F
!}
'N 5.2 INTERLABORATORY COMPARISON PROGRAM Technical Specification 3.12.3 states, in part:
Analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program that has been approved by the Commission. ;
Participation in an approved Interlaboratory Comparison Program ensures that an independent check on the precision and accuracy of the measurements of radioactive materials :
i'n environmental sample matrices is performed. This check is performed as part of the QA program for environmental monitoring in order to demonstrate that the results are valid for the purpose of Section IV.B.2 of Appendix I to 10CFR50.
A summary of the Interlaboratory. Comparison Program results obtained is required to be included in the Annual Radiological Environmental Operating Report pursuant to Technical Speci-fication 6.9.1.11.
I l
i i
I I
l O l Quantum HCGS ODCM 5.0-9 Rev. 1, 11/85
]